Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024139	s-igg3	g/l (g/l)	3070	4169	0.00%
3024139	s-igg3	— (—)	1398	1857	100.00%	Distribution not available
3024139	s-immunoglobuliinig,alaluokka3	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Undetermined asthma

292

213

14.35

317.62

1.7

1.2

0.35

0.43

g/l

2.17

216

140

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1324

2822

3.35

316.97

1.4

0.39

0.40

g/l

0.48

961

1924

Acute pancreatitis (for exclusion)

459

635

7.58

314.85

1.6

1.3

0.41

0.42

g/l

0.04

210

464

Inflammatory bowel disease treatment related agents

1995

2063

5.62

307.65

1.5

1.2

0.38

0.42

g/l

2.28

1425

1392

Asthma (only as main-diagnosis)

1224

1035

7.30

307.65

1.5

1.3

0.36

0.41

g/l

1.79

902

647

Pneumonia, organism unspecified

1244

2549

3.59

307.65

1.4

0.39

0.41

g/l

0.57

905

1725

Undetermined asthma, excluding more controls

292

206

14.84

307.65

1.7

1.2

0.35

0.42

g/l

1.68

216

136

First line medication for Crohn's disease

1818

1841

5.50

307.65

1.5

1.2

0.38

0.42

g/l

3.61

1296

1239

Asthma

1280

1035

6.77

307.65

1.5

1.3

0.37

0.41

g/l

1.59

947

647

Asthma, unspecified (mode)

749

922

6.57

307.65

1.5

1.3

0.38

0.41

g/l

0.53

528

585

Systemic connective tissue disorders

676

1190

5.88

307.65

1.7

1.3

0.38

0.42

g/l

1.26

492

816

907

1550

6.00

307.65

1.5

1.3

0.35

0.41

g/l

4.38

691

1063

Acute pancreatitis

459

558

8.63

307.65

1.6

1.3

0.41

g/l

0.04

210

412

Oral corticosteroids

1973

1961

6.24

307.65

1.5

1.2

0.38

0.42

g/l

2.15

1412

1317

Certain disorders involving the immune mechanism

567

679

8.89

307.65

1.9

1.3

0.31

0.42

g/l

6.69

425

472

Immunodeficiencies

350

140

30.69

307.65

2.0

1.3

0.27

0.39

g/l

3.02

283

Asthma (only as main-diagnosis), excluding more controls

1216

992

7.47

307.65

1.5

1.3

0.36

0.40

g/l

1.23

895

623

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

959

2002

4.54

307.65

1.5

1.3

0.43

0.40

g/l

1.03

685

1378

Immunodeficiency with predominantly antibody defects

275

53.90

307.65

2.1

1.3

0.25

0.39

g/l

2.13

229

All pneumoniae

1361

2838

3.36

307.65

1.4

0.39

0.40

g/l

0.33

987

1932

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1278

1872

4.35

307.65

1.4

1.3

0.40

0.42

g/l

1.02

932

1239

Pneumonias (Asthma/COPD co-morbidities)

1356

2825

3.38

307.65

1.4

0.39

0.40

g/l

0.25

984

1925

Asthma, including avohilmo

1535

2808

3.22

307.65

1.5

1.3

0.38

0.42

g/l

2.18

1132

1894

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1354

2777

3.55

307.65

1.5

1.3

0.38

0.41

g/l

1.88

976

1935

Influenza and pneumonia

1431

2805

3.41

307.65

1.4

1.3

0.39

0.41

g/l

0.55

1043

1909

Asthma, hospital admission 2, infections

1096

2026

5.47

307.65

1.5

1.3

0.36

0.42

g/l

4.78

831

1394

Asthma, hospital admissions , main diagnosis only

1266

2926

3.95

307.65

1.5

1.3

0.37

0.42

g/l

3.06

939

2006

Bronchiectasis

267

150

19.43

307.65

1.4

1.3

0.40

0.43

g/l

0.41

200

104

ILD medications: immunosuppressive drugs

1029

1601

6.32

307.65

1.6

1.2

0.40

0.42

g/l

0.70

735

1077

Asthma, hospital admissions 3, pneumonia

682

1073

6.56

307.65

1.4

1.3

0.38

0.44

g/l

3.57

521

733

Asthma (mode)

1239

1039

6.68

307.65

1.5

1.3

0.37

0.41

g/l

1.65

920

650

Asthma-related infections

1096

2026

5.47

307.65

1.5

1.3

0.36

0.42

g/l

4.78

831

1394

Asthma, unspecified (mode), excluding more controls

746

887

6.74

307.65

1.5

1.3

0.38

0.40

g/l

0.30

525

565

Chronic sinusitis

758

1469

5.30

307.65

1.5

1.3

0.35

0.44

g/l

5.82

574

979

1278

1872

4.35

307.65

1.4

1.3

0.40

0.42

g/l

1.02

932

1239

Asthma-related pneumonia or sepsis

682

1073

6.56

307.65

1.4

1.3

0.38

0.44

g/l

3.57

521

733

Fever of other and unknown origin

892

1683

5.03

307.65

1.4

1.3

0.39

0.42

g/l

1.20

636

1169

Asthma, excluding more controls

1260

992

6.92

307.65

1.5

1.3

0.37

0.40

g/l

1.01

928

623

Asthma (diagnoses ohter than nonallergic)

1334

2880

4.04

307.65

1.5

1.3

0.37

0.42

g/l

3.27

988

1975

ILD medications

1943

1868

5.83

307.65

1.5

1.2

0.38

0.42

g/l

3.01

1393

1246

Asthma-related pneumonia

680

1068

6.57

307.65

1.4

1.3

0.38

0.44

g/l

3.57

519

731

ILD medications: prednisolone, methylprednisolone, prednisone

1933

1821

6.14

307.65

1.5

1.2

0.38

0.42

g/l

3.66

1388

1212

Abnormal findings on diagnostic imaging of lung

751

1394

5.39

307.65

1.4

1.3

0.43

0.41

g/l

0.42

554

963

Chronic lower respiratory diseases

1612

2636

3.36

307.65

1.4

1.3

0.39

0.41

g/l

0.60

1191

1767

Asthma/COPD (KELA code 203)

1241

2620

3.39

303.05

1.5

1.3

0.38

0.41

g/l

1.01

926

1756

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

291

128

17.62

288.68

1.5

1.3

0.48

0.45

g/l

0.28

202

Other systemic involvement of connective tissue (FG)

473

748

6.49

282.78

1.8

1.3

0.38

0.41

g/l

0.68

348

510

Second line medication for Crohn's disease

855

2272

3.84

277.39

1.6

1.3

0.40

g/l

0.00

609

1588

L04AX Other immunosuppressants

834

2217

3.84

270.48

1.6

1.3

0.40

g/l

0.10

598

1542

Autoimmune diseases related-to ILD

1086

2977

3.26

265.99

1.4

0.39

0.40

g/l

0.50

744

2084

Other pulmonary diagnosis

891

1045

4.32

264.22

1.3

0.39

0.41

g/l

0.63

626

654

Excluding asthma or asthma-COPD overlap

889

1045

4.31

262.95

1.3

0.39

0.41

g/l

0.49

622

654

ILD differential diagnosis

884

1039

4.31

261.47

1.3

0.39

0.41

g/l

0.49

619

650

COPD differential diagnosis

884

1040

4.31

261.20

1.3

0.39

0.41

g/l

0.50

620

650

Other systemic involvement of connective tissue

489

878

5.75

259.16

1.8

1.3

0.38

0.39

g/l

0.40

359

606

COPD/asthma/ILD related infections

1215

1874

3.29

251.86

1.4

1.3

0.39

0.42

g/l

1.78

879

1240

COPD/asthma related infections

1215

1874

3.29

251.86

1.4

1.3

0.39

0.42

g/l

1.78

879

1240

Abnormalities of breathing

1114

2028

3.31

248.23

1.4

1.3

0.40

0.41

g/l

0.14

796

1361

Cough

590

1229

4.71

247.31

1.4

1.3

0.36

0.42

g/l

3.06

449

829

Asthma and opportunity respiratory infection

186

21.71

243.50

1.4

1.3

0.37

0.44

g/l

0.73

134

Allergic asthma (mode), excluding more controls

355

480

7.42

241.23

1.5

1.3

0.34

0.39

g/l

1.75

286

303

Other and unspecified immunodeficiencies with predominantly antibody defects

142

56.13

240.63

2.2

1.4

0.24

0.33

g/l

1.01

117

Allergic asthma (mode)

355

491

7.26

236.44

1.5

1.3

0.34

0.39

g/l

2.13

286

310

Acute sinusitis

752

1878

3.80

236.40

1.5

1.3

0.37

0.41

g/l

2.23

569

1273

Other respiratory diseases principally affecting the interstitium

332

453

7.63

230.34

1.4

1.3

0.47

0.41

g/l

1.36

231

315

1281

2339

2.92

225.42

1.4

1.3

0.39

0.43

g/l

1.71

942

1564

Autoimmune diseases excluding thyroid diseases

1256

2411

2.93

224.85

1.4

1.3

0.43

0.39

g/l

1.65

889

1676

Disorders of gallbladder, biliary tract and pancreas

1166

2574

2.96

222.91

1.5

1.3

0.43

0.40

g/l

0.76

695

1912

Any gastric operation

932

1305

3.62

222.43

1.4

1.2

0.40

0.38

g/l

1.05

616

1020

GASTRO-related operations

932

1305

3.62

222.43

1.4

1.2

0.40

0.38

g/l

1.05

616

1020

Other interstitial pulmonary diseases

297

373

8.33

221.52

1.4

1.3

0.50

0.41

g/l

2.12

205

257

Non-allergic asthma (mode), excluding more controls

288

343

8.53

220.75

1.5

1.2

0.39

0.40

g/l

0.28

216

223

Interstitial lung disease endpoints

297

377

8.24

219.56

1.4

1.3

0.50

0.41

g/l

2.27

205

260

Interstitial lung disease

297

377

8.24

219.56

1.4

1.3

0.50

0.41

g/l

2.27

205

260

ILD, hospital admissions

295

372

8.30

219.32

1.4

1.3

0.49

0.41

g/l

2.09

203

259

ILD, hospital admission 2, with pulmonary infections

207

161

13.55

217.32

1.4

0.46

0.47

g/l

0.10

143

115

ILD medications: azathioprine

290

365

8.25

215.54

1.7

1.2

0.43

0.42

g/l

0.14

204

252

General symptoms and signs

1267

2221

2.89

214.58

1.4

1.3

0.38

0.41

g/l

1.86

907

1519

Autoimmune diseases excluding thyroid diseases, strict definition

1205

2335

2.91

214.00

1.4

1.3

0.43

0.39

g/l

1.51

859

1633

Non-allergic asthma (mode)

288

357

8.20

213.64

1.5

1.2

0.39

0.41

g/l

0.49

216

230

Reimbursement for rheumatic diseases

773

2316

3.39

208.20

1.5

1.4

0.44

0.40

g/l

0.98

564

1613

Azathioprine

290

382

7.88

207.37

1.7

1.2

0.43

0.42

g/l

0.24

204

263

Bacterial pneumonia (organism specified)

579

1290

4.17

205.03

1.4

0.39

0.43

g/l

1.27

416

882

ILD, hospital admissions 1, main diag only

267

324

8.64

205.00

1.4

1.3

0.49

0.41

g/l

1.85

185

228

Bacterial pneumoniae

531

1081

4.43

201.91

1.4

0.39

0.43

g/l

1.30

386

730

ILD, hospital admissions 3, with pneumonia sepsis

183

146

13.25

189.31

1.2

1.3

0.47

0.46

g/l

0.08

126

Chronic rhinitis, nasopharyngitis and pharyngitis

465

1047

4.55

189.05

1.4

0.36

0.42

g/l

2.63

374

706

Symptoms and signs involving the circulatory and respiratory systems

1145

2043

2.84

188.30

1.4

1.3

0.38

0.41

g/l

1.98

819

1367

Bacterial pneumonia, not elsewhere classified

497

1026

4.37

185.62

1.3

0.40

0.43

g/l

0.90

359

691

Obesity related asthma

470

1093

4.40

183.42

1.4

1.3

0.39

0.43

g/l

0.52

331

727

Bronchitis

1186

3024

2.60

180.39

1.4

1.3

0.38

0.42

g/l

1.90

867

2067

Other acute lower respiratory infections

682

2032

3.25

170.57

1.5

1.4

0.38

0.41

g/l

1.01

503

1404

Nonhereditary hypogammaglobulinemia

101

52.80

170.45

2.3

1.3

0.23

0.34

g/l

1.41

Chronic pancreatitis

241

323

7.79

170.10

1.9

1.2

0.43

0.40

g/l

0.27

122

240

Acute upper respiratory infections

1127

2747

2.60

168.98

1.4

1.3

0.38

0.42

g/l

2.80

831

1866

Dyspnoea

980

2847

2.67

163.33

1.4

0.40

0.41

g/l

0.24

695

1998

Autoimmune diseases

1194

2422

2.54

161.32

1.4

1.3

0.42

0.39

g/l

1.31

837

1685

Used for control exclusion in common control thyroid runs

1128

2214

2.61

159.80

1.4

1.3

0.41

0.39

g/l

0.71

772

1561

Examination and observation for other reasons

690

1274

3.33

157.39

1.5

1.3

0.41

0.42

g/l

0.35

587

748

Bacterial infection, other or unspecified

587

1577

3.41

156.07

1.4

0.40

0.42

g/l

0.57

419

1086

Asthma and allergy, excluding more controls

212

265

8.11

155.72

1.5

1.3

0.33

0.38

g/l

1.19

175

176

Asthma and allergy

212

269

7.99

153.77

1.5

1.2

0.33

0.39

g/l

1.49

175

173

Diseases of the respiratory system

621

856

3.67

151.15

1.4

1.3

0.39

0.42

g/l

0.91

435

537

Acute bronchitis

518

1451

3.56

150.17

1.5

1.3

0.38

0.42

g/l

1.05

384

1004

Kela reimbursement Agammaglobulinemia (D80-84)

62.03

148.43

2.2

1.4

0.25

0.38

g/l

0.93

Other bacterial diseases

1004

2759

2.54

148.41

1.4

0.41

0.40

g/l

0.18

708

1917

Pain in joint

648

1328

3.27

147.75

1.4

0.37

0.43

g/l

2.65

476

890

Enlarged lymph nodes

264

456

5.97

145.90

1.5

1.2

0.42

g/l

0.08

192

320

Other diseases of pleura

502

1265

3.58

142.73

1.5

1.4

0.40

0.43

g/l

1.03

347

870

Any reimbursement code in KELA

651

974

3.38

141.60

1.4

1.3

0.38

0.39

g/l

0.29

453

675

Cholangitis (primary sclerosing, PSC)

144

125

12.20

141.36

1.8

1.2

0.43

0.40

g/l

0.21

Suggestive for eosinophilic asthma

188

237

8.31

139.96

1.9

1.3

0.30

0.41

g/l

3.46

146

160

Acute upper respiratory infections of multiple and unspecified sites

805

2256

2.70

137.15

1.4

1.3

0.37

0.42

g/l

2.40

591

1536

Other diseases of biliary tract

161

171

9.84

137.11

2.1

1.3

0.46

0.43

g/l

0.24

128

Septicaemia

456

1225

3.64

136.19

1.4

1.3

0.42

0.43

g/l

0.03

322

858

Other necrotizing vasculopathies

159

170

9.88

135.05

1.4

0.35

0.41

g/l

0.92

114

124

Other diseases of upper respiratory tract

1101

2404

2.41

134.52

1.4

1.3

0.38

0.43

g/l

2.55

806

1603

Anaemias

341

462

5.00

134.44

1.4

1.3

0.39

0.41

g/l

0.36

239

340

Tramadol

826

1993

2.69

134.01

1.4

0.40

0.41

g/l

0.11

593

1377

Other specified/unspecified systemic involvement of connective tissue

154

160

10.25

133.80

2.4

1.4

0.39

g/l

0.00

124

109

Finngen Rheumatological endpoints

1023

2406

2.45

132.61

1.5

1.3

0.40

g/l

0.06

732

1639

FESS (DNB20)

250

454

5.73

131.50

1.7

1.4

0.36

0.41

g/l

1.36

181

310

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

161

181

9.33

131.45

1.7

1.4

0.48

0.42

g/l

0.70

108

124

Early onset COPD, excluding more controls

217

341

6.48

131.44

1.6

1.3

0.41

0.44

g/l

0.48

155

221

Gastrointestinal diseases

629

971

3.28

130.67

1.5

1.3

0.39

0.40

g/l

0.34

433

716

Ethmoidectomy

255

477

5.56

129.85

1.7

1.4

0.36

0.41

g/l

1.44

185

330

Diseases of oesophagus, stomach and duodenum

1090

2879

2.32

128.39

1.4

0.41

0.40

g/l

0.06

782

1992

Other necrotizing vasculopathies (FG)

137

128

11.31

128.09

1.5

1.3

0.36

0.44

g/l

0.94

Explicit Sepsis

478

1378

3.38

127.39

1.4

1.3

0.42

g/l

0.10

340

962

Pain in throat and chest

819

1912

2.64

126.52

1.4

1.3

0.37

0.41

g/l

1.73

600

1277

Diseases of liver

426

1206

3.60

126.31

1.3

1.4

0.52

0.40

g/l

1.98

275

847

Abnormal findings on examination of blood, without diagnosis

515

1550

3.16

122.21

1.6

1.4

0.44

0.42

g/l

0.42

363

1064

Other septicaemia

397

1074

3.69

121.68

1.4

0.43

g/l

0.02

285

757

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

550

1818

3.00

121.17

1.4

1.3

0.37

0.42

g/l

2.60

382

1205

Headache

652

1992

2.76

119.39

1.5

1.3

0.39

0.42

g/l

0.69

480

1379

Bacterial Sepsis

464

1262

3.32

118.09

1.4

0.42

0.43

g/l

0.16

329

868

Codeine

945

2207

2.37

113.81

1.4

0.37

0.41

g/l

2.41

657

1529

Certain infectious and parasitic diseases

988

2124

2.35

113.12

1.4

1.3

0.38

0.42

g/l

1.53

683

1455

Opioids

990

2257

2.32

112.18

1.4

0.38

0.41

g/l

1.80

687

1559

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

353

396

4.51

110.61

1.3

0.36

0.41

g/l

1.73

245

254

Medical observation and evaluation for suspected diseases and conditions

687

1277

2.78

110.34

1.5

1.3

0.38

0.42

g/l

1.65

530

751

Polyarthropathies

712

1843

2.60

109.39

1.4

0.42

0.41

g/l

0.17

523

1265

Other diseases of pancreas

136

156

9.11

109.28

1.7

1.3

0.43

0.41

g/l

0.19

112

Vasomotor and allergic rhinitis

433

1338

3.23

108.60

1.5

1.3

0.36

0.41

g/l

2.35

344

893

Other and unspecified dermatitis

555

2007

2.80

108.45

1.5

1.4

0.40

0.41

g/l

0.29

399

1410

Dermatitis

636

2479

2.60

107.03

1.5

1.4

0.40

0.41

g/l

0.37

457

1751

Other immunodeficiencies

27.39

106.56

2.3

1.3

0.31

0.38

g/l

0.66

Other soft tissue disorders, not elsewhere classified

912

2489

2.28

104.20

1.4

1.3

0.38

0.40

g/l

0.68

669

1696

Parasetamol

792

1635

2.49

103.44

1.4

1.3

0.39

g/l

0.02

559

1077

Infections, IBD-co-morbidities

199

233

6.34

103.43

1.6

1.2

0.38

0.39

g/l

0.18

139

157

Other specific joint derangements/joint disorders

758

2107

2.44

102.01

1.3

1.4

0.38

0.40

g/l

0.99

552

1446

Mixed connective tissue disease

143

194

7.76

100.21

1.8

1.5

0.39

g/l

0.05

113

131

Implicit bacterial Sepsis

384

1071

3.33

99.42

1.4

0.43

0.44

g/l

0.13

274

744

Symptoms and signs involving the digestive system and abdomen

963

2177

2.23

98.70

1.4

1.3

0.39

0.42

g/l

1.39

655

1529

L04AA Selective immunosuppressants

312

860

3.72

96.65

1.5

1.3

0.39

0.40

g/l

0.14

230

599

Sicca syndrome [Sjögren]

159

251

6.60

96.65

1.6

1.4

0.40

0.39

g/l

0.08

104

179

Abdominal and pelvic pain

949

2176

2.21

94.92

1.4

1.3

0.38

0.42

g/l

1.82

644

1528

Gastro-oesophageal reflux disease

662

2439

2.43

94.60

1.4

0.37

0.41

g/l

1.57

462

1692

Primary_lymphoid and hematopoietic malignant neoplasms

290

772

3.83

94.31

1.4

0.32

0.42

g/l

5.26

205

548

Malaise and fatigue

449

1280

2.96

93.00

1.3

0.36

0.43

g/l

3.92

325

894

Other diseases of intestines

1036

2920

2.08

92.79

1.4

1.3

0.39

0.40

g/l

0.20

744

2025

Primary_lymphoid and hematopoietic malignant neoplasms

290

782

3.79

92.66

1.4

0.32

0.43

g/l

5.86

205

550

Adrenocortical insufficiency

10.96

89.88

1.7

1.4

0.41

0.38

g/l

0.17

Codeine or tramadol medication

1068

2942

2.03

88.32

1.4

0.37

0.42

g/l

3.59

739

2038

Low back pain

698

2338

2.32

87.47

1.5

1.3

0.39

0.41

g/l

0.52

498

1585

Dermatitis and eczema

1024

3354

2.02

87.26

1.4

1.3

0.39

0.41

g/l

0.67

729

2322

Implicit Sepsis

671

2235

2.36

87.21

1.4

0.41

g/l

0.03

464

1547

Other disorders of adrenal gland

111

133

8.86

86.51

1.6

1.4

0.41

0.37

g/l

0.35

Noninfective enteritis and colitis

510

1987

2.60

85.91

1.3

1.4

0.38

0.40

g/l

0.69

342

1405

Nasal polyp

235

576

4.16

85.85

1.7

1.3

0.34

0.45

g/l

4.53

192

385

Other diseases of blood and blood-forming organs, wide

285

815

3.57

83.56

1.4

0.41

g/l

0.03

191

572

Exclusions for E4_PCOS_BROAD

256

683

3.84

83.22

1.5

1.4

0.37

0.39

g/l

0.33

125

507

Other special examinations and investigations of persons without complaint or reported diagnosis

628

1277

2.51

83.05

1.4

1.3

0.40

0.42

g/l

0.36

452

751

Haemorrhage from respiratory passages

304

839

3.40

81.87

1.4

1.3

0.44

g/l

0.14

213

556

Drug-induced adrenocortical insufficiency

17.20

80.65

1.9

1.4

0.35

0.31

g/l

0.31

Heart failure, not strict

674

2043

2.30

80.35

1.5

1.4

0.45

0.40

g/l

1.11

472

1407

Vocal cord dysfunction

165

296

5.28

78.75

1.7

1.2

0.35

0.43

g/l

2.13

110

198

Other disorders of white blood cells

110

146

7.90

78.56

1.4

0.42

0.39

g/l

0.29

102

Dorsalgia

915

2437

2.05

77.60

1.4

1.3

0.38

0.41

g/l

1.74

647

1650

Diagnoses used for exclusion with ILD

289

874

3.36

77.52

1.4

1.3

0.38

0.43

g/l

1.42

196

623

Diseases of the skin and subcutaneous tissue

942

2334

2.04

77.23

1.4

1.3

0.40

g/l

0.08

653

1587

Budesonide

154

292

5.38

77.04

1.4

1.2

0.44

0.43

g/l

0.11

103

196

All influenza

264

759

3.53

76.59

1.5

1.3

0.36

0.42

g/l

2.16

197

530

Neurological diseases

848

2037

2.11

76.22

1.3

1.4

0.38

0.41

g/l

1.89

581

1438

Idiopathic pulmonary fibrosis

107

142

7.80

76.19

1.4

1.2

0.54

0.40

g/l

1.97

103

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

126

200

6.53

76.16

1.5

1.4

0.41

g/l

0.02

141

Disorders of other endocrine glands

461

1787

2.57

75.91

1.5

1.3

0.36

0.40

g/l

1.45

266

1281

Viral Sepsis

225

588

3.90

75.30

1.4

0.39

0.41

g/l

0.15

162

419

Implicit viral Sepsis

224

585

3.91

75.03

1.4

0.39

0.41

g/l

0.16

161

416

Disorders of lacrimal system

423

1611

2.66

74.97

1.5

1.4

0.39

0.41

g/l

0.41

294

1123

Diseases of salivary glands

241

664

3.70

74.72

1.6

1.3

0.40

0.43

g/l

0.44

162

444

Nausea and vomiting

272

795

3.41

74.59

1.4

1.3

0.38

0.43

g/l

1.04

200

572

Cholelithiasis, broad definition with cholecystitis

724

2318

2.16

74.46

1.4

1.3

0.44

0.40

g/l

0.84

461

1723

Oedema, not elsewhere classified

282

855

3.32

74.45

1.6

1.3

0.38

0.44

g/l

1.88

210

593

Neurological diseases, wide definition

321

463

3.51

74.11

1.4

1.2

0.39

0.37

g/l

0.32

219

319

Cardiovascular diseases

646

1534

2.31

73.73

1.4

1.3

0.37

0.38

g/l

0.44

440

1099

General examination and investigation of persons without complaint and reported diagnosis

579

1277

2.43

73.16

1.4

1.3

0.36

0.42

g/l

2.94

482

751

Respiratory disorders in diseases classified elsewhere

18.28

73.11

1.9

1.3

0.34

0.38

g/l

0.20

Unspecified acute lower respiratory infection

198

485

4.18

72.55

1.5

1.4

0.38

0.41

g/l

0.65

149

333

Other diseases of the respiratory system

220

581

3.86

72.51

1.4

1.3

0.34

0.43

g/l

3.09

154

413

Other respiratory disorders and diseases

220

581

3.86

72.51

1.4

1.3

0.34

0.43

g/l

3.09

154

413

Sulfasalazine

252

728

3.50

72.51

1.4

1.2

0.39

0.43

g/l

0.80

175

487

Other disorders involving the immune mechanism, not elsewhere classified

10.69

72.44

2.5

1.3

0.39

0.40

g/l

0.06

Wegener granulomatosis

18.05

72.05

1.7

1.4

0.35

g/l

0.03

Osteoporosis

248

676

3.56

71.77

1.5

1.3

0.37

0.43

g/l

1.38

176

462

Eosinophilic disease (BM)

23.28

71.69

1.6

1.2

0.45

0.61

g/l

0.59

Other heart diseases

508

1363

2.49

71.41

1.4

1.3

0.42

0.39

g/l

0.47

362

963

Pain in limb

699

2391

2.13

70.62

1.4

1.3

0.41

0.40

g/l

0.16

512

1638

Other disorders of lacrimal gland

359

1300

2.80

70.33

1.6

1.3

0.40

0.41

g/l

0.25

249

901

Oxycodone

319

1047

2.98

69.75

1.5

1.4

0.39

0.44

g/l

1.70

220

731

Other arthritis (FG)

313

1059

3.00

69.42

1.4

1.3

0.42

0.41

g/l

0.12

228

715

Irritable bowel syndrome

307

1029

3.03

69.29

1.5

1.4

0.34

0.39

g/l

2.15

216

698

Other inflammatory liver diseases

113

178

6.60

68.88

1.3

1.4

0.52

0.34

g/l

3.32

122

Pneumonia due to other infectious organisms, not elsewhere classified

11.37

67.54

1.4

1.3

0.39

g/l

0.01

Pain (limb, back, neck, head abdominally)

635

1416

2.26

67.38

1.4

0.39

0.42

g/l

1.15

453

951

Cardiovascular diseases (excluding rheumatic etc)

662

1766

2.18

67.17

1.4

1.3

0.37

0.39

g/l

0.51

442

1257

Lower back pain or/and sciatica

904

3311

1.91

66.73

1.4

0.40

g/l

0.00

649

2280

COPD

346

1016

2.84

66.69

1.4

1.3

0.47

0.44

g/l

0.60

251

667

Episodal and paroxysmal disorders

1003

2762

1.87

65.29

1.4

0.38

0.41

g/l

1.23

678

1951

Aplastic and other anaemias

383

1402

2.62

65.28

1.4

0.44

0.42

g/l

0.35

243

988

Other chronic obstructive pulmonary disease

331

969

2.87

65.25

1.4

1.3

0.47

0.44

g/l

0.68

240

637

Cholelithiasis

678

2289

2.09

65.02

1.4

1.3

0.44

0.40

g/l

0.79

431

1702

Other heart diseases, wide

858

2766

1.94

64.79

1.4

0.42

0.38

g/l

0.96

599

1940

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.66

64.36

2.6

1.3

0.39

0.42

g/l

0.17

Hypothyroidism, levothyroxine purchases

275

468

3.42

64.35

1.4

1.3

0.39

0.40

g/l

0.22

183

336

Hypothyroidism and >3 levothyroxin purchases

275

468

3.42

64.35

1.4

1.3

0.39

0.40

g/l

0.22

183

336

Simple and mucopurulent chronic bronchitis

9.87

64.26

1.3

0.37

0.46

g/l

0.72

Hypothyroidism (congenital or acquired)

276

473

3.39

63.79

1.4

1.3

0.38

0.40

g/l

0.34

184

339

5-aminosalicylic acid

204

559

3.70

63.69

1.4

1.2

0.40

0.41

g/l

0.11

125

368

Pain, not elsewhere classified

258

821

3.18

63.65

1.7

1.3

0.35

0.41

g/l

2.25

206

565

15.22

63.57

1.5

1.3

0.44

0.40

g/l

0.15

Other dorsopathies, not elsewhere classified

893

2465

1.92

63.45

1.4

1.3

0.38

0.41

g/l

1.22

631

1672

Disorders of thyroid, IBD co-morbidities

167

266

4.63

63.34

1.4

1.2

0.33

0.40

g/l

1.56

118

173

Other headache syndromes

410

1673

2.48

62.97

1.4

0.38

0.41

g/l

0.93

293

1178

Disorders of eyelid, lacrimal system and orbit

731

2898

1.99

62.96

1.5

1.4

0.37

0.42

g/l

2.75

520

2032

COPD (mode)

201

418

3.85

62.38

1.3

0.50

0.43

g/l

0.93

145

262

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.32

62.18

2.0

1.3

0.46

0.35

g/l

0.72

Spondylopathies

672

1970

2.09

61.89

1.4

0.38

0.41

g/l

1.37

466

1322

Temporomandibular joint disorders

175

440

4.04

61.82

1.5

1.4

0.37

0.44

g/l

1.09

118

310

Other specified/unspecified arthritis

277

935

3.00

61.79

1.4

0.42

g/l

0.03

199

632

Osteopathies and chondropathies

497

2103

2.26

61.60

1.5

1.4

0.36

0.41

g/l

2.46

348

1467

Other and unspecified anaemias

350

1292

2.65

61.40

1.4

0.44

0.43

g/l

0.17

224

908

Rheumatoid arthritis

310

1006

2.83

61.03

1.5

1.4

0.40

0.42

g/l

0.20

233

684

Pleural effusion

154

356

4.41

60.89

1.5

1.3

0.45

0.42

g/l

0.42

103

250

Other joint disorders

796

2165

1.97

60.83

1.4

0.37

0.40

g/l

1.68

572

1483

Sleep disorders (combined)

866

3037

1.88

60.73

1.3

1.4

0.39

0.41

g/l

0.39

572

2139

Allergic rhinitis

357

1375

2.61

60.68

1.4

1.3

0.34

0.39

g/l

2.32

290

944

Other anaemias

351

1305

2.62

60.34

1.4

0.44

0.43

g/l

0.18

225

915

Condition for Implicit Sepsis (Organ dysfunction codes)

715

2631

1.99

60.25

1.3

1.4

0.41

0.40

g/l

0.16

489

1843

Diseases of the eye and adnexa

775

1965

1.99

59.69

1.4

1.3

0.37

0.41

g/l

1.80

552

1338

Fibrosis and cirrhosis of liver

109

191

5.90

59.68

1.2

1.5

0.75

0.38

g/l

2.21

130

Intestinal infectious diseases

822

3431

1.88

59.31

1.4

1.3

0.37

0.41

g/l

2.83

579

2390

Viral pneumonia

147

336

4.47

59.03

1.3

0.38

0.40

g/l

0.15

104

241

Childhood asthma (age<16), excluding more controls

141

232

4.89

58.67

1.3

1.2

0.37

g/l

0.02

102

141

Childhood asthma (age<16)

141

233

4.87

58.43

1.3

1.2

0.37

g/l

0.01

102

141

ILD-related respiratory insufficiency

10.91

58.40

1.2

0.42

0.47

g/l

0.26

Endocrine, nutritional and metabolic diseases

770

2001

1.97

58.14

1.4

1.3

0.39

0.40

g/l

0.10

508

1440

Dental caries

278

963

2.90

58.08

1.5

1.3

0.39

0.40

g/l

0.24

209

657

Migraine

466

1749

2.29

58.04

1.4

1.3

0.36

0.40

g/l

1.82

339

1253

Soft tissue disorders

910

2562

1.86

57.99

1.5

1.3

0.38

0.40

g/l

1.10

645

1748

Arthropathies

819

2180

1.92

57.78

1.4

0.38

0.40

g/l

0.91

591

1497

Symptoms and signs involving the skin and subcutaneous tissue

606

2989

2.03

57.73

1.5

1.3

0.38

0.41

g/l

1.71

466

2083

Hernia of abdominal wall, postoperative

147

342

4.36

57.56

1.5

1.3

0.48

0.39

g/l

1.13

101

271

Dorsopathies

900

2500

1.85

56.38

1.4

1.3

0.38

0.41

g/l

1.22

631

1702

Other noninfective gastroenteritis and colitis

265

923

2.91

55.88

1.5

1.3

0.36

0.40

g/l

1.17

185

662

Eosinophilia

13.81

55.33

1.6

1.2

0.45

0.43

g/l

0.07

Pneumocystosis

15.79

55.17

1.6

1.4

0.40

0.41

g/l

0.03

Respiratory insufficiency

8.42

55.16

1.3

0.38

0.48

g/l

1.05

Hypertensive diseases (excluding secondary)

510

1336

2.24

55.14

1.4

1.3

0.37

0.39

g/l

0.50

340

942

COPD, hospital admission 2, with asthma infections

271

805

2.91

55.06

1.4

0.44

0.43

g/l

0.13

198

553

Methotrexate

140

325

4.38

55.05

1.6

1.2

0.38

0.43

g/l

0.78

101

226

Diseases of the musculoskeletal system and connective tissue

490

1071

2.31

54.75

1.4

1.3

0.37

0.39

g/l

0.45

343

732

Complications of surgical and medical care, not elsewhere classified

823

3236

1.84

54.57

1.4

0.41

g/l

0.08

600

2239

Sarcoidosis

168

451

3.81

54.34

1.4

1.3

0.37

0.42

g/l

1.14

111

324

Other diseases of pericardium

8.16

53.94

1.4

1.2

0.39

0.37

g/l

0.14

Infection due to other mycobacteria

17.39

53.51

1.3

0.41

0.43

g/l

0.08

Provisional assignment of new diseases of uncertain etiology

430

1928

2.25

53.32

1.5

1.3

0.41

0.40

g/l

0.31

320

1342

L04AD Calcineurin inhibitors

161

426

3.89

53.31

1.4

0.44

0.39

g/l

0.87

112

304

Codes for special purposes

430

1932

2.25

53.05

1.5

1.3

0.41

0.40

g/l

0.31

320

1345

Chronic laryngitis and laryngotracheitis

150

379

4.03

52.78

1.4

1.3

0.36

0.44

g/l

2.06

111

253

Diarrhoea and gastroenteritis of presumed infectious origin

621

2898

1.96

52.65

1.4

1.3

0.37

0.41

g/l

2.13

441

2024

Inflammatory bowel disease

331

1333

2.51

52.50

1.3

0.38

0.39

g/l

0.23

217

931

Dentinal caries

244

838

2.94

52.35

1.5

1.3

0.39

0.41

g/l

0.40

183

568

Other intervertebral disc disorders

689

2190

1.94

52.13

1.4

0.41

g/l

0.01

492

1477

COPD, hospital admissions 3, with asthma pneumonia sepsis

227

629

3.11

51.79

1.4

0.44

g/l

0.09

171

436

Symptoms and signs concerning food and fluid intake

120

259

4.73

51.72

1.5

1.3

0.42

0.41

g/l

0.11

192

Covid-19 confirmed case

284

1071

2.69

51.57

1.5

1.3

0.38

0.41

g/l

0.43

190

727

Functional dyspepsia

252

894

2.86

51.45

1.4

0.37

0.40

g/l

0.79

185

611

Colitis, primary sclerosing

11.97

51.23

1.4

1.2

0.47

0.29

g/l

2.10

Persons encountering health services for examination and investigation

542

1277

2.14

50.76

1.4

1.3

0.40

0.42

g/l

0.38

403

751

Other functional intestinal disorders

380

1579

2.31

49.81

1.5

1.4

0.36

0.41

g/l

1.75

270

1105

Mycoses

267

997

2.72

49.51

1.5

1.3

0.42

0.41

g/l

0.25

183

700

Diseases of the digestive system

383

1684

2.29

49.50

1.5

1.4

0.41

0.42

g/l

0.18

262

1158

Fungal Sepsis

8.49

49.47

1.4

0.39

0.37

g/l

0.14

Depression medications

287

506

2.88

49.12

1.4

1.3

0.38

0.40

g/l

0.30

197

361

Antihypertensive medication - note that there are other indications

592

1614

2.02

48.94

1.4

1.3

0.34

0.39

g/l

3.66

398

1151

Renal failure

339

1292

2.42

48.88

1.4

0.51

0.43

g/l

1.65

216

903

Complications of medical and surgical care

599

2971

1.93

48.72

1.4

0.39

0.42

g/l

1.09

435

2068

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

111

7.02

48.60

1.5

1.4

0.51

0.41

g/l

0.48

Protozoal diseases

8.89

48.53

1.5

1.4

0.43

0.42

g/l

0.06

Voice disturbances

261

974

2.72

48.46

1.4

0.37

0.40

g/l

0.48

186

679

Anxiety disorders, excluding more controls

724

2614

1.85

48.37

1.5

1.4

0.37

0.42

g/l

2.70

535

1798

Biological medicines for asthma

12.29

48.30

1.4

1.3

0.31

0.34

g/l

0.31

Implicit fungal Sepsis

8.87

48.03

1.4

0.40

0.38

g/l

0.12

Fibromyalgia

116

260

4.57

47.90

1.6

1.4

0.35

0.39

g/l

0.57

178

Other diseases of liver

197

638

3.14

47.49

1.3

1.4

0.44

0.38

g/l

1.14

126

451

Primary biliary cholangitis (PBC)

12.75

47.43

1.2

1.03

0.28

g/l

2.07

Hypopituitarism

117

267

4.53

47.36

1.5

1.3

0.45

0.38

g/l

0.73

202

Purpura and other haemorrhagic conditions

159

452

3.59

47.31

1.5

1.4

0.43

0.40

g/l

0.42

121

322

Rheumatoid arthritis, including avohilmo

346

1493

2.34

47.11

1.5

1.4

0.41

0.40

g/l

0.09

257

1019

Sleep apnoea

753

2847

1.81

46.91

1.3

1.4

0.39

0.40

g/l

0.19

498

2005

Persons encountering health services in other circumstances, wide

998

3080

1.69

46.67

1.4

1.3

0.38

0.41

g/l

2.13

722

2119

Rheumatism, unspecified

155

440

3.59

46.17

1.8

1.4

0.51

0.40

g/l

0.56

114

305

Coagulation defects, purpura and other haemorrhagic conditions

207

701

3.00

46.16

1.5

1.4

0.40

0.41

g/l

0.11

156

488

Viral infections characterized by skin and mucous membrane lesions

382

1732

2.23

46.13

1.5

1.4

0.35

0.40

g/l

2.24

279

1207

Explicit bacterial Sepsis

115

264

4.45

46.01

1.4

0.41

0.40

g/l

0.08

194

Osteoporosis with pathological fracture (FG)

121

6.45

45.81

1.6

1.2

0.32

0.45

g/l

1.77

Chronic hepatitis, not elsewhere classified

7.88

45.74

1.5

1.4

0.51

0.29

g/l

3.38

Abnormalities of heart beat

266

1020

2.61

45.74

1.3

1.4

0.40

0.42

g/l

0.18

186

673

Persons encountering health services for specific procedures and health care

907

3311

1.71

45.69

1.3

1.4

0.40

g/l

0.06

645

2303

Urticaria and erythema

357

1583

2.28

45.62

1.5

1.4

0.35

0.40

g/l

2.12

268

1109

Ulcerative colitis

256

976

2.66

45.59

1.3

0.40

g/l

0.09

168

683

Other general symptoms and signs

130

6.20

45.48

1.7

1.3

0.36

0.41

g/l

0.43

Sleep apnoea, including avohilmo

790

2927

1.76

45.00

1.4

0.39

0.41

g/l

0.24

519

2054

Cardiac arrhythmias

556

1881

1.97

44.78

1.3

1.4

0.44

0.38

g/l

1.06

380

1329

Other antidepressants

861

2601

1.74

44.43

1.4

0.37

0.42

g/l

3.38

585

1801

Ulcerative colitis, NAS

169

520

3.31

44.42

1.3

1.4

0.40

0.39

g/l

0.11

115

370

Seropositive rheumatoid arthritis

220

784

2.83

44.37

1.5

1.3

0.40

0.41

g/l

0.13

167

531

Anxiety disorders

771

3130

1.76

44.24

1.5

1.3

0.36

0.40

g/l

2.28

566

2147

Other chronic obstructive pulmonary disease, including avohilmo

401

1548

2.17

44.13

1.4

0.45

0.42

g/l

0.59

295

1059

Cholecystectomy

563

2627

1.91

43.94

1.4

0.41

g/l

0.06

352

1873

Early onset COPD

217

775

2.84

43.90

1.6

1.4

0.41

0.40

g/l

0.10

155

526

Atypical mycobacterium lung infection

20.52

43.57

1.2

1.3

0.42

0.44

g/l

0.05

Chronic kidney disease

233

862

2.72

43.54

1.4

1.3

0.47

0.43

g/l

0.64

151

611

Symptoms and signs involving speech and voice

294

1226

2.43

43.33

1.4

0.37

0.41

g/l

0.75

212

846

Other pleural conditions

204

4.85

43.25

1.5

1.3

0.46

g/l

0.05

148

Neurotic, stress-related and somatoform disorders

761

3114

1.75

42.98

1.5

1.3

0.36

0.40

g/l

2.26

560

2141

Hypermobility syndrome

165

5.38

42.80

1.6

1.4

0.30

0.40

g/l

1.52

116

Myalgia

219

797

2.78

42.73

1.5

1.3

0.34

0.41

g/l

2.39

160

538

Neoplasms

691

2040

1.83

42.44

1.4

0.39

0.40

g/l

0.14

464

1438

Polymyalgia rheumatica

115

281

4.16

42.41

1.5

1.3

0.39

0.42

g/l

0.32

200

Complications of procedures, not elsewhere classified

641

3082

1.81

42.13

1.4

0.42

0.40

g/l

0.32

477

2131

Lumbar disc prolapse

507

2070

1.96

42.05

1.4

0.43

0.41

g/l

0.19

358

1392

Sciatica+with lumbago

407

1862

2.09

41.72

1.4

1.3

0.41

g/l

0.02

298

1265

Disorders of conjunctiva

686

3275

1.76

41.31

1.5

1.3

0.36

0.41

g/l

3.41

511

2274

Pulmonary heart disease, diseases of pulmonary circulation

259

1043

2.51

41.16

1.4

0.38

0.43

g/l

1.37

196

722

Depression or dysthymia

598

1788

1.88

40.85

1.4

0.38

0.42

g/l

2.19

412

1235

Dentofacial anomalies [including malocclusion]

265

1072

2.47

40.69

1.5

1.3

0.37

0.41

g/l

0.89

182

749

Streptococcal septicaemia

211

4.65

40.66

1.4

1.3

0.43

0.40

g/l

0.17

160

Constipation

687

2800

1.77

40.46

1.4

0.40

0.41

g/l

0.23

474

1990

Persons encountering health services for other counselling and medical advice, not elsewhere classified

893

3077

1.66

40.32

1.4

1.3

0.39

0.41

g/l

0.63

675

2116

Dysphagia

196

695

2.85

40.17

1.4

1.3

0.36

0.44

g/l

2.04

134

488

COPD, hospital admissions

331

1253

2.25

40.10

1.4

0.47

0.42

g/l

1.28

240

845

Multiple myeloma and malignant plasma cell neoplasms

6.69

39.77

1.4

1.3

0.23

0.48

g/l

3.47

Symptoms and signs involving the nervous and musculoskeletal systems

469

2428

1.95

39.66

1.6

1.4

0.38

0.41

g/l

0.93

341

1705

Renal tubulo-interstitial diseases

677

2972

1.76

39.57

1.4

0.44

0.40

g/l

1.25

462

2084

Other disorders of fluid, electrolyte and acid-base balance

244

936

2.54

39.54

1.4

1.3

0.42

0.44

g/l

0.32

166

638

Benign neoplasm of colon, rectum, anus and anal canal

434

1533

2.04

39.29

1.4

0.43

0.42

g/l

0.07

322

1076

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

139

410

3.45

39.13

1.5

1.4

0.31

0.41

g/l

2.78

289

Chronic diseases of tonsils and adenoids

602

2089

1.83

39.09

1.3

0.39

0.42

g/l

1.08

453

1388

COPD, early/later onset

331

1264

2.23

39.02

1.4

0.47

0.42

g/l

1.31

240

854

Pneumonia derived septicemia

7.56

38.80

1.4

0.41

0.42

g/l

0.01

Nutritional anaemias

378

1776

2.09

38.76

1.5

1.3

0.39

0.42

g/l

1.16

280

1239

Other symptoms and signs involving the nervous and musculoskeletal systems

361

1721

2.12

38.53

1.6

1.3

0.37

0.40

g/l

0.80

262

1202

Pneumonia due to Streptococcus pneumoniae

6.67

38.48

1.5

1.2

0.34

0.40

g/l

0.57

Drug-induced cataract

8.66

38.43

1.5

1.3

0.33

0.37

g/l

0.28

Other disorders of skin and subcutaneous tissue

525

2601

1.86

38.33

1.4

0.40

0.42

g/l

0.69

384

1809

Benign neoplasm of colon, rectum, anus and anal canal

449

2080

1.96

38.32

1.4

0.42

0.43

g/l

0.03

335

1427

Spondyloarthritis

171

579

2.99

38.16

1.4

1.3

0.38

0.40

g/l

0.29

117

408

Multiple myeloma, excluding all cancers (controls excluding all cancers)

107

6.28

38.04

1.4

0.23

0.43

g/l

3.40

Inflammatory diseases of the central nervous system

105

261

4.12

37.99

1.5

1.4

0.33

0.37

g/l

0.74

179

Hypertensive diseases

669

2147

1.77

37.96

1.4

0.39

g/l

0.05

454

1504

Giant cell arteritis

7.34

37.90

1.2

1.5

0.33

0.40

g/l

0.49

Metabolic disorders

752

2759

1.70

37.77

1.5

1.4

0.39

0.41

g/l

0.41

532

1921

Hypertension

666

2145

1.77

37.32

1.4

0.39

g/l

0.08

451

1502

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

768

3126

1.68

37.30

1.4

0.39

0.41

g/l

0.55

526

2226

Nerve, nerve root and plexus disorders

826

3157

1.65

37.19

1.4

0.39

0.41

g/l

0.86

582

2183

Unspecified jaundice

6.62

37.15

2.0

1.2

0.42

g/l

0.01

Bleeding

630

2612

1.76

37.09

1.4

0.43

0.40

g/l

0.86

448

1808

Colitis, primary sclerosing, strict definition

11.06

36.88

1.4

1.2

0.42

0.29

g/l

1.51

Multiple myeloma and malignant plasma cell neoplasms

107

6.18

36.88

1.4

0.23

0.43

g/l

3.30

Pulmonary embolism

235

954

2.49

36.78

1.4

0.37

0.42

g/l

1.74

174

655

Later onset COPD, excluding more controls

108

206

4.12

36.72

1.1

1.3

0.59

0.46

g/l

1.32

134

Spondylopathies (FG)

146

462

3.21

36.69

1.5

1.3

0.37

0.41

g/l

0.62

102

307

Intestinal malabsorption

118

5.87

36.61

1.3

0.43

0.36

g/l

0.56

Benign neoplasm: Colon

375

1391

2.08

36.55

1.4

0.43

0.42

g/l

0.10

276

984

Benign neoplasms

664

2150

1.76

36.54

1.4

0.37

0.41

g/l

1.72

454

1506

Hypertension, essential

634

2044

1.78

36.52

1.4

0.39

g/l

0.04

428

1426

Benign neoplasm: Colon

381

1853

2.03

36.30

1.5

1.4

0.43

g/l

0.02

282

1276

Pulmonary heart disease

235

960

2.47

36.30

1.4

0.37

0.42

g/l

1.79

174

661

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

391

1204

2.07

36.19

1.5

1.3

0.39

0.40

g/l

0.18

256

850

Other and unspecified iron deficiency

267

1156

2.33

36.19

1.5

1.3

0.39

0.42

g/l

0.80

196

811

Dialysis, with operation codes

137

422

3.31

36.06

1.4

0.46

0.39

g/l

0.80

302

Diverticular disease of intestine

510

1815

1.88

36.04

1.6

1.4

0.39

0.42

g/l

1.13

384

1243

Diseases of arteries, arterioles and capillaries (FINNGEN)

201

511

2.78

35.97

1.4

0.51

0.41

g/l

1.65

146

343

Abnormal findings on diagnostic imaging of other body structures

125

364

3.50

35.93

1.6

1.4

0.46

0.40

g/l

0.56

255

Migraine with aura

220

876

2.54

35.92

1.4

0.36

0.39

g/l

0.47

162

624

Diseases of the ear and mastoid process

954

3041

1.59

35.64

1.4

0.39

0.41

g/l

0.95

667

2134

Nephropathy related operations

134

411

3.32

35.53

1.4

0.47

0.39

g/l

0.78

293

Abnormal results of function studies

100

252

4.06

35.53

1.5

1.3

0.43

0.41

g/l

0.26

177

Iron deficiency anaemia

327

1534

2.13

35.48

1.5

1.4

0.38

0.42

g/l

1.22

241

1065

Conjunctivitis

614

3105

1.73

35.11

1.5

1.3

0.35

0.41

g/l

4.07

466

2147

Crohn disease

150

497

3.07

34.93

1.2

1.4

0.37

0.39

g/l

0.19

354

Diseases of pulp and periapical tissues

295

1352

2.20

34.91

1.5

1.3

0.40

0.41

g/l

0.30

225

921

Other diseases of hard tissues of teeth

516

2109

1.84

34.81

1.5

1.3

0.38

0.41

g/l

1.16

363

1440

Other specified/unspecified necrotizing vasculopathies

12.49

34.64

1.4

0.44

0.37

g/l

0.25

Heart failure and antihypertensive medication

215

543

2.64

34.51

1.4

1.3

0.47

0.41

g/l

0.93

145

380

Atrial fibrillation and flutter

265

731

2.39

34.49

1.3

1.4

0.44

0.41

g/l

0.67

190

505

Hypothyroidism, strict autoimmune

506

1818

1.85

34.35

1.3

0.41

0.40

g/l

0.09

346

1287

Mood disorders, excluding more controls

746

2743

1.66

34.31

1.4

0.37

0.42

g/l

2.46

531

1884

Acute renal failure

168

598

2.85

34.31

1.4

1.3

0.54

0.43

g/l

1.12

425

Persons encountering health services in other circumstances

325

1557

2.10

34.25

1.4

1.3

0.34

0.41

g/l

3.34

200

1057

IBD patients in KELA-register

229

951

2.44

34.23

1.2

1.3

0.40

0.39

g/l

0.10

139

666

Unspecified chronic bronchitis

8.14

34.21

1.3

1.4

0.32

0.43

g/l

0.89

Other gastritis (incl. Duodenitis)

184

689

2.70

34.08

1.5

1.4

0.43

0.42

g/l

0.17

136

466

Glomerular diseases

174

635

2.78

33.95

1.6

1.3

0.43

0.41

g/l

0.28

116

448

Noninfectious colitis NAS

140

453

3.14

33.95

1.5

1.4

0.35

0.41

g/l

1.10

105

326

Recurrent or chronic depression

355

1245

2.07

33.94

1.3

0.34

0.41

g/l

3.66

255

867

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

2491

1.86

33.89

1.4

0.40

0.41

g/l

0.32

338

1725

Benign neoplasm of other and ill-defined parts of digestive system

162

571

2.88

33.75

1.5

1.4

0.38

0.41

g/l

0.58

117

396

SLE (Finngen)

6.85

33.74

1.6

1.5

0.47

0.34

g/l

1.34

Chronic periapical parodontitis

187

711

2.66

33.64

1.6

1.3

0.38

0.42

g/l

0.72

135

472

Syncope and collapse

293

1193

2.19

33.61

1.3

0.41

0.44

g/l

0.55

201

827

Other and unspecified disorders of white blood cells

100

6.10

33.56

1.3

0.39

g/l

0.02

Polyarthrosis

163

551

2.87

33.55

1.6

1.5

0.42

g/l

0.02

108

382

Depression

770

3271

1.63

33.49

1.4

0.37

0.41

g/l

1.92

549

2252

Benign neoplasms

788

2702

1.64

33.40

1.4

1.3

0.37

0.41

g/l

2.50

543

1871

Biological medication for rheuma

178

664

2.72

33.34

1.3

1.4

0.40

0.38

g/l

0.21

121

451

Pericarditis

7.02

33.24

1.2

0.42

0.39

g/l

0.16

Diaphragmatic hernia

279

1282

2.20

32.85

1.4

1.3

0.39

0.42

g/l

0.60

209

889

Infections of the skin and subcutaneous tissue

470

2586

1.82

32.57

1.4

0.42

0.39

g/l

0.57

354

1787

IBD (strict) with PSC

12.00

32.46

1.3

0.49

0.32

g/l

1.14

Mood disorders

814

3363

1.60

32.44

1.4

0.37

0.41

g/l

2.21

577

2325

Collagenous colitis

260

3.85

32.44

1.4

0.35

0.38

g/l

0.49

185

Diseases of middle ear and mastoid

487

2209

1.82

32.43

1.4

1.3

0.39

g/l

0.01

339

1521

Heart failure,strict

350

1241

2.05

32.39

1.4

0.47

0.42

g/l

0.95

238

836

Benign neoplasm of other and ill-defined parts of digestive system

162

586

2.81

32.18

1.5

1.4

0.38

0.40

g/l

0.30

117

406

Other disorders of teeth and supporting structures

185

716

2.61

32.13

1.7

1.3

0.40

0.43

g/l

0.45

142

469

Mood [affective] disorders

811

3361

1.59

32.11

1.4

0.37

0.41

g/l

2.19

575

2323

Urticaria

279

1295

2.18

32.09

1.5

1.4

0.35

0.39

g/l

1.93

212

903

Ulcerative colitis (strict) with PSC

13.74

32.00

1.3

0.46

0.28

g/l

1.08

Candidiasis

138

459

3.06

31.96

1.5

1.4

0.41

0.40

g/l

0.04

321

Spondylosis

379

1674

1.95

31.85

1.5

1.4

0.36

0.43

g/l

2.98

246

1136

Pulmonary eosinophilia, not elsewhere classified

13.29

31.83

1.8

1.3

0.35

0.39

g/l

0.18

Inflammatory bowel disease, strict (require KELA)

229

983

2.36

31.82

1.2

1.3

0.40

0.39

g/l

0.13

139

689

Acute suppurative otitis media

265

1123

2.23

31.82

1.4

1.3

0.39

0.38

g/l

0.24

192

778

Disorders of sclera, cornea, iris and ciliary body

435

2367

1.85

31.76

1.4

0.39

0.40

g/l

0.31

301

1655

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

288

1360

2.14

31.69

1.6

1.3

0.35

0.40

g/l

1.56

161

953

Migraine with aura and triptan purchases

163

598

2.77

31.54

1.4

0.36

0.38

g/l

0.36

123

415

Migraine without aura

190

755

2.55

31.26

1.4

0.35

0.39

g/l

0.82

141

545

Other reaction to severe stress, and adjustment disorders

325

1614

2.03

31.21

1.6

1.3

0.36

0.40

g/l

1.18

235

1114

Temporomandibular joint disorders, including avohilmo

361

1857

1.96

31.21

1.4

0.37

0.39

g/l

0.57

250

1307

All influenza (not pneumonia)

138

465

3.01

31.18

1.3

0.36

0.42

g/l

1.48

323

Other bacterial intestinal infections

156

565

2.80

30.90

1.4

1.3

0.37

0.41

g/l

0.94

114

396

Other diseases of lip and oral mucosa

147

516

2.89

30.89

1.4

1.3

0.42

g/l

0.01

111

354

Care involving use of rehabilitation procedures

502

2723

1.76

30.86

1.4

0.42

0.41

g/l

0.11

355

1910

Pneumococcal septicemia

6.25

30.82

1.5

1.3

0.42

0.41

g/l

0.02

Abnormal serum enzyme levels

226

965

2.33

30.75

1.5

1.3

0.43

g/l

0.12

170

664

Nonsuppurative otitis media

223

821

2.37

30.60

1.5

1.3

0.38

g/l

0.05

162

579

Polypectomy (DHB20)

204

4.17

30.59

2.0

1.3

0.35

0.40

g/l

0.71

139

Herpesviral [herpes simplex] infections

125

406

3.13

30.20

1.4

0.38

0.42

g/l

0.49

289

DVT of lower extremities and pulmonary embolism

295

1438

2.06

29.54

1.4

1.3

0.37

0.43

g/l

2.19

212

1003

Cholecystitis

109

330

3.34

29.49

1.8

1.2

0.49

0.41

g/l

1.05

235

Erysipelas

363

1737

1.92

29.27

1.5

1.4

0.43

0.41

g/l

0.35

263

1198

Congenital malformations of the respiratory system

7.33

29.21

1.5

1.4

0.35

0.39

g/l

0.34

Enterocolitis due to Clostridium difficile

256

3.69

29.16

1.5

1.4

0.38

0.41

g/l

0.29

183

Bacterial intestinal infections, IBD co-morbidities

155

577

2.72

29.15

1.4

1.3

0.37

0.40

g/l

0.65

114

404

Thrombocytopenia, unspecified

194

4.17

29.15

1.6

1.4

0.46

0.40

g/l

0.66

134

COPD related to multimorbidity

258

1002

2.18

29.15

1.4

0.45

0.42

g/l

0.51

183

681

Seropositive rheumatoid arthritis, wide

220

965

2.30

29.10

1.5

1.4

0.40

0.41

g/l

0.05

167

665

Venous thromboembolism

381

1982

1.88

29.09

1.5

1.4

0.37

0.43

g/l

1.46

270

1366

Factors influencing health status and contact with health services

235

493

2.40

29.03

1.3

0.36

0.44

g/l

1.83

165

312

COPD, hospital admissions 1, only main diagnosis

238

908

2.25

28.97

1.3

1.4

0.47

0.43

g/l

0.63

170

623

Other disorders of urethra and urinary system

516

2242

1.73

28.94

1.4

1.3

0.39

0.41

g/l

0.66

359

1575

Suppurative and unspecified otitis media

330

1490

1.98

28.93

1.4

1.3

0.39

0.38

g/l

0.10

236

1035

Other specified/unspecified inflammatory spondylopathies

138

4.83

28.85

1.6

1.4

0.39

0.41

g/l

0.21

Polyarteritis nodosa and related conditions

10.30

28.83

1.7

1.3

0.35

0.32

g/l

0.27

Systemic lupus erythematosus

5.83

28.80

1.6

1.3

0.47

0.33

g/l

1.32

Deposits [accretions] on teeth

235

3.78

28.79

1.7

1.3

0.38

g/l

0.04

177

Weight loss

278

3.56

28.69

1.4

1.3

0.41

g/l

0.04

199

Gout

174

624

2.56

28.65

1.4

0.42

0.44

g/l

0.24

113

428

Abnormal weight loss

246

3.73

28.58

1.4

1.3

0.43

0.41

g/l

0.21

173

Any mental disorder

870

2831

1.54

28.52

1.4

0.38

0.42

g/l

2.34

628

1948

Postviral fatigue syndrome

13.35

28.51

2.0

1.2

0.36

0.40

g/l

0.18

Anxiety (asthma-related co-morbidities)

495

2254

1.74

28.46

1.4

0.38

0.39

g/l

0.15

374

1564

Psychiatric diseases

861

2798

1.55

28.41

1.4

0.38

0.41

g/l

1.30

620

1926

Zoster [herpes zoster]

145

530

2.77

28.27

1.5

1.3

0.33

0.42

g/l

2.21

112

362

Pollen allergy

201

850

2.37

28.25

1.4

0.34

0.37

g/l

0.80

171

596

Non-follicular lymphoma, hilmo, excluding all cancers

262

3.62

28.24

1.5

1.4

0.31

0.41

g/l

2.02

189

Cystitis

640

2396

1.64

28.12

1.4

1.3

0.40

0.41

g/l

0.42

473

1693

Other diseases of urinary system

774

2782

1.57

28.08

1.4

0.40

0.41

g/l

0.14

548

1953

Unknown and unspecified causes of morbidity

174

4.27

27.97

1.3

0.36

0.42

g/l

0.81

128

Non-follicular lymphoma

264

3.59

27.92

1.5

1.4

0.31

0.41

g/l

1.80

185

Alcohol-induced chronic pancreatitis

205

4.00

27.90

1.2

0.45

0.40

g/l

0.25

142

Visual disturbances and blindness

385

2107

1.84

27.68

1.6

1.4

0.35

0.41

g/l

3.75

290

1455

Hypothyroidism, drug reimbursement

124

286

3.13

27.63

1.7

1.3

0.41

0.43

g/l

0.12

210

Mucosal proctocolitis

132

466

2.88

27.54

1.4

1.3

0.43

0.38

g/l

0.61

328

Other/unspecified dorsalgia

278

1364

2.04

27.25

1.2

1.4

0.35

0.41

g/l

2.29

192

931

Transplanted organ and tissue status

109

348

3.19

27.19

1.5

1.4

0.45

0.40

g/l

0.53

262

Other and unspecified tonsillitis

273

1125

2.07

27.09

1.4

0.37

0.39

g/l

0.53

195

743

Other Crohn's disease

237

3.71

27.04

1.2

1.3

0.40

0.39

g/l

0.05

163

Atopic dermatitis, strict definition with reimbursement

270

1280

2.06

27.02

1.4

1.3

0.35

0.39

g/l

0.94

204

894

Disturbances of skin sensation

239

1122

2.15

26.81

1.3

0.36

0.39

g/l

0.95

174

758

Other symptoms and signs involving the digestive system and abdomen

129

457

2.85

26.69

1.4

1.3

0.36

0.42

g/l

1.12

330

Other/unspecified seropositive rheumatoid arthritis

213

957

2.25

26.66

1.5

1.4

0.40

0.41

g/l

0.07

163

660

Heart failure, strict

367

1417

1.88

26.50

1.4

0.47

0.43

g/l

0.86

250

966

Thyroiditis, ILD-related definition

111

364

3.10

26.42

1.5

1.3

0.37

0.41

g/l

0.53

255

Alcohol-induced acute pancreatitis

106

5.27

26.33

1.3

0.44

0.38

g/l

0.54

Spinal stenosis

330

1351

1.93

26.27

1.4

0.41

0.44

g/l

0.65

245

910

Encephalitis

6.12

26.22

1.3

0.31

0.39

g/l

0.64

All anxiety disorders

499

2382

1.70

26.21

1.4

1.3

0.38

0.39

g/l

0.28

378

1651

Temporal arteritis

6.65

26.12

1.2

1.3

0.33

0.42

g/l

0.66

Deviated nasal septum

236

1114

2.13

26.02

1.2

1.3

0.42

0.43

g/l

0.27

157

726

Other encephalitis

6.35

25.99

1.3

0.31

0.40

g/l

0.71

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

210

949

2.23

25.94

1.5

1.4

0.40

0.41

g/l

0.15

160

653

Symptoms and signs involving cognition, perception, emotional state and behaviour

715

3237

1.55

25.88

1.3

1.4

0.40

0.41

g/l

0.04

505

2256

Non-invasive ventilation

164

622

2.50

25.82

1.3

0.32

0.41

g/l

2.43

421

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

429

2433

1.74

25.76

1.6

1.3

0.34

0.40

g/l

3.60

331

1692

COPD-related respiratory insufficiency

259

3.48

25.71

1.4

1.3

0.34

0.43

g/l

2.00

185

Other ulcerative colitis

186

4.02

25.69

1.3

0.40

0.37

g/l

0.27

128

Hypokalaemia

103

329

3.18

25.64

1.3

0.47

0.42

g/l

0.52

222

Visual disturbances

361

1985

1.83

25.63

1.6

1.4

0.35

0.41

g/l

3.92

271

1362

Other nutritional deficiencies

493

2891

1.68

25.58

1.4

0.40

g/l

0.05

352

2046

Tumor necrosis factor alpha inhibitors

152

601

2.57

25.46

1.3

1.4

0.42

0.38

g/l

0.57

100

414

Polyneuropathies and other disorders of the peripheral nervous system

170

708

2.43

25.41

1.4

1.3

0.42

g/l

0.00

127

494

Viral pneumonia (unknown virus, not influenza)

192

3.94

25.37

1.2

1.3

0.41

0.38

g/l

0.10

133

Cirrhosis of liver, NAS

121

4.84

25.34

1.2

1.3

0.54

0.38

g/l

1.64

Missing teeth due to accident, extraction or parodontitis

112

379

3.00

25.27

1.5

1.4

0.37

0.41

g/l

0.71

259

Atrial fibrillation and flutter with reimbursement

193

522

2.39

25.26

1.4

0.44

0.42

g/l

0.29

138

358

Benzodiazepine use

740

3453

1.53

25.11

1.3

1.4

0.38

0.41

g/l

1.44

508

2409

Continuous positive airway pressure

149

498

2.61

25.10

1.4

0.33

0.41

g/l

2.51

131

342

Other complications of surgical and medical care, not elsewhere classified

303

3.26

25.10

1.4

0.40

0.41

g/l

0.01

214

Lymphoid leukaemia

138

4.52

25.08

1.4

1.2

0.35

0.44

g/l

0.92

Glomerulonephritis

103

334

3.14

25.05

1.7

1.4

0.44

0.41

g/l

0.34

236

Giant cell arteritis with polymyalgia rheumatica

6.36

25.01

1.2

1.3

0.33

0.45

g/l

0.90

Lymphoid leukaemia

139

4.49

24.85

1.4

1.3

0.35

0.41

g/l

0.60

101

Other and unspecified polyneuropathies, also in other diseases

150

596

2.55

24.83

1.4

1.3

0.41

0.42

g/l

0.09

112

418

Shoulder lesions

540

2004

1.66

24.80

1.4

1.3

0.39

0.41

g/l

0.36

396

1353

Ulcerative colitis (strict definition, require KELA)

165

687

2.43

24.72

1.2

1.4

0.38

g/l

0.05

485

Pain in thoracic spine

131

488

2.72

24.70

1.4

1.3

0.40

0.43

g/l

0.57

103

335

All-cause Heart Failure

356

1395

1.85

24.69

1.4

0.47

0.43

g/l

0.83

244

949

Non-rheumatic valve diseases

317

1215

1.92

24.55

1.4

0.47

0.40

g/l

1.83

216

836

Other symptoms and signs involving the circulatory and respiratory systems

145

4.35

24.39

1.4

1.3

0.41

0.42

g/l

0.04

100

Agranulocytosis

106

355

3.04

24.38

1.3

1.4

0.40

0.39

g/l

0.03

245

Suppurative and necrotic conditions of lower respiratory tract

133

4.54

24.37

1.4

1.3

0.33

0.43

g/l

1.25

Valvular heart disease excluding rheumatic fever

320

1235

1.90

24.36

1.4

0.47

0.40

g/l

1.84

218

852

Concussion

356

1702

1.82

24.28

1.5

1.4

0.38

0.41

g/l

0.77

249

1195

Diseases of oral cavity, salivary glands and jaws

671

2192

1.58

24.27

1.4

1.3

0.39

0.42

g/l

0.92

482

1502

Cervicobrachial syndrome

177

766

2.33

24.26

1.6

1.3

0.40

0.42

g/l

0.25

141

516

Papulosquamous disorders

300

1585

1.91

24.21

1.4

0.38

0.41

g/l

1.06

219

1084

Intracranial trauma

411

1760

1.75

24.11

1.5

1.4

0.39

0.41

g/l

0.45

287

1236

Non-selective monoamine reuptake inhibitors

284

1434

1.93

23.83

1.4

0.35

0.42

g/l

3.31

201

999

Insulin, combination of fast acting with intermediate-acting or long-acting

433

2354

1.70

23.80

1.5

1.3

0.41

g/l

0.03

280

1655

Disorders of lens

475

1781

1.69

23.68

1.4

0.40

0.42

g/l

0.26

328

1271

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

159

665

2.42

23.62

1.2

1.4

0.38

g/l

0.02

467

Secondary hypertension

195

3.76

23.60

1.3

1.2

0.48

0.42

g/l

0.43

132

Follow-up examination after treatment for conditions other than malignant neoplasms

294

991

1.95

23.60

1.4

1.3

0.38

0.44

g/l

1.70

222

591

Congenital malformations, deformations and chromosomal abnormalities

468

2713

1.66

23.49

1.5

1.4

0.40

0.38

g/l

0.57

321

1898

Cervical disc disorders

258

1309

1.98

23.47

1.4

0.36

0.43

g/l

2.67

176

887

Adalimumab

102

342

3.04

23.47

1.3

1.4

0.42

0.38

g/l

0.41

239

Allergic conjunctivitis

444

2615

1.68

23.38

1.6

1.3

0.34

0.40

g/l

3.25

344

1817

Paralytic ileus and intestinal obstruction

173

754

2.31

23.30

1.3

0.41

0.43

g/l

0.44

115

516

Hypoparathyroidism

5.38

23.08

2.5

1.3

0.37

g/l

0.00

Presence of other functional implants

373

1487

1.79

23.07

1.4

0.38

0.43

g/l

1.17

206

1058

Stomatitis and related lesions

258

3.35

23.07

1.4

0.41

g/l

0.03

172

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

406

2384

1.71

22.96

1.4

0.38

0.41

g/l

1.29

296

1658

Other overlap syndromes

8.87

22.92

1.6

1.4

0.33

0.36

g/l

0.12

Disorders of orbit

120

4.62

22.75

1.7

1.4

0.34

0.38

g/l

0.38

Other (seronegative) rheumatoid arthritis, wide

154

646

2.41

22.72

1.5

1.4

0.34

0.42

g/l

1.69

117

446

Disorders of parathyroid gland

147

597

2.45

22.56

1.8

1.3

0.34

0.41

g/l

1.89

104

411

Asthma mixed form (mode), excluding more controls

5.52

22.43

1.7

1.3

0.33

0.39

g/l

0.66

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

120

450

2.70

22.41

1.3

1.4

0.51

0.41

g/l

1.50

316

Use of hypnotics and sedatives

787

3077

1.48

22.27

1.3

1.4

0.37

0.41

g/l

1.75

568

2129

Disorders of the thyroid gland

689

2982

1.52

22.08

1.5

1.3

0.38

0.41

g/l

1.51

455

2127

Iridocyclitis

189

877

2.18

21.97

1.5

1.3

0.37

0.40

g/l

0.52

135

613

Lung diseases due to external agents

100

344

2.94

21.92

1.3

0.40

0.42

g/l

0.16

250

Systemic sclerosis (FG)

6.71

21.87

1.2

1.3

0.43

0.34

g/l

0.73

Disorders of skin appendages

369

2141

1.73

21.85

1.3

1.4

0.38

0.40

g/l

0.35

268

1483

Correction of physiology of bite - demanding therapy visit

243

3.36

21.75

1.4

0.41

0.37

g/l

0.28

166

GI-bleeding

211

1025

2.07

21.70

1.4

1.3

0.42

0.43

g/l

0.11

147

716

Recurring oral aphthae, including avohilmo

123

475

2.62

21.69

1.3

1.4

0.37

0.40

g/l

0.43

324

Hypo-osmolality and hyponatraemia

125

486

2.59

21.54

1.4

1.3

0.39

0.42

g/l

0.37

338

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

169

758

2.25

21.40

1.2

1.4

0.38

g/l

0.10

101

524

Gout, FINNGEN

174

790

2.22

21.32

1.4

0.42

0.46

g/l

0.61

113

544

123

479

2.60

21.32

1.6

1.3

0.38

0.40

g/l

0.26

325

Atopic dermatitis

422

2167

1.67

21.30

1.3

0.36

0.39

g/l

0.94

316

1527

Migraine without aura and triptan purchases

151

649

2.35

21.14

1.4

0.35

0.38

g/l

0.67

113

452

Other anxiety disorders

355

1816

1.74

21.11

1.3

0.38

0.39

g/l

0.45

274

1245

Extracorporeal dialysis

176

3.78

21.06

1.5

1.3

0.52

0.40

g/l

0.65

123

Insulin medication

433

2254

1.65

20.93

1.5

1.3

0.41

0.40

g/l

0.17

280

1567

Coxibs

214

535

2.14

20.88

1.3

0.39

0.44

g/l

1.07

150

360

Triptan medication for migraine, single purchase ok

601

2654

1.54

20.85

1.4

0.38

0.39

g/l

0.19

421

1847

Migraine, single triptan purchase ok & required. ICD-code if available is included

601

2654

1.54

20.85

1.4

0.38

0.39

g/l

0.19

421

1847

Hypothyreosis and Thyroxine purchase for inclusion criteria

659

2893

1.51

20.77

1.4

1.3

0.39

0.41

g/l

0.59

436

2061

Other metabolic disorders

118

457

2.62

20.70

1.7

1.3

0.34

0.40

g/l

1.23

312

Disorders of synovium and tendon

371

1964

1.71

20.67

1.5

1.3

0.39

0.41

g/l

0.30

261

1339

Other pulmonary heart/vessel disease

4.94

20.67

1.3

0.41

0.45

g/l

0.30

Hypothyroidism, other/unspecified

637

2783

1.52

20.56

1.4

1.3

0.39

0.41

g/l

0.72

419

1989

Other skin changes

130

530

2.48

20.48

1.8

1.3

0.40

0.41

g/l

0.18

100

374

Pain and other conditions associated with female genital organs and menstrual cycle

171

750

2.21

20.47

1.4

0.42

0.40

g/l

0.09

121

521

Asthma mixed form (mode)

5.07

20.45

1.7

1.3

0.33

0.42

g/l

1.15

Vasculitis limited to skin, not elsewhere classified

6.23

20.42

1.4

1.2

0.33

0.46

g/l

0.75

Other diseases of intestine

331

2.91

20.41

1.4

1.3

0.38

0.41

g/l

0.39

225

Nonalcoholic fatty liver disease

332

2.91

20.36

1.3

1.4

0.40

0.38

g/l

0.24

227

Personal history of allergy to drugs, medicaments and biological substances

8.90

20.35

1.6

1.1

0.33

0.42

g/l

0.41

Secondary right heart disease

5.18

20.31

1.2

1.3

0.42

0.44

g/l

0.11

Selective serotonin reuptake inhibitors

736

2628

1.48

20.17

1.3

1.4

0.38

0.41

g/l

2.16

511

1824

Disorders of oesophagus in diseases classified elsewhere

8.21

20.14

1.4

1.1

0.58

0.36

g/l

1.54

Diseases of spleen

7.56

20.08

1.8

1.3

0.47

0.39

g/l

0.38

Rotator cuff syndrome

405

1811

1.67

19.98

1.4

1.3

0.45

0.41

g/l

0.50

303

1223

Somatoform disorder

143

616

2.35

19.95

1.4

1.3

0.32

0.41

g/l

2.62

419

Recurring oral aphthae

142

4.04

19.93

1.5

1.3

0.36

0.38

g/l

0.12

Otitis media, unspecified

111

389

2.66

19.83

1.4

1.3

0.37

g/l

0.01

287

Acute laryngitis and tracheitis

106

392

2.69

19.69

1.3

0.37

g/l

0.00

257

Myocarditis

113

4.41

19.68

1.4

1.2

0.36

0.38

g/l

0.18

Obesity and other hyperalimentation

453

2820

1.60

19.65

1.4

0.40

g/l

0.00

323

1994

Dermatitis due to substances taken internally

139

4.03

19.62

1.5

0.39

g/l

0.01

Care involving dialysis

244

3.21

19.57

1.5

1.3

0.52

0.40

g/l

0.81

170

Gastroduodenal ulcer

159

720

2.22

19.52

1.3

0.46

0.44

g/l

0.28

108

486

Other and unspecified vasculitis limited to skin

6.32

19.51

1.4

1.2

0.33

0.47

g/l

0.66

Acute and subacute iridocyclitis

160

730

2.21

19.47

1.5

1.3

0.38

0.40

g/l

0.33

109

514

Other specified/unspecified soft tissue disorders

102

4.59

19.42

1.5

1.3

0.44

0.40

g/l

0.24

Triptan medication for migraine, min. 3 purchases

433

2115

1.62

19.41

1.4

1.3

0.34

0.40

g/l

4.18

321

1481

Other diseases of the digestive system

207

1042

2.00

19.37

1.3

0.43

g/l

0.04

147

726

Total colectomy operation

111

4.43

19.28

1.6

1.3

0.38

0.39

g/l

0.04

Total colectomy

111

4.43

19.28

1.6

1.3

0.38

0.39

g/l

0.04

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

187

3.53

19.23

1.6

1.4

0.43

0.40

g/l

0.21

130

Other viral diseases, not elsewhere classified

169

790

2.16

19.23

1.4

0.37

0.39

g/l

0.35

128

562

Other or unspecified ileus, impaction or obstruction

124

509

2.46

19.22

1.3

0.43

0.42

g/l

0.15

348

Idiopathic thrombocytopenic purpura

5.15

19.14

1.3

0.45

0.42

g/l

0.18

Glomerular disorders in diseases classified elsewhere

360

2.76

19.13

1.4

0.42

0.39

g/l

0.27

253

Obesity

449

2810

1.59

19.12

1.4

0.40

g/l

0.01

319

1987

Systemic sclerosis

5.84

19.11

1.2

0.43

0.35

g/l

0.53

Sequelae with surgical and medical care as external cause

152

685

2.24

19.08

1.5

1.3

0.40

0.41

g/l

0.21

112

471

Other inflammation of eyelid

110

429

2.60

19.07

1.5

1.3

0.33

0.41

g/l

2.20

300

Cerebrovascular diseases (FINNGEN)

220

797

1.99

19.01

1.3

0.45

0.40

g/l

0.27

162

550

Lung cancer and mesothelioma

247

3.00

18.97

1.2

1.3

0.52

0.45

g/l

0.57

161

Dizziness and giddiness

509

2676

1.55

18.87

1.4

0.42

0.41

g/l

0.10

360

1865

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.84

18.78

1.5

1.3

0.39

0.41

g/l

0.10

Other viral diseases

249

1345

1.86

18.76

1.6

1.3

0.38

g/l

0.15

181

951

Cutaneous abscess, furuncle and carbuncle

202

1021

2.00

18.75

1.3

0.42

0.39

g/l

0.41

149

704

Arthrosis

475

1639

1.60

18.72

1.3

1.4

0.41

g/l

0.05

337

1119

Direct fill therapy

130

553

2.38

18.72

1.4

0.37

0.38

g/l

0.10

401

Sequelae of external causes of morbidity and mortality

185

907

2.06

18.69

1.5

1.3

0.40

0.41

g/l

0.19

136

626

Nonorganic sleeping disorders, excluding more controls

148

670

2.23

18.38

1.3

0.36

0.40

g/l

1.04

446

Cervicalgia

145

651

2.25

18.36

1.8

1.3

0.40

0.43

g/l

0.53

105

440

Acetic acid derivatives and related substances

208

529

2.06

18.35

1.5

1.3

0.38

0.45

g/l

1.41

146

357

Anterior Iridocyclitis

166

788

2.13

18.31

1.5

1.3

0.37

0.40

g/l

0.42

114

548

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

270

3.01

18.27

1.5

1.4

0.34

0.38

g/l

0.57

188

Adverse effects, not elsewhere classified

167

799

2.11

18.06

1.6

1.3

0.33

0.39

g/l

2.55

119

557

Emphysema

121

4.10

18.02

1.2

1.3

0.45

0.43

g/l

0.12

Chronic gastritis

171

826

2.08

17.97

1.3

1.4

0.43

0.45

g/l

0.06

139

562

Diseases of arteries, arterioles and capillaries

407

1886

1.62

17.85

1.4

0.48

0.42

g/l

1.87

288

1290

Other abnormal immunological findings in serum

6.35

17.78

1.7

1.2

0.60

0.39

g/l

1.20

Other arthrosis

332

1399

1.71

17.72

1.3

1.4

0.40

0.42

g/l

0.49

240

961

Drug-induced osteoporosis

8.65

17.68

2.1

1.4

0.30

0.36

g/l

0.24

Other and unspecified urticaria

166

799

2.10

17.68

1.4

1.3

0.33

0.40

g/l

2.87

122

557

Seronegative rheumatoid arthritis

319

2.79

17.63

1.4

1.3

0.34

0.42

g/l

1.23

210

Volume depletion

208

3.26

17.60

1.4

1.3

0.34

0.44

g/l

1.29

142

Psoriatic and enteropathic arthropathies

377

2.63

17.50

1.3

0.43

0.42

g/l

0.10

254

Endocarditis

5.18

17.47

1.4

1.2

0.38

0.39

g/l

0.02

Paroxysmal tachycardia

162

648

2.13

17.45

1.4

1.3

0.49

0.40

g/l

0.46

112

440

SLE, ICD10

112

4.22

17.35

1.6

1.4

0.44

0.33

g/l

0.97

SLE, strict definition

112

4.22

17.35

1.6

1.4

0.44

0.33

g/l

0.97

Multiple myeloma

6.55

17.19

1.4

1.3

0.19

0.46

g/l

2.64

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.55

17.19

1.4

1.3

0.19

0.46

g/l

2.64

Acute tubulo-interstitial nephritis

404

2260

1.59

17.12

1.4

0.40

g/l

0.03

293

1588

Crohn's disease of small intestine

233

3.10

17.07

1.3

1.4

0.35

0.37

g/l

0.17

163

Intestinal stricture

204

1069

1.92

17.07

1.3

1.4

0.41

0.42

g/l

0.10

139

741

Hernia

658

3094

1.45

17.06

1.4

0.40

0.41

g/l

0.06

460

2132

Chronic ulcer of skin, not elsewhere classified

154

3.63

16.99

1.9

1.3

0.46

0.43

g/l

0.19

110

Benign neoplasm: Colon, unspecified

155

734

2.12

16.98

1.4

1.5

0.37

0.42

g/l

1.23

110

512

Internal derangement of knee

254

1425

1.79

16.93

1.5

1.4

0.35

0.41

g/l

1.89

176

975

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

4.43

16.92

1.7

1.4

0.35

0.40

g/l

0.35

Exposure to unspecified factor

685

3734

1.43

16.89

1.4

0.38

0.41

g/l

0.99

440

2646

Gingivitis and periodontal diseases

618

2170

1.48

16.76

1.4

1.3

0.40

0.42

g/l

0.47

450

1481

Other disorders of ear

634

2918

1.45

16.71

1.5

1.4

0.39

0.41

g/l

0.65

448

2046

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.38

16.70

1.7

1.3

0.35

0.40

g/l

0.31

Non-ischemic cardiomyopathy

182

751

2.00

16.59

1.4

1.3

0.47

0.41

g/l

0.83

123

515

Bronchitis, not specified as acute or chronic

222

3.10

16.46

1.5

1.3

0.41

g/l

0.06

149

Other arrhythmias

426

2094

1.56

16.37

1.4

0.44

0.38

g/l

0.71

283

1464

Keratitis

251

1423

1.78

16.34

1.4

0.39

0.40

g/l

0.04

168

980

Chronic iridocyclitis

149

3.63

16.33

1.5

1.3

0.33

0.40

g/l

0.96

105

Insulin, fast-acting

257

1466

1.76

16.33

1.5

1.3

0.41

g/l

0.04

170

1029

Seropositive rheumatoid arthritis, strict definition

119

518

2.32

16.31

1.4

1.3

0.45

0.41

g/l

0.37

354

Dermatographic urticaria

219

3.11

16.24

1.8

1.4

0.36

0.38

g/l

0.18

149

Ulcerative enterocolitis

4.54

16.20

1.4

1.3

0.35

0.33

g/l

0.13

Persons with potential health hazards related to communicable diseases

306

1822

1.68

16.16

1.4

1.3

0.30

0.39

g/l

5.52

185

1313

Other diseases of stomach and duodenum

146

3.62

16.02

1.3

0.45

0.42

g/l

0.17

Gonarthrosis [arthrosis of knee](FG)

446

1693

1.56

15.99

1.3

0.40

0.41

g/l

0.24

324

1157

Deforming dorsopathies

192

1010

1.91

15.92

1.4

0.48

0.43

g/l

0.34

147

685

Benign neoplasm: Colon, unspecified

155

757

2.06

15.91

1.4

1.3

0.37

0.44

g/l

1.60

110

530

Viral infections of the central nervous system

238

2.99

15.85

1.4

0.29

0.39

g/l

2.54

158

6-mercaptopurine

5.27

15.85

2.3

1.2

0.51

0.35

g/l

0.68

Diabetes mellitus

737

3144

1.40

15.79

1.4

0.41

0.40

g/l

0.23

494

2225

Crohn's disease NAS

218

3.08

15.73

1.2

1.3

0.38

g/l

0.02

150

Diabetes, varying definitions

733

3131

1.40

15.71

1.4

0.41

0.40

g/l

0.25

488

2218

Hepatic failure, not elsewhere classified

4.72

15.70

1.4

1.3

0.50

0.33

g/l

1.64

Gastric ulcer

106

446

2.39

15.67

1.3

1.4

0.47

0.43

g/l

0.37

306

Other and unspecified effects of external causes

215

1180

1.84

15.64

1.5

1.3

0.35

0.40

g/l

1.60

151

821

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

447

2.40

15.63

1.7

1.3

0.38

0.41

g/l

0.52

315

Convulsions, not elsewhere classified

154

745

2.05

15.62

1.4

1.3

0.40

0.41

g/l

0.20

110

512

Excessive, frequent and irregular menstruation

292

944

1.73

15.61

1.3

1.4

0.37

0.39

g/l

0.41

203

649

Oxicams

169

467

2.07

15.57

1.3

0.45

g/l

0.00

124

315

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

658

3020

1.42

15.53

1.4

0.40

0.41

g/l

0.15

445

2120

Benign neoplasm: Transverse colon

279

2.80

15.52

1.6

1.4

0.42

g/l

0.00

196

Systemic sclerosis, icd10

4.82

15.52

1.2

1.3

0.43

0.37

g/l

0.41

Genitourinary diseases

462

1505

1.54

15.51

1.4

0.38

0.40

g/l

0.53

322

1035

Heart failure and bmi 25plus

195

701

1.93

15.48

1.3

1.4

0.45

0.40

g/l

0.76

124

437

Algoneurodystrophy

100

4.20

15.44

1.4

1.3

0.31

0.34

g/l

0.37

Benign neoplasm: Transverse colon

280

2.79

15.42

1.6

1.4

0.42

g/l

0.03

202

Other disorders of eye and adnexa

116

513

2.29

15.36

1.3

1.4

0.33

0.42

g/l

2.46

356

Other/unspecified rheumatoid arthritis

355

2.56

15.33

1.5

1.3

0.36

0.42

g/l

0.81

243

Other infectious diseases

216

3.05

15.32

1.5

1.3

0.46

0.41

g/l

0.34

151

Radiculopathy

109

470

2.34

15.27

1.4

1.3

0.52

0.45

g/l

0.18

329

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.72

15.24

1.9

1.2

0.42

0.40

g/l

0.12

Pruritus

333

2.61

15.23

1.6

1.3

0.44

0.43

g/l

0.03

236

Misadventures to patients during surgical and medical care

107

459

2.36

15.20

1.4

1.3

0.40

0.41

g/l

0.12

327

Symptoms and signs involving the urinary system

502

2624

1.48

15.20

1.5

1.4

0.44

0.41

g/l

0.34

358

1813

Congenital malformations and deformations of the musculoskeletal system

373

2.52

15.17

1.6

1.3

0.37

0.38

g/l

0.10

279

Cerebral cysts

157

3.43

15.10

1.7

1.3

0.41

0.39

g/l

0.13

109

Ascites

152

3.47

15.09

1.3

1.2

0.60

0.42

g/l

1.32

110

Postprocedural disorders of nervous system

245

2.90

15.07

1.5

1.4

0.36

0.38

g/l

0.19

175

Unspecified kidney failure

218

3.02

15.06

1.4

1.2

0.47

0.43

g/l

0.21

154

Conjunctivitis (acute, non atopic)

207

1133

1.83

15.03

1.4

1.3

0.36

0.40

g/l

1.30

155

790

Invasive ventilation

208

3.08

15.03

1.3

0.33

0.40

g/l

0.82

149

Chorioretinal inflammation

4.91

15.03

1.4

0.36

0.31

g/l

0.54

Psoriasis

205

1123

1.84

15.02

1.2

1.4

0.41

g/l

0.01

144

777

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

284

2.75

15.02

1.3

1.4

0.46

0.40

g/l

0.39

200

Ocular pain

273

2.79

15.02

1.4

1.5

0.34

0.41

g/l

1.26

189

Combined immunodeficiencies

8.37

15.02

1.4

1.2

0.33

g/l

0.03

Personality disorders, excluding more controls

188

1002

1.89

15.01

1.3

0.37

0.40

g/l

0.68

129

672

Disorders of ocular muscles, binocular movement, accommodation and refraction

338

2103

1.60

15.00

1.5

1.4

0.40

0.39

g/l

0.13

248

1479

Other enthesopathies

205

1124

1.84

14.96

1.6

1.3

0.35

0.40

g/l

1.58

150

756

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.74

14.92

1.3

1.2

0.37

0.35

g/l

0.06

Vascular disorders of the intestines

116

3.84

14.84

1.3

0.48

0.45

g/l

0.18

Acute pharyngitis

111

486

2.29

14.77

1.3

0.32

0.39

g/l

1.93

323

Obesity due to excess calories

327

2045

1.61

14.75

1.3

1.4

0.42

0.40

g/l

0.13

229

1420

Insulin, intermediate and long-acting

352

2195

1.58

14.73

1.4

0.40

0.42

g/l

0.35

233

1540

Fissure and fistula of anal and rectal regions

165

849

1.96

14.66

1.2

1.3

0.51

0.42

g/l

0.46

109

566

Insulin, fast-acting or short human

258

1522

1.70

14.60

1.5

1.3

0.41

g/l

0.06

171

1061

Hepatomegaly and splenomegaly, not elsewhere classified

8.10

14.57

1.4

1.2

0.48

0.29

g/l

1.35

Rare circulating lymphoid malignancy

4.54

14.55

1.9

1.2

0.42

0.41

g/l

0.06

Other CVD (FINNGEN)

199

2.87

14.51

1.3

0.34

0.40

g/l

1.05

132

Pyogenic arthritis

161

3.34

14.50

1.3

0.41

0.44

g/l

0.17

111

Senile cataract

391

1558

1.56

14.48

1.4

0.41

g/l

0.05

265

1111

Other diseases of jaws

213

3.00

14.44

1.6

1.5

0.36

0.40

g/l

0.28

136

TMD related pain

110

3.91

14.39

1.4

0.35

0.37

g/l

0.13

Other cataract

268

1229

1.70

14.37

1.5

1.3

0.40

0.41

g/l

0.27

186

878

Nephrotic syndrome

4.13

14.34

1.9

1.3

0.36

0.35

g/l

0.07

Reactive arthropathies, FINNGEN

209

3.01

14.28

1.4

1.3

0.43

0.41

g/l

0.20

144

Heartburn

269

2.74

14.26

1.4

1.3

0.32

0.40

g/l

1.66

190

Chronic nephritic syndrome

111

3.86

14.19

2.0

1.3

0.51

0.39

g/l

1.20

Pyothorax

102

4.00

14.19

1.4

1.3

0.30

0.43

g/l

1.61

Cluster headache, strict

4.24

14.18

1.3

1.2

0.31

0.36

g/l

0.37

Postprocedural endocrine and metabolic disorders, not elsewhere classified

424

2.36

14.16

1.8

1.3

0.34

0.40

g/l

1.20

290

Demyelinating diseases of the central nervous system

323

2.57

14.08

1.4

0.31

0.39

g/l

1.53

223

Cluster headache, wide

4.12

14.04

1.3

0.31

0.36

g/l

0.45

Ulcerative ileocolitis

131

3.58

13.96

1.2

1.3

0.42

0.34

g/l

0.70

Pneumothorax

155

3.33

13.96

1.3

1.2

0.39

0.41

g/l

0.15

113

Acute lymphadenitis

207

3.00

13.92

1.9

1.3

0.40

0.36

g/l

0.42

146

Meniscus derangement

348

1514

1.58

13.78

1.3

1.4

0.37

0.41

g/l

1.05

221

1032

Diseases of pulp and periapical tissues, including avohilmo

774

2955

1.36

13.74

1.4

0.39

0.41

g/l

0.43

528

2069

Dental operations

429

1449

1.52

13.73

1.4

1.3

0.39

0.43

g/l

0.84

294

1015

Exposure to other specified factors

512

3345

1.44

13.73

1.5

1.4

0.38

0.40

g/l

0.80

367

2321

Soft tissue disorders related to use, overuse and pressure

171

911

1.89

13.72

1.4

1.3

0.42

0.41

g/l

0.17

130

610

Polyarthritis, unspecified

4.22

13.72

1.8

1.4

0.32

0.43

g/l

1.04

Cardiac murmurs and other cardiac sounds

249

2.77

13.70

1.1

1.4

0.36

0.40

g/l

0.38

185

Dental pulpitis 4

775

2961

1.36

13.69

1.4

0.40

0.41

g/l

0.41

532

2072

Type 2 diabetes

671

2876

1.39

13.66

1.5

1.4

0.41

0.40

g/l

0.17

454

2027

Haemorrhoids and perianal venous thrombosis

174

933

1.87

13.65

1.2

1.4

0.43

g/l

0.00

116

634

Disorders of mineral metabolism

231

2.85

13.64

1.4

0.47

0.41

g/l

0.21

156

Abscess of lung

6.08

13.64

1.4

1.3

0.42

0.38

g/l

0.20

Adenocarcinoma and ductal carcinoma of pancreas

5.02

13.62

1.1

1.3

0.56

0.41

g/l

0.63

Benign neoplasm: Stomach

282

2.66

13.59

1.8

1.4

0.36

0.39

g/l

0.22

197

Exclusions for E4_PCOS_CONSORTIUM

525

2281

1.45

13.58

1.4

0.39

0.40

g/l

0.15

321

1651

Dental pulpitis 1

774

2963

1.36

13.52

1.4

0.40

0.41

g/l

0.38

530

2075

Benign neoplasm: Caecum

277

2.67

13.52

1.6

1.4

0.37

0.41

g/l

0.34

196

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

5.78

13.48

1.5

1.3

0.30

0.32

g/l

0.10

Atopic dermatitis, strict definition

240

1393

1.70

13.45

1.4

0.36

0.38

g/l

0.42

183

979

Secondary and unspecified malignant neoplasm of lymph nodes

233

2.83

13.43

1.4

0.38

0.41

g/l

0.20

163

Dental caries 1 and operation codes

592

2141

1.42

13.42

1.4

1.3

0.41

0.42

g/l

0.16

403

1517

Disorders of optic nerve and visual pathways

325

2.52

13.40

1.5

1.4

0.37

0.39

g/l

0.26

226

Other disorders of bone

152

786

1.95

13.38

1.4

1.3

0.31

0.40

g/l

3.94

111

548

Diseases of tongue

170

3.16

13.32

1.5

0.39

0.43

g/l

0.35

116

Rash and other nonspecific skin eruption

320

2.53

13.32

1.4

0.39

0.40

g/l

0.08

231

Localized swelling, mass and lump of skin and subcutaneous tissue

210

1205

1.75

13.23

1.7

1.3

0.37

0.41

g/l

0.76

173

819

Type 2 diabetes, wide definition

474

2114

1.47

13.21

1.5

1.3

0.42

0.41

g/l

0.23

346

1545

Chronic lymphocytic leukaemia

5.03

13.16

1.3

0.29

0.43

g/l

0.91

Ulcerative colitis (strict definition, all Crohn cases excluded)

118

561

2.12

13.13

1.2

1.4

0.41

0.38

g/l

0.44

396

Ankylosing spondylitis

287

2.61

13.13

1.3

1.4

0.39

0.41

g/l

0.25

199

Abnormal findings on diagnostic imaging of central nervous system

127

3.53

13.10

1.6

1.3

0.32

0.40

g/l

1.15

Tonsillectomy and adenotomy

439

2072

1.48

13.05

1.4

1.3

0.37

0.38

g/l

0.08

329

1430

Benign neoplasm: Caecum

283

2.61

12.97

1.6

1.4

0.37

0.39

g/l

0.20

201

Crohn's disease of large intestine

173

3.12

12.96

1.3

0.30

0.37

g/l

0.88

121

Gout, idiopatic and unspecified

140

712

1.98

12.94

1.4

1.3

0.44

0.45

g/l

0.14

497

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

4.94

12.91

1.3

1.2

0.29

0.40

g/l

0.75

Chronic lymphocytic leukaemia, helper endpoint

4.94

12.91

1.3

1.2

0.29

0.40

g/l

0.75

TMD related operations

137

694

1.99

12.84

1.4

0.41

0.39

g/l

0.20

480

Behavioural syndromes associated with physiological disturbances and physical factors

239

1432

1.68

12.84

1.3

1.4

0.37

0.39

g/l

0.32

165

1016

Diseases of the myoneural junction and muscle

362

2.40

12.83

1.5

1.4

0.31

0.41

g/l

2.16

257

Benign neoplasm: Stomach

291

2.57

12.78

1.8

1.4

0.36

0.41

g/l

0.54

197

Other and unspecified drugs and medicaments

251

2.70

12.75

1.4

0.36

0.39

g/l

0.35

172

Other noninfective disorders of lymphatic vessels and lymph nodes

4.26

12.75

1.4

1.3

0.80

0.34

g/l

0.54

Inflammatory diseases of female pelvic organs

414

2106

1.49

12.72

1.4

0.37

0.40

g/l

0.76

300

1488

Hypersensitivity pneumonitis due to organic dust

6.14

12.68

1.1

1.4

0.49

0.36

g/l

0.54

Other demyelinating diseases of the central nervous system

130

3.46

12.67

1.5

1.4

0.31

0.39

g/l

1.10

Persons encountering health services for specific procedures, not carried out

235

2.76

12.66

1.4

1.3

0.44

0.37

g/l

0.73

158

Pleural plaque

191

2.96

12.66

1.3

1.2

0.50

0.44

g/l

0.40

138

Sacroiliitis, not elsewhere classified

135

3.39

12.62

1.4

0.41

0.38

g/l

0.26

Bullous disorders

135

3.38

12.62

1.4

1.3

0.51

0.41

g/l

0.66

Subjective visual disturbances

170

930

1.84

12.62

1.4

1.3

0.32

0.40

g/l

3.64

128

629

Gonarthrosis

389

1474

1.52

12.60

1.3

1.4

0.40

0.42

g/l

0.26

281

1016

Scleritis and episcleritis

192

2.96

12.59

1.4

1.5

0.39

0.37

g/l

0.22

135

Diffuse large B-cell lymphoma

102

3.79

12.58

1.4

1.3

0.30

0.43

g/l

1.32

Disorders of muscles

317

2.49

12.57

1.3

0.42

g/l

0.02

218

Ischemic heart diseases

489

2128

1.44

12.53

1.4

0.43

0.40

g/l

0.85

345

1464

Non-Hodgkin lymphoma, all

4.28

12.48

1.4

1.2

0.29

0.39

g/l

0.69

Other diseases of oesophagus

231

2.75

12.48

1.2

1.3

0.36

0.41

g/l

0.42

163

Brachial plexus disorders

349

2.41

12.44

1.5

1.4

0.34

0.37

g/l

0.48

237

Other meningitis

5.52

12.38

1.6

1.2

0.30

0.39

g/l

0.52

Sleep disorders

164

893

1.85

12.37

1.3

1.4

0.35

0.40

g/l

1.13

111

622

Panic disorder

119

584

2.05

12.20

1.4

1.3

0.40

g/l

0.04

397

Nonorganic sleeping disorders

148

784

1.90

12.18

1.3

1.4

0.36

0.40

g/l

0.79

544

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

240

931

1.68

12.16

1.2

1.4

0.38

0.36

g/l

0.36

173

666

Coeliac disease

428

2.24

12.14

1.7

1.4

0.42

0.39

g/l

0.20

298

Other bursopathies

391

2.30

12.06

1.6

1.2

0.35

0.41

g/l

1.05

263

Failure and rejection of transplanted organs and tissues

5.87

12.06

1.3

0.38

0.35

g/l

0.16

Lichen simplex chronicus and prurigo

160

3.10

11.98

1.1

1.5

0.45

0.40

g/l

0.42

112

Special screening examination for other diseases and disorders

208

2.81

11.98

1.3

0.34

0.40

g/l

0.55

126

Postmenopausal osteoporosis with pathological fracture

120

3.47

11.95

1.3

0.26

0.41

g/l

2.14

Oter anti-inflammatory and antirheumatic agents, non-steroids

147

416

1.97

11.94

1.2

1.3

0.37

0.45

g/l

1.79

108

284

Ovarian cyst

259

912

1.65

11.93

1.3

1.4

0.35

0.39

g/l

1.12

179

622

Aortic aneurysm

127

632

1.99

11.88

1.4

1.3

0.47

0.45

g/l

0.20

443

Chronic tubulo-interstitial nephritis

3.93

11.84

1.3

1.5

0.43

0.36

g/l

0.51

Carpal tunnel syndrome

384

2356

1.48

11.76

1.4

0.40

0.41

g/l

0.42

280

1637

Obesity, other/unspecified

237

1453

1.64

11.73

1.5

1.4

0.44

0.39

g/l

0.39

187

1008

Erythema nodosum

4.09

11.71

1.6

1.4

0.38

0.35

g/l

0.21

Ulcerative rectosigmoiditis

280

2.53

11.71

1.3

0.33

0.37

g/l

0.56

193

Psoriatic arthropathies

328

2.40

11.71

1.3

1.4

0.43

0.44

g/l

0.12

224

Hyperlipidaemia, other/unspecified

216

1222

1.68

11.68

1.5

1.4

0.42

0.45

g/l

0.38

161

832

External causes of morbidity and mortality

505

1779

1.43

11.65

1.4

1.3

0.38

0.41

g/l

0.93

355

1237

Psoriasis vulgaris

133

691

1.94

11.63

1.2

1.3

0.41

g/l

0.03

478

Other disorders of conjunctiva

423

2.22

11.62

1.5

1.3

0.41

g/l

0.02

294

Cardiomyopathy

108

521

2.09

11.60

1.4

1.3

0.48

0.42

g/l

0.88

361

Hypothyroidism, strict autoimmune, 3 medication purchases required

551

2714

1.39

11.57

1.3

0.40

0.41

g/l

0.25

382

1935

Ischaemic heart disease, wide definition

475

2088

1.43

11.54

1.4

0.44

0.40

g/l

1.01

328

1444

Fenamates

104

324

2.18

11.51

1.5

1.3

0.36

0.46

g/l

2.16

223

Chronic periodontitis

101

477

2.14

11.49

1.4

1.3

0.44

0.43

g/l

0.08

326

Erythema multiforme

4.76

11.48

1.3

0.37

g/l

0.02

Crohn disease (strict definition, require KELA, min 2 HDR)

225

2.71

11.46

1.2

1.3

0.43

0.38

g/l

0.30

156

Subacute thyroiditis

3.75

11.44

1.5

1.4

0.28

0.37

g/l

1.14

Other neurological diseases

437

2454

1.44

11.42

1.4

0.39

0.41

g/l

0.70

304

1701

L04AC Interleukin inhibitors

165

3.02

11.41

1.3

1.4

0.33

0.37

g/l

0.25

113

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

5.51

11.41

1.5

1.2

0.48

0.40

g/l

0.29

Other peripheral vascular diseases

231

2.67

11.41

1.3

1.4

0.46

0.39

g/l

0.75

161

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.29

11.32

1.1

1.2

0.56

0.38

g/l

0.83

Other external causes of accidental injury

624

2291

1.37

11.31

1.4

1.3

0.39

0.41

g/l

0.46

433

1610

Diffuse large B-cell lymphoma, helper endpoint

110

3.52

11.30

1.4

1.2

0.30

0.40

g/l

1.05

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

110

3.52

11.30

1.4

1.2

0.30

0.40

g/l

1.05

Colectomy operation

107

520

2.07

11.30

1.4

1.3

0.48

0.40

g/l

0.87

362

Systemic lupus erythematosus, unspecified

3.73

11.29

1.4

0.50

0.34

g/l

1.17

Abnormal findings on examination of urine, without diagnosis

115

3.45

11.27

1.4

1.3

0.40

0.38

g/l

0.10

Crohn disease (strict definition, require KELA)

227

2.68

11.27

1.2

1.3

0.43

0.39

g/l

0.24

158

Enthesopathies of lower limb, excluding foot

142

762

1.88

11.25

1.5

1.3

0.38

0.42

g/l

1.06

104

508

372

2330

1.47

11.24

1.3

1.4

0.43

0.40

g/l

0.54

223

1614

Hernia of abdominal wall

279

1797

1.56

11.23

1.5

1.4

0.44

0.41

g/l

0.42

199

1253

Gout, unspecified

116

582

2.01

11.22

1.3

0.43

0.44

g/l

0.06

412

Meningitis

156

3.06

11.22

1.6

1.3

0.30

0.37

g/l

1.03

109

Faecal incontinence

199

2.79

11.22

1.4

1.2

0.29

0.43

g/l

2.74

131

Alcohol use disorder, Swedish definition

352

2207

1.49

11.20

1.2

1.4

0.43

0.40

g/l

0.46

211

1531

Other obstetric conditions, not elsewhere classified

241

958

1.64

11.20

1.2

1.4

0.38

0.36

g/l

0.25

175

685

Reactive arthropathies

281

2.48

11.13

1.4

0.43

0.45

g/l

0.10

187

Acute generalized exanthematous pustulosis

131

3.26

11.13

1.5

1.3

0.39

0.38

g/l

0.04

Coxarthrosis [arthrosis of hip](FG)

280

1293

1.57

11.12

1.3

0.46

0.41

g/l

0.97

218

877

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

641

2912

1.35

11.00

1.4

0.42

0.40

g/l

0.49

433

2061

Hodgkin lymphoma

4.09

10.99

1.6

1.2

0.41

0.31

g/l

0.88

Paracetamol of NSAID medication

128

320

2.02

10.95

1.4

1.3

0.37

0.43

g/l

0.89

231

Viral and other specified intestinal infections

153

828

1.82

10.91

1.6

1.3

0.39

0.40

g/l

0.03

102

579

Injuries to the abdomen, lower back, lumbar spine and pelvis

236

1464

1.61

10.85

1.2

1.4

0.43

0.41

g/l

0.29

171

1010

Haemolytic anaemias

3.69

10.84

1.7

1.3

0.40

0.39

g/l

0.01

Retention of urine

189

937

1.71

10.82

1.4

0.44

g/l

0.00

132

642

Substance abuse, excluding more controls

348

2064

1.48

10.81

1.3

1.4

0.40

0.42

g/l

0.34

236

1398

Viral pneumonia (known virus, not influenza)

4.52

10.79

1.4

1.2

0.36

0.41

g/l

0.22

Disorders of vestibular function (Vertigo)

280

1809

1.54

10.79

1.3

1.4

0.37

0.41

g/l

0.87

186

1264

Tongue abnormality

165

2.95

10.79

1.5

0.36

0.39

g/l

0.37

114

Extreme obesity with alveolar hypoventilation

104

3.52

10.75

1.4

1.3

0.31

0.37

g/l

0.41

Phlebitis and thrombophlebitis (not including DVT)

146

803

1.83

10.73

1.3

1.4

0.29

0.40

g/l

6.11

569

Cluster headache, strict, including avohilmo

155

3.02

10.72

1.3

0.31

0.37

g/l

0.67

106

Rosacea

412

2.18

10.71

1.3

1.4

0.41

g/l

0.02

286

Trochanteric bursitis

386

2.22

10.70

1.5

1.4

0.45

0.42

g/l

0.37

266

Disorders of plasma-protein metabolism, not elsewhere classified

7.92

10.68

1.3

0.34

0.33

g/l

—

Hodgkin lymphoma, hilmo

3.98

10.62

1.6

1.3

0.41

0.35

g/l

0.39

Other abnormalities of plasma proteins

5.94

10.61

1.9

1.2

0.44

0.39

g/l

0.07

391

2439

1.44

10.59

1.3

1.4

0.43

0.40

g/l

0.64

236

1690

Hyperparathyroidism

104

507

2.04

10.55

1.4

1.3

0.31

0.41

g/l

3.58

353

Dental caries, including avohilmo

520

1916

1.39

10.53

1.4

1.3

0.39

0.42

g/l

0.76

350

1352

Other CVD

103

507

2.04

10.52

1.4

1.3

0.38

0.43

g/l

0.96

352

Other and unspecified rosacea

277

2.45

10.50

1.3

1.5

0.40

0.41

g/l

0.08

195

Thyroiditis

236

2.58

10.45

1.5

0.29

0.43

g/l

3.58

166

Generalized skin eruption due to drugs and medicaments

111

3.39

10.44

1.5

1.3

0.43

0.36

g/l

0.30

Cluster headache, wide,, including avohilmo

163

2.93

10.42

1.3

0.31

0.38

g/l

0.94

110

Dental caries 1

520

1920

1.39

10.40

1.4

1.3

0.39

0.42

g/l

0.85

350

1356

Menorrhagia

243

834

1.62

10.36

1.4

0.37

0.39

g/l

0.53

170

572

Benign neoplasm: Pancreas

4.36

10.36

1.5

1.3

0.34

0.39

g/l

—

Secondary uncertain malignant neoplasm

353

2.26

10.36

1.5

1.4

0.41

0.42

g/l

0.12

250

Disorders of calcium metabolism

169

2.88

10.34

1.3

1.4

0.55

0.41

g/l

0.34

115

Optic neuritis

148

3.03

10.31

1.6

1.4

0.34

0.40

g/l

0.67

103

Isolated proteinuria

3.72

10.31

1.3

0.42

0.35

g/l

0.61

Other or ill-defined heart diseases

132

3.14

10.30

1.4

1.2

0.42

0.38

g/l

0.24

Spondylolisthesis/Spondylolysis

112

573

1.97

10.29

1.6

1.3

0.53

0.44

g/l

0.29

391

Hyperhidrosis

4.60

10.27

1.4

1.2

0.45

0.42

g/l

0.16

Substance use, excluding alcohol

145

808

1.81

10.24

1.4

1.3

0.39

0.38

g/l

0.09

100

557

Dental operations, only avohilmo

452

1638

1.42

10.21

1.4

0.40

0.42

g/l

0.41

303

1147

Cerebral palsy and other paralytic syndromes

394

2.18

10.20

1.3

1.4

0.32

0.40

g/l

1.96

277

Chronic hepatitis NAS

5.45

10.20

1.2

0.48

0.32

g/l

—

Dental caries 3 and operation codes

605

2306

1.35

10.18

1.4

0.41

0.42

g/l

0.32

410

1641

Cytomegalovirus infection, IBD co-morbidity

4.30

10.16

1.4

1.2

0.43

0.31

g/l

0.57

Neuromuscular dysfunction of bladder

257

2.48

10.16

1.3

0.36

0.40

g/l

0.23

179

Benign neoplasm: Pancreas

4.29

10.15

1.5

1.6

0.34

0.36

g/l

—

Otalgia

270

2.44

10.10

1.7

1.3

0.33

0.40

g/l

1.08

197

Carrier of infectious disease

4.04

10.10

1.6

1.3

0.30

0.37

g/l

0.50

Irregular menses

323

1772

1.48

10.09

1.5

1.4

0.34

0.41

g/l

2.51

231

1274

Other bullous disorders

4.03

10.09

1.2

1.4

0.46

0.39

g/l

0.35

Vitamin deficiency

124

3.19

10.03

1.2

1.4

0.40

0.38

g/l

0.12

Vitamin deficiency, wide

124

3.19

10.03

1.2

1.4

0.40

0.38

g/l

0.12

Synovial cyst of popliteal space [Baker]

183

2.76

10.03

1.3

0.32

0.42

g/l

1.47

126

Exophthalmic conditions

6.30

10.01

1.6

1.3

0.26

0.32

g/l

0.40

Accidents

613

2291

1.34

9.99

1.4

1.3

0.40

0.41

g/l

0.27

428

1610

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

242

2.51

9.94

1.2

1.3

0.43

0.39

g/l

0.23

167

Dystonia

173

2.82

9.93

1.4

1.5

0.37

0.36

g/l

0.06

117

Cardiomyopathy, other and unspecified

201

2.66

9.93

1.4

1.2

0.48

0.39

g/l

0.90

144

Acquired haemolytic anaemia

4.34

9.89

1.7

1.4

0.38

0.41

g/l

0.14

Other medical care

233

1452

1.57

9.81

1.3

1.4

0.40

0.43

g/l

0.46

163

1003

Hypotension

394

2.15

9.78

1.3

0.38

0.43

g/l

0.56

276

Coronary atherosclerosis

394

1783

1.43

9.77

1.4

0.45

0.40

g/l

1.34

277

1219

Episcleritis

164

2.85

9.72

1.5

1.4

0.40

0.37

g/l

0.21

116

Other/unspecified reactive arthropathies

221

2.57

9.72

1.4

1.3

0.44

0.37

g/l

0.60

154

Tuberculosis, IBD comorbidity

153

2.90

9.70

2.1

1.4

0.49

0.43

g/l

0.43

111

Insomnia

120

642

1.88

9.70

1.4

0.36

0.40

g/l

0.82

450

Achalasia of cardia

5.40

9.68

1.3

1.4

0.25

0.29

g/l

—

Neuralgia and neuritis, unspecified

132

3.07

9.68

1.4

0.34

0.35

g/l

0.13

Cytomegaloviral disease

4.10

9.57

1.4

1.3

0.43

0.32

g/l

0.56

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

179

1079

1.67

9.56

1.2

1.3

0.34

0.40

g/l

1.87

122

735

Injury, poisoning and certain other consequences of external causes

402

1414

1.43

9.49

1.5

1.3

0.40

0.41

g/l

0.28

290

950

Viral meningitis

113

3.24

9.49

1.4

1.3

0.28

0.39

g/l

1.94

Other congenital malformations

341

2.22

9.48

1.3

1.4

0.42

0.37

g/l

0.83

247

Disorders of refraction and accommodation

190

1162

1.64

9.47

1.4

1.3

0.39

g/l

0.01

144

813

Type 2 diabetes, definitions combined

605

2725

1.33

9.46

1.4

0.40

g/l

0.02

408

1921

Abnormality of white blood cells, not elsewhere classified

6.83

9.45

1.3

1.2

0.23

0.32

g/l

—

Diseases of inner ear

318

2139

1.46

9.45

1.3

1.4

0.38

0.41

g/l

0.98

208

1495

Covid-19 suspected case

155

903

1.73

9.43

1.4

1.3

0.51

0.39

g/l

1.29

134

616

Mouth breathing

271

1805

1.51

9.41

1.4

0.43

0.41

g/l

0.15

185

1263

Amyloidosis

5.25

9.40

1.5

1.4

0.23

0.37

g/l

1.01

Special screening examination for infectious and parasitic diseases

149

633

1.77

9.39

1.4

1.3

0.34

0.39

g/l

1.51

114

363

Falls/tendency to fall

791

3090

1.28

9.38

1.4

0.40

g/l

0.17

551

2152

Procreative management

239

1302

1.56

9.38

1.5

1.4

0.35

0.37

g/l

0.43

161

898

Umbilical hernia

168

1003

1.68

9.34

1.5

1.4

0.47

0.41

g/l

0.96

116

700

Endometriosis

233

878

1.59

9.34

1.3

1.4

0.41

0.39

g/l

0.15

171

599

Hyperkinetic disorders, excluding more controls

385

2.12

9.28

1.3

0.34

0.39

g/l

0.99

259

conjunctival haemorrhage

191

2.65

9.27

1.6

1.3

0.37

0.43

g/l

0.51

135

Fentanyl

214

2.54

9.26

1.4

1.2

0.40

0.46

g/l

0.43

154

Small fibre neuropathy

3.77

9.21

1.6

1.3

0.49

0.41

g/l

0.24

Benign paroxysmal vertigo

168

1007

1.68

9.21

1.3

1.4

0.36

0.41

g/l

0.84

109

698

Dental pulpitis 4, only avohilmo

755

3069

1.29

9.18

1.4

0.39

0.41

g/l

0.75

508

2154

Acute bronchiolitis

224

2.44

9.18

1.4

1.3

0.37

0.36

g/l

0.12

177

Anaemia in chronic diseases classified elsewhere

4.35

9.17

1.4

1.2

0.52

0.38

g/l

0.28

Disorders of lipoprotein metabolism and other lipidaemias

484

2237

1.36

9.12

1.4

0.40

0.42

g/l

0.39

349

1540

Other and unspecified visual disturbances

290

2.30

9.07

1.8

1.3

0.33

0.41

g/l

1.21

200

Benign neoplasm: Small intestine

106

3.26

9.07

1.2

1.5

0.46

0.42

g/l

0.21

Erosion of teeth

4.19

9.06

1.3

0.37

0.36

g/l

0.04

Etanercept

217

2.52

9.05

1.5

1.3

0.47

0.38

g/l

0.87

152

Disorders of vitreous body and globe

286

1895

1.48

9.02

1.4

0.37

0.42

g/l

1.24

211

1317

Chronic suppurative otitis media, including avohilmo

266

2.36

9.01

1.8

1.4

0.32

0.41

g/l

1.99

188

Allergic purpura

3.60

8.99

1.3

0.36

0.35

g/l

0.05

Other hearing loss

143

811

1.74

8.98

1.5

1.3

0.37

0.45

g/l

1.66

560

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

138

2.93

8.98

1.5

1.2

0.47

0.42

g/l

0.27

101

Conductive and sensorineural hearing loss

468

2384

1.36

8.95

1.5

1.3

0.41

g/l

0.03

323

1662

Benign neoplasm: Small intestine

107

3.23

8.94

1.2

1.4

0.46

0.39

g/l

0.46

Diplopia

430

2.04

8.89

1.9

1.3

0.37

0.41

g/l

0.52

305

Diabetes insipidus

5.96

8.89

1.9

1.2

0.28

0.32

g/l

—

Type 2 diabetes, strict (exclude DM1)

606

2758

1.31

8.87

1.4

0.40

g/l

0.02

409

1935

Nummular dermatitis

219

2.49

8.87

1.4

0.33

0.42

g/l

1.31

156

Ankylosing spondylitis, ICD10

327

2.19

8.74

1.3

0.39

0.38

g/l

0.02

226

Injuries to the knee and lower leg

786

3552

1.27

8.73

1.5

1.4

0.38

0.41

g/l

1.58

566

2459

Other bacterial agents as the cause of diseases classified to other chapters

6.22

8.72

1.2

0.39

0.36

g/l

—

Unspecified/other endometriosis

347

2.15

8.70

1.5

1.4

0.30

0.39

g/l

1.82

238

Sensorineural hearing loss

436

2233

1.37

8.65

1.5

1.3

0.41

g/l

0.05

295

1552

Coxarthrosis

260

1172

1.51

8.65

1.3

1.4

0.47

0.43

g/l

0.43

201

811

Disorders of vitreous body

277

1848

1.47

8.63

1.4

0.38

0.42

g/l

1.08

202

1285

Haemorrhage, not elsewhere classified

3.99

8.62

1.2

1.3

0.39

0.50

g/l

0.67

Cellulitis

137

792

1.74

8.61

1.4

1.3

0.39

0.41

g/l

0.21

110

548

Dental caries 3

545

2093

1.33

8.60

1.4

0.40

0.42

g/l

0.87

365

1488

Other diseases of anus and rectum

159

956

1.67

8.60

1.2

1.4

0.46

0.43

g/l

0.15

126

663

Allergic urticaria

272

2.30

8.58

1.3

1.5

0.35

0.38

g/l

0.43

189

Diabetes, insulin treatment (Kela reimbursement)

652

3088

1.29

8.57

1.4

0.42

0.40

g/l

0.45

441

2174

Lupus erythematosus

4.12

8.56

1.2

0.52

0.37

g/l

0.54

Benign neoplasm of major salivary glands

285

2.27

8.55

1.6

1.4

0.36

0.40

g/l

0.35

199

Benign neoplasm: salivary glands, exclude unknown (D119)

254

2.35

8.53

1.6

1.4

0.36

0.41

g/l

0.46

177

Diabetes medication

682

3232

1.29

8.49

1.4

0.41

0.40

g/l

0.28

463

2281

Oesophagitis

121

3.01

8.47

1.3

1.2

0.42

0.38

g/l

0.19

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.72

8.47

1.3

1.4

0.60

0.43

g/l

0.91

Benign neoplasm: Duodenum

3.95

8.46

1.2

1.5

0.50

0.39

g/l

0.61

Benign neoplasm: Ascending colon

371

2.09

8.45

1.4

1.3

0.56

0.42

g/l

0.38

258

Unspecified misadventure during surgical and medical care

149

2.79

8.41

1.3

1.4

0.45

0.38

g/l

0.62

103

Childhood allergy (age < 16)

115

519

1.84

8.40

1.4

1.3

0.37

g/l

0.07

368

Adenocarcinoma of pancreas

4.52

8.39

1.1

1.2

0.59

0.42

g/l

0.56

Viral encephalitis, not elsewhere classified/unspecified

4.06

8.39

1.3

0.29

0.38

g/l

0.74

Tuberculosis, wide

166

2.67

8.38

2.1

1.4

0.49

0.44

g/l

0.34

119

Dental pulpitis 1, only avohilmo

751

3091

1.27

8.34

1.4

0.39

0.41

g/l

0.53

504

2172

Gout, strict definition

496

1.93

8.33

1.4

1.3

0.44

0.46

g/l

0.20

352

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

152

828

1.68

8.32

1.3

0.37

0.38

g/l

0.29

111

587

Vasomotor rhinitis (mode)

214

2.46

8.31

1.7

1.4

0.35

0.37

g/l

0.23

147

Other abnormal findings of blood chemistry

112

3.08

8.30

1.6

1.3

0.33

0.37

g/l

0.31

Other obstructive and reflux uropathy

112

3.07

8.29

1.2

1.3

0.49

0.37

g/l

0.39

Ulcer of oesophagus

156

2.72

8.25

1.3

1.2

0.48

0.42

g/l

0.34

107

Complications of internal orthopaedic prosthetic devices, implants and grafts

119

670

1.79

8.21

1.3

1.4

0.37

0.44

g/l

1.21

461

CR(E)ST syndrome

4.65

8.18

1.4

1.3

0.31

0.38

g/l

0.36

Malignant neoplasm of pancreas

129

2.90

8.18

1.2

1.3

0.48

0.45

g/l

0.10

Other noninflammatory disorders of vulva and perineum

310

2.18

8.17

1.4

1.3

0.39

0.40

g/l

0.06

211

Lesion of ulnar nerve

514

1.90

8.15

1.5

1.3

0.36

0.41

g/l

0.93

360

Benign neoplasm: Duodenum

3.83

8.11

1.2

1.3

0.50

0.49

g/l

0.05

Supplementary factors related to causes of morbidity and mortality classified elsewhere

195

1253

1.56

8.11

1.6

1.3

0.38

0.40

g/l

0.53

145

859

Colonic or urogenital fistula

170

1058

1.62

8.10

1.2

1.3

0.51

0.41

g/l

0.46

113

731

Type 2 diabetes, definitions combined, including avohilmo

605

2766

1.30

8.09

1.4

0.40

g/l

0.08

404

1944

Juvenile arthritis (FINNGEN)

158

2.69

8.08

1.3

0.39

0.36

g/l

0.20

111

Duodenal ulcer

229

2.37

8.07

1.2

1.3

0.54

0.43

g/l

0.62

162

Endometriosis of pelvic peritoneum

114

629

1.80

8.06

1.4

0.46

0.40

g/l

0.43

433

Iron deficiency anaemia secondary to blood loss (chronic)

467

1.94

8.05

1.5

1.3

0.40

0.42

g/l

0.25

325

Ulcer of lower limb, not elsewhere classified

365

2.07

8.03

1.3

0.39

0.42

g/l

0.26

255

Benign neoplasm: Ascending colon

379

2.05

8.01

1.4

0.56

0.41

g/l

0.40

265

Viral warts

346

2.10

7.99

1.5

1.4

0.33

0.41

g/l

1.59

235

Fall on same level

781

3480

1.26

7.98

1.3

1.4

0.43

0.40

g/l

0.59

550

2428

Other and unspecified disorders of vitreous body

230

1529

1.50

7.97

1.4

0.37

0.41

g/l

0.93

173

1057

Filling of root of tooth

3.32

7.97

1.9

1.3

0.29

0.36

g/l

0.68

Acute epiglottitis

5.28

7.97

1.6

1.4

0.40

0.42

g/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.33

7.96

1.1

1.2

0.59

0.41

g/l

0.65

Injuries to the ankle and foot

458

3137

1.33

7.95

1.4

1.3

0.40

g/l

0.05

341

2167

Other diseases of arteries and capillaries

237

2.34

7.95

1.7

1.4

0.38

0.39

g/l

0.09

169

Heart failure and coronary heart disease

150

669

1.68

7.95

1.4

0.49

0.45

g/l

0.43

107

458

Vitamin D deficiency

4.03

7.94

1.1

1.4

0.37

0.33

g/l

0.23

Acute nasopharyngitis (common cold)

398

2.01

7.93

1.3

0.40

0.39

g/l

0.09

255

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

225

2.38

7.93

1.5

1.4

0.39

g/l

0.01

160

Fibroblastic disorders

126

729

1.74

7.93

1.4

1.3

0.45

0.44

g/l

0.06

502

Other specified/unspecified bacterial intestinal infections

177

2.57

7.92

1.2

1.5

0.32

0.36

g/l

0.44

123

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.99

7.91

1.2

0.63

0.43

g/l

1.00

Superficial injury of lower leg

155

951

1.64

7.84

1.3

0.36

0.40

g/l

0.83

121

650

Olecranon bursitis

178

2.56

7.84

1.4

1.2

0.40

0.42

g/l

0.16

122

Nonspecific lymphadenitis

208

2.43

7.84

1.5

1.3

0.42

0.36

g/l

0.71

149

STROKE

346

1721

1.40

7.82

1.3

1.4

0.43

0.39

g/l

0.41

250

1178

Diseases of external ear

204

1336

1.53

7.80

1.3

1.4

0.38

0.41

g/l

0.84

149

929

Arthropathic psoriasis

397

2.01

7.78

1.3

1.4

0.45

0.39

g/l

0.87

278

Benign neoplasm: Descending colon

167

2.60

7.77

1.3

1.4

0.47

0.40

g/l

0.61

122

Polycystic ovarian syndrome, consortium definition

457

2061

1.34

7.77

1.4

0.35

0.41

g/l

2.72

322

1465

TMD muscular pain linked with fibromyalgia

5.21

7.74

1.9

1.4

0.35

0.26

g/l

—

Post-traumatic stress disorder

285

2.20

7.71

1.3

0.34

0.41

g/l

1.19

191

Other specified and unspecified disorders of eyelid

5.14

7.71

1.9

1.3

0.20

0.39

g/l

—

Type of accident

178

1134

1.58

7.71

1.6

1.3

0.39

0.41

g/l

0.32

133

780

Glaucoma

296

1830

1.42

7.69

1.3

1.4

0.40

0.43

g/l

0.21

197

1285

Hyperkalaemia

112

2.98

7.66

1.7

1.3

0.39

0.48

g/l

0.66

Excessive attrition of teeth

269

997

1.47

7.60

1.5

1.4

0.37

0.40

g/l

0.57

191

679

Symptoms and signs involving emotional state

3.21

7.57

1.1

1.3

0.31

0.37

g/l

0.59

Dental caries 1, only avohilmo

517

2011

1.32

7.57

1.4

1.3

0.40

0.42

g/l

0.69

347

1422

Chronic suppurative otitis media

200

2.42

7.50

1.8

1.3

0.34

0.39

g/l

0.69

140

Stenosis and insufficiency of lacrimal passages

269

2.21

7.50

1.3

0.37

0.43

g/l

0.53

191

Other/unspecified cytomegaloviral diseases

3.99

7.48

1.4

1.2

0.42

0.31

g/l

0.49

Appendectomy

419

3028

1.34

7.47

1.3

1.4

0.41

0.40

g/l

0.15

284

2117

Other coagulation defects

238

2.29

7.45

1.5

1.4

0.30

0.39

g/l

1.94

162

MS-disease / Multiple Sclerosis

270

2.21

7.45

1.4

0.30

0.38

g/l

1.42

189

Benign neoplasm of major salivary glands

303

2.13

7.41

1.6

1.4

0.36

0.39

g/l

0.27

212

Other/unspecified synovitis and tenosynovitis

363

2.03

7.41

1.5

1.3

0.35

0.42

g/l

1.06

254

Postprocedural disorders of digestive system, not elsewhere classified

3.39

7.40

2.2

1.2

0.32

0.36

g/l

0.36

Adhesive capsulitis of shoulder

101

560

1.81

7.39

1.3

0.39

0.42

g/l

0.47

382

Hypertensive heart and/or renal disease

127

576

1.72

7.39

1.4

0.54

0.42

g/l

0.50

382

Fracture of lumbar spine and pelvis

110

625

1.77

7.38

1.2

1.3

0.42

0.41

g/l

0.04

430

Hallux valgus (acquired)

188

877

1.56

7.37

1.5

1.4

0.40

0.43

g/l

0.64

141

608

Disorders of choroid and retina

462

2552

1.32

7.35

1.4

0.38

0.41

g/l

0.98

314

1778

Pneumonitis due to solids and liquids

172

2.52

7.33

1.3

1.2

0.38

0.43

g/l

0.29

123

Other follicular disorders

259

2.22

7.33

1.4

0.40

0.39

g/l

0.05

178

Thoracic aortic aneurysm

406

1.96

7.32

1.5

1.3

0.45

0.42

g/l

0.17

287

Other and unspecified follicular disorders

110

2.95

7.30

1.5

1.3

0.37

g/l

0.02

Spondylopathies in diseases classified elsewhere

5.54

7.30

1.2

0.32

0.46

g/l

—

Adult respiratory distress syndrome

5.53

7.29

1.1

1.2

0.23

0.34

g/l

—

Other retinal disorders

341

1992

1.38

7.28

1.4

0.39

0.43

g/l

1.01

227

1381

Cervicocranial syndrome

305

2.11

7.28

1.5

1.3

0.29

0.45

g/l

5.86

216

Abnormal involuntary movements

435

1.92

7.26

1.4

1.3

0.34

0.41

g/l

1.32

303

Benign neoplasm: Descending colon

173

2.51

7.26

1.3

1.4

0.47

0.41

g/l

0.39

119

Other embolism and thrombosis

415

1.94

7.22

1.8

1.3

0.37

0.40

g/l

0.40

291

Unspecified haematuria

224

1298

1.48

7.21

1.6

1.4

0.40

0.43

g/l

0.63

167

890

Personality disorders

188

1234

1.53

7.17

1.3

0.37

0.38

g/l

0.22

129

848

Cramp and spasm

145

2.66

7.15

1.4

0.35

0.41

g/l

0.41

101

Other juvenile arthritis

145

2.66

7.15

1.3

1.4

0.41

0.39

g/l

0.11

Other keratitis

382

1.98

7.14

1.4

0.34

0.40

g/l

0.84

265

Lichen planus

403

1.95

7.13

1.9

1.3

0.32

0.41

g/l

1.68

281

Peritonsillar abscess

118

692

1.71

7.13

1.3

0.40

g/l

0.02

447

Noninflammatory disorders of female genital tract

278

971

1.45

7.12

1.4

0.40

0.39

g/l

0.15

196

671

Cardiomyopathies, Primary/intrinsic

349

2.02

7.07

1.4

1.3

0.49

0.43

g/l

0.60

240

Ulcerative proctitis

206

2.36

7.06

1.4

1.3

0.33

0.38

g/l

0.73

145

Metatarsalgia

276

2.15

7.06

1.6

1.3

0.29

0.42

g/l

3.07

191

Other disorders of kidney and ureter

398

1.95

7.03

1.4

0.46

0.41

g/l

0.25

281

Conduction disorders

148

763

1.62

7.01

1.3

0.43

0.40

g/l

0.46

100

532

Excessive vomiting in pregnancy

317

2.07

7.00

1.4

1.5

0.37

0.40

g/l

0.19

218

Vascular diseases of the intestine

3.42

6.98

1.1

1.3

0.48

0.41

g/l

0.28

Other disorders of central nervous system

4.98

6.98

1.5

1.4

0.28

0.36

g/l

—

Other and unspecified iridocyclitis

113

2.87

6.97

1.8

1.3

0.36

0.39

g/l

0.22

Preparation and fitting of bite rail to mouth

102

579

1.78

6.95

1.5

1.4

0.43

0.38

g/l

0.62

403

Other localized connective tissue disorders

4.04

6.93

1.6

1.2

0.31

0.35

g/l

—

Later onset COPD

115

525

1.73

6.90

1.1

1.4

0.59

0.45

g/l

2.15

370

Infective dermatitis

380

1.96

6.90

1.4

1.3

0.50

0.42

g/l

0.88

271

Other endocrine disorders

212

2.30

6.89

1.3

0.37

g/l

0.00

168

Other contact dermatitis

253

2.19

6.87

1.5

1.4

0.30

0.40

g/l

1.71

180

Phobic anxiety disorders

515

1.82

6.87

1.5

1.3

0.38

0.40

g/l

0.12

346

Disorders of adult personality and behaviour

197

1320

1.50

6.84

1.3

1.4

0.36

0.38

g/l

0.45

139

913

Other and unspecified nerve root and plexus disorders, also in other diseases

118

701

1.69

6.83

1.3

0.38

0.41

g/l

0.40

489

Superficial injury of abdomen, lower back and pelvis

538

1.80

6.83

1.2

1.4

0.47

0.40

g/l

0.72

378

Non-allergic asthma

280

2.12

6.82

1.9

1.5

0.49

0.40

g/l

0.82

198

Other symptoms and signs involving cognitive functions and awareness

232

1504

1.45

6.80

1.3

1.4

0.39

0.43

g/l

0.56

166

1030

Restless leg syndrome

396

1.93

6.80

1.7

1.4

0.37

0.41

g/l

0.51

274

Decubitus ulcer and pressure area

109

2.87

6.80

1.5

1.2

0.52

0.46

g/l

0.27

Seborrhoeic keratosis

119

710

1.68

6.78

1.6

1.3

0.42

0.41

g/l

0.13

493

Disorders of continuity of bone

321

2.04

6.77

1.5

1.3

0.37

0.38

g/l

0.08

219

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

5.13

6.74

1.3

1.2

0.27

0.30

g/l

—

Eustachian salpingitis and obstruction

322

2.04

6.73

1.6

1.3

0.33

0.41

g/l

1.11

222

Psoriatic arthropathies, ICD10

398

1.93

6.71

1.3

1.4

0.43

0.39

g/l

0.48

275

Operations 2 for CAVS

130

779

1.64

6.67

1.4

0.48

0.44

g/l

0.58

550

Calcific aortic valvular stenosis, diagnosis (helper)

130

779

1.64

6.67

1.4

0.48

0.44

g/l

0.58

550

Artrosis, including avohilmo

540

2313

1.28

6.67

1.3

1.4

0.40

g/l

0.05

386

1582

Inflammation of lacrimal passages (acute and unspecified)

4.09

6.66

1.7

1.2

0.32

0.36

g/l

0.26

Other diseases of blood and blood-forming organs

187

2.38

6.63

1.3

1.4

0.34

0.36

g/l

0.20

129

Hypertensive Heart Disease

110

524

1.72

6.62

1.5

1.3

0.53

0.42

g/l

0.35

349

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

197

1314

1.49

6.62

1.4

0.38

g/l

0.02

152

926

Vulvovaginal ulceration/inflammation in other diseases

206

2.31

6.62

1.5

1.4

0.41

0.39

g/l

0.19

145

Cardiomyopathy (excluding other)

358

1.97

6.61

1.4

1.3

0.49

0.43

g/l

0.65

246

Osteonecrosis

157

2.51

6.61

1.5

1.4

0.35

0.37

g/l

0.09

107

Calcific aortic valvular stenosis, including rheumatic fever

130

782

1.63

6.56

1.4

0.48

0.44

g/l

0.57

553

Other enthesopathy of foot (+metatarsalgia)

305

2.05

6.53

1.5

1.3

0.29

0.42

g/l

3.37

208

Unspecified fall

281

2012

1.39

6.53

1.5

1.4

0.40

0.41

g/l

0.11

188

1403

Nail disorders

272

2.11

6.52

1.2

1.4

0.37

0.40

g/l

0.18

190

Injuries to the wrist and hand

632

3674

1.25

6.52

1.3

1.4

0.38

0.40

g/l

0.97

453

2551

Calcific aortic valvular stenosis, operated

130

784

1.63

6.52

1.4

0.48

0.44

g/l

0.55

555

Calcific aortic valvular stenosis

130

784

1.63

6.52

1.4

0.48

0.44

g/l

0.55

555

Glaucoma suspect

190

1277

1.49

6.51

1.4

0.43

g/l

0.01

129

887

Dental caries 3, only avohilmo

543

2175

1.28

6.46

1.4

0.40

0.42

g/l

0.84

364

1545

Fracture of rib(s), sternum and thoracic spine

157

1016

1.55

6.43

1.2

1.3

0.45

0.42

g/l

0.24

118

697

Adjustment and management of implanted device

504

1.79

6.43

1.1

1.3

0.41

0.46

g/l

0.70

357

Glucagon-like peptide-1 (GLP-1) analogues

298

1784

1.38

6.43

1.3

1.4

0.47

0.42

g/l

0.89

208

1228

Presence of cardiac and vascular implants and grafts

217

1129

1.46

6.37

1.4

0.44

g/l

0.06

166

789

Cardiodefibrillation

179

1194

1.50

6.33

1.3

1.4

0.44

g/l

0.03

108

832

Kidney transplant status

179

2.38

6.32

1.7

1.3

0.47

0.38

g/l

0.77

127

Acne

385

1.91

6.32

1.3

0.42

0.40

g/l

0.24

263

Dental pulpitis 2

441

1727

1.31

6.31

1.4

1.3

0.39

0.42

g/l

1.09

295

1219

Injuries to the thorax

243

1723

1.41

6.29

1.3

1.4

0.42

g/l

0.04

181

1180

Complications following infusion, transfusion and therapeutic injection

4.51

6.27

1.5

1.3

0.31

0.38

g/l

—

Anogenital herpesviral [herpes simplex] infection

224

2.21

6.26

1.5

1.4

0.36

g/l

0.01

152

Pure hypercholesterolaemia

396

2018

1.32

6.25

1.4

0.40

0.42

g/l

0.33

283

1382

Other specified and unspecified retinal disorders

3.09

6.21

1.6

1.2

0.29

0.38

g/l

1.15

Other protozoal intestinal diseases

4.05

6.21

1.5

1.3

0.29

0.35

g/l

0.33

Tuberculosis

132

2.60

6.21

1.9

1.3

0.47

0.43

g/l

0.28

Other disorders of eyelid

223

1507

1.43

6.20

1.5

1.3

0.37

0.43

g/l

1.80

163

1057

Perforation of tympanic membrane

305

2.02

6.18

1.3

1.4

0.38

0.41

g/l

0.22

214

Hard cardiovascular diseases

453

2251

1.29

6.17

1.3

1.4

0.46

0.40

g/l

0.80

334

1523

Dental pulpitis 2, only avohilmo

450

1772

1.30

6.17

1.4

1.3

0.39

0.42

g/l

1.13

300

1257

Disorders resulting from impaired renal tubular function

2.87

6.12

1.3

0.58

0.41

g/l

0.39

Lesion of lateral popliteal nerve

139

2.55

6.12

1.4

1.3

0.38

0.39

g/l

0.08

Prurigo nodularis

3.81

6.11

1.1

1.4

0.49

0.36

g/l

0.55

Abnormal blood-pressure reading, without diagnosis

2.86

6.11

1.5

1.4

0.28

0.42

g/l

2.14

Use of pramipexole

120

739

1.63

6.10

1.4

0.36

0.40

g/l

0.80

514

Lateral epicondylitis

462

1.81

6.09

1.5

1.3

0.37

0.40

g/l

0.62

312

Autoimmune thyroiditis

3.66

6.07

1.3

1.2

0.27

0.41

g/l

1.74

Acute peritonitis

164

2.40

6.05

1.5

1.3

0.47

0.41

g/l

0.30

115

Allergic colitis

100

2.85

6.02

1.3

1.4

0.34

0.41

g/l

0.68

Other aneurysm

123

2.63

5.98

1.6

1.3

0.63

0.42

g/l

1.50

Other and unspecified psoriasis

190

2.28

5.97

1.2

1.5

0.49

0.40

g/l

0.68

133

Substance abuse

348

2517

1.32

5.96

1.3

1.4

0.40

g/l

0.02

236

1720

Atypical facial pain

147

2.48

5.96

1.6

1.4

0.32

0.38

g/l

0.67

103

Sudden idiopathic hearing loss

297

2.00

5.88

1.8

1.3

0.37

0.41

g/l

0.34

212

Barrett oesophagus

107

2.74

5.87

1.5

1.2

0.53

0.39

g/l

0.36

Polyuria

123

770

1.61

5.86

1.4

1.3

0.39

0.43

g/l

0.43

540

Corneal ulcer

114

701

1.64

5.85

1.6

1.4

0.40

g/l

0.02

488

Crohn disease (strict definition, all UC cases excluded)

173

2.34

5.85

1.1

1.3

0.36

g/l

0.04

121

Peripheral artery disease

199

1106

1.45

5.81

1.4

0.50

0.44

g/l

0.98

151

756

Elevated blood glucose level

245

2.10

5.78

2.1

1.3

0.36

0.40

g/l

0.32

164

Trigeminal neuralgia

174

2.32

5.77

1.7

1.4

0.36

0.38

g/l

0.13

122

Idiopathic gout

232

2.13

5.76

1.4

1.3

0.47

0.43

g/l

0.31

161

Other sleep disorders

341

1.92

5.76

1.4

0.38

0.40

g/l

0.09

248

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

0.35

0.40

g/l

0.36

106

Mental and behavioural disorders due to tobacco

280

2.02

5.71

1.3

1.4

0.40

0.38

g/l

0.12

190

Mental and behavioural disorders due to psychoactive substance use

358

2584

1.31

5.69

1.3

1.4

0.40

g/l

0.03

239

1774

Other diseases of gallbladder

2.99

5.69

1.2

1.3

0.29

0.39

g/l

1.08

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

566

2686

1.25

5.69

1.3

1.4

0.40

g/l

0.00

376

1897

Other disorders of optic [2nd] nerve and visual pathways

188

2.26

5.68

1.5

1.3

0.39

g/l

0.02

132

Malignant neoplasm, wide definition for exclusion

566

2687

1.25

5.67

1.3

1.4

0.40

g/l

0.00

376

1897

Drug-induced neutropenia

214

2.17

5.67

1.4

1.5

0.39

0.37

g/l

0.10

146

Ganglion

122

769

1.59

5.67

1.5

1.3

0.40

g/l

0.07

521

Heterophoria

295

1.98

5.64

1.6

1.5

0.37

0.36

g/l

0.06

200

Atherosclerosis, excluding cerebral and coronary sclerosis

183

1000

1.47

5.64

1.4

0.50

0.43

g/l

0.88

135

693

Disturbance of activity and attention

439

1.79

5.61

1.4

0.34

0.38

g/l

0.63

315

Iron deficiency

3.34

5.61

1.2

0.37

0.38

g/l

0.04

Other and unspecified diseases of blood and blood-forming organs

3.33

5.61

1.4

1.3

0.34

0.37

g/l

0.11

Smoking dependency

282

2.00

5.60

1.3

1.4

0.40

0.38

g/l

0.12

191

Intestinal adhesions without obstruction

202

2.19

5.59

1.7

1.4

0.34

0.43

g/l

0.98

144

Other psoriatic arthropathies

388

1.84

5.57

1.3

1.4

0.42

0.39

g/l

0.43

269

Open wound of lower leg

490

1.74

5.57

1.6

1.3

0.34

0.40

g/l

1.43

341

Appendicitis, broad definition

463

3354

1.26

5.57

1.4

0.41

0.40

g/l

0.04

305

2341

Other and unspecified acquired haemolytic anaemias

5.39

5.56

2.0

1.2

0.41

0.30

g/l

—

Infections with a predominantly sexual mode of transmission

199

1394

1.43

5.56

1.3

1.4

0.38

0.39

g/l

0.06

146

951

Other and unspecified glaucoma

152

2.39

5.55

1.6

1.3

0.30

0.44

g/l

2.01

104

Other extrapyramidal and movement disorders in other diseases

124

789

1.58

5.55

1.5

1.3

0.37

0.41

g/l

0.80

550

Otitis externa

136

884

1.55

5.54

1.3

0.37

0.40

g/l

0.50

108

615

Correction of physiology of bite - very demanding therapy visit

2.88

5.54

1.4

0.39

0.40

g/l

0.03

Artificial joint operation, meniscal resection

528

2815

1.25

5.52

1.4

0.40

0.41

g/l

0.42

356

1957

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

564

2686

1.24

5.51

1.3

1.4

0.40

g/l

0.01

374

1896

Impetigo

153

2.38

5.49

1.4

1.2

0.57

0.38

g/l

0.44

113

Diseases of appendix

465

3365

1.26

5.49

1.4

0.41

0.40

g/l

0.02

307

2349

Desensitization to allergens

217

2.14

5.49

1.3

1.4

0.33

0.37

g/l

0.72

148

Dislocation, sprain and strain of joints and ligaments of knee

382

2752

1.29

5.49

1.4

1.3

0.36

0.41

g/l

2.11

265

1891

Disorder of the sleep-wake schedule

3.53

5.48

1.3

0.37

g/l

0.03

Oesophageal varices

2.80

5.48

1.8

1.3

0.60

0.36

g/l

1.19

Acute appendicitis, no complications

351

2691

1.30

5.45

1.4

0.38

0.40

g/l

0.59

230

1875

Superficial injury of hip and thigh

405

1.81

5.44

1.3

0.43

0.41

g/l

0.14

279

Abrasion of teeth

171

854

1.48

5.41

1.3

1.4

0.38

0.40

g/l

0.21

120

574

Benign neoplasm of mouth and pharynx

356

1.87

5.41

1.4

1.3

0.36

0.39

g/l

0.30

245

Localized scleroderma [morphea]

4.20

5.39

1.5

1.2

0.32

0.34

g/l

—

Contact with and exposure to communicable diseases

215

1532

1.40

5.37

1.4

0.30

0.38

g/l

3.60

110

1091

Injuries to the head

690

3715

1.21

5.36

1.5

1.3

0.37

0.41

g/l

1.70

479

2601

Familial hypercholesterolemia

459

1.75

5.35

1.6

1.4

0.40

0.45

g/l

0.68

315

Haemorrhage in early pregnancy

180

1218

1.45

5.34

1.2

1.4

0.33

0.39

g/l

2.07

135

870

Type 1 diabetes

159

1076

1.48

5.33

1.5

1.3

0.43

0.39

g/l

0.40

110

756

Myeloid leukaemia

3.32

5.32

1.5

1.3

0.34

0.40

g/l

0.40

Other and unspecified myopathies

213

2.13

5.32

1.5

1.4

0.36

0.42

g/l

0.56

147

Benign neoplasm of mouth and pharynx

358

1.86

5.32

1.4

0.36

0.40

g/l

0.42

247

Generalized anxiety disorder

588

1.66

5.31

1.3

0.37

0.40

g/l

0.32

392

Erosion of teeth, including avohilmo

125

778

1.56

5.29

1.3

1.4

0.39

0.40

g/l

0.15

529

Other maternal disorders predominantly related to pregnancy

364

1762

1.30

5.25

1.2

1.4

0.35

0.40

g/l

1.82

262

1259

Acne vulgaris

289

1.95

5.25

1.2

1.3

0.40

0.37

g/l

0.21

198

Benign neoplasm: Rectum, anus and anal canal

101

621

1.63

5.23

1.5

1.4

0.39

0.42

g/l

0.46

441

Neovascular glaucoma

2.78

5.21

1.5

1.3

0.40

0.35

g/l

0.21

Mature T/NK-cell lymphomas, hilmo

4.09

5.20

1.3

1.2

0.27

0.31

g/l

—

Papilloedema, unspecified

3.27

5.19

1.4

0.30

0.36

g/l

0.50

Chronic Coagulation defects

2.98

5.17

1.7

1.3

0.30

0.35

g/l

0.33

Dermatophytosis

420

1.77

5.16

1.6

1.4

0.49

0.40

g/l

0.98

294

Gonarthrosis,primary

499

2518

1.25

5.15

1.3

1.4

0.41

g/l

0.04

355

1753

Other hammer toe(s) (acquired)

463

1.71

5.11

1.5

0.35

0.43

g/l

1.62

316

Normotensive glaucoma

184

2.19

5.09

1.5

1.3

0.41

0.46

g/l

0.32

132

Testicular hypofunction

104

2.63

5.08

1.4

1.2

0.37

0.40

g/l

0.08

Atrophic disorders of skin

504

1.70

5.08

1.5

1.4

0.35

0.40

g/l

0.97

350

Specific personality disorders

156

1065

1.47

5.07

1.3

1.4

0.38

g/l

0.01

112

735

Dialysis

128

2.45

5.06

1.4

1.3

0.54

0.39

g/l

0.41

Oral lichen ruber planus, including avohilmo

185

2.18

5.04

1.5

0.34

0.39

g/l

0.60

131

Myocardial infarction

250

1321

1.36

5.04

1.3

1.4

0.45

0.42

g/l

0.45

180

878

Pacemaker

141

917

1.50

5.03

1.2

1.4

0.44

g/l

0.01

652

Squamous cell neoplasms and carcinomas of the skin

245

2.01

5.02

1.1

1.3

0.48

0.45

g/l

0.13

177

Plantar fascial fibromatosis

294

1.92

5.01

1.4

1.3

0.36

0.42

g/l

0.98

203

Lichen simplex chronicus

2.84

4.99

1.2

1.3

0.42

g/l

0.01

Benign neoplasm: Parotid gland

226

2.05

4.96

1.5

1.4

0.36

0.38

g/l

0.16

157

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

171

1193

1.44

4.96

1.2

1.3

0.40

g/l

0.02

123

818

Hyperkinetic disorders

486

1.70

4.96

1.3

1.4

0.34

0.38

g/l

0.69

351

Extrapyramidal and movement disorders

187

1327

1.41

4.94

1.5

1.4

0.37

0.43

g/l

1.52

128

914

Myeloid leukaemia

3.16

4.93

1.5

1.3

0.34

0.37

g/l

0.22

Diseases of peritoneum

310

1.88

4.92

1.5

1.4

0.73

0.41

g/l

0.67

215

Female infertility

184

794

1.44

4.91

1.4

0.39

g/l

0.03

134

549

Other and unspecified coagulation defects

155

2.28

4.90

1.5

1.4

0.27

0.39

g/l

2.62

108

Malignant neoplasm of breast

155

1613

0.69

4.90

1.2

1.4

0.41

0.40

g/l

0.11

101

1151

Other abnormal uterine and vaginal bleeding

134

631

1.52

4.88

1.2

1.4

0.38

0.39

g/l

0.06

428

Superficial injury of wrist and hand

127

839

1.52

4.87

1.4

0.35

0.40

g/l

1.04

583

Anti-inflammatory and antirheumatic products, non-steroids

175

605

1.46

4.86

1.3

0.36

0.43

g/l

1.51

128

418

Allergic contact dermatitis

503

1.68

4.86

1.3

1.4

0.36

0.40

g/l

0.56

352

Benign neoplasm: Parotid gland

228

2.03

4.86

1.5

1.4

0.36

0.40

g/l

0.36

156

Arthropathies in other diseases classified elsewhere

2.73

4.86

1.4

1.3

0.31

0.41

g/l

0.90

Paralytic strabismus

188

2.14

4.85

1.7

1.4

0.38

0.41

g/l

0.17

129

AV-block

380

1.75

4.85

1.2

1.3

0.48

0.42

g/l

0.62

275

Visual impairment including blindness (binocular or monocular)

162

2.24

4.85

1.1

1.3

0.42

g/l

0.00

119

Benign neoplasm: Rectum

557

1.64

4.84

1.5

1.4

0.37

0.42

g/l

0.76

394

Glaucoma secondary to other eye disorders

2.66

4.83

1.5

1.3

0.40

0.43

g/l

0.14

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

263

1.96

4.83

1.4

1.3

0.39

0.36

g/l

0.26

178

Injuries to the shoulder and upper arm

489

3324

1.24

4.82

1.4

0.41

g/l

0.13

353

2296

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

249

1.98

4.81

1.1

1.4

0.48

0.47

g/l

0.05

182

Other epidermal thickening

119

2.46

4.81

1.4

1.3

0.32

0.40

g/l

0.94

Other disorders of bladder

327

1.85

4.80

1.3

1.2

0.50

0.43

g/l

0.32

228

Respiratory tuberculosis, confirmed and not-confirmed

119

2.46

4.80

2.1

1.3

0.47

0.42

g/l

0.26

Respiratory tuberculosis

119

2.46

4.80

2.1

1.3

0.47

0.42

g/l

0.26

Other superficial mycoses

3.21

4.79

1.6

1.3

0.43

0.37

g/l

0.27

Abdominal aortic aneurysm (AAA)

207

2.07

4.78

1.3

1.2

0.46

0.47

g/l

0.05

150

Injury of muscle and tendon at forearm level

3.33

4.77

1.3

0.54

0.37

g/l

0.35

Benign neoplasm: Pituitary gland, craniopharyngeal duct

157

2.25

4.76

1.4

1.3

0.34

0.40

g/l

0.38

110

Otitis externa, unspecified

394

1.76

4.75

1.4

0.38

0.39

g/l

0.10

274

Lichen ruber planus, wide definition including periferal and oral lichen planus

117

764

1.54

4.74

1.7

1.4

0.36

0.40

g/l

0.80

523

Impingement syndrome of shoulder

130

868

1.50

4.74

1.4

1.3

0.36

0.42

g/l

1.94

100

597

Hypertrophic disorders of skin

190

2.12

4.73

1.3

1.4

0.36

0.38

g/l

0.18

133

Other disorders of patella

101

638

1.59

4.73

1.2

1.4

0.38

0.41

g/l

0.54

428

Opening and dilatation of root channel of tooth

217

2.05

4.72

1.8

1.3

0.33

0.38

g/l

0.50

150

Unspecific neurodegenerative disorder

759

0.57

4.72

1.2

1.4

0.41

0.46

g/l

0.42

531

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

208

1328

1.38

4.70

1.3

1.4

0.43

g/l

0.05

135

932

Unspecified nephritic syndrome

3.06

4.69

1.5

1.3

0.68

0.36

g/l

1.53

Chronic mastoiditis

3.06

4.69

1.9

1.3

0.42

0.41

g/l

0.02

Heart failure and hypertrophic cardiomyopathy

3.75

4.67

1.4

1.1

0.46

0.38

g/l

—

Striking against or struck by other objects

199

1442

1.38

4.66

1.4

1.3

0.35

0.40

g/l

1.68

132

999

Other disorders starting during childhood or adolecense, excluding more controls

184

2.12

4.66

1.3

0.36

0.35

g/l

0.10

139

Convalescence

165

2.20

4.66

1.5

1.4

0.32

0.37

g/l

0.69

114

Other/unspecified enthesopathies, not elsewhere classified

253

1.95

4.63

1.8

1.3

0.36

0.41

g/l

0.43

178

Valvular operations

397

1.75

4.62

1.5

1.3

0.50

0.41

g/l

0.97

280

Disorder of lipoprotein metabolism, unspecified

391

1.75

4.57

1.3

1.4

0.43

0.44

g/l

0.11

268

Speech and linguistic disorders, excluding more controls

272

1.88

4.56

1.2

1.3

0.41

0.36

g/l

0.52

192

Sleep disorders, other/unspecified

110

2.49

4.56

1.2

1.3

0.32

0.38

g/l

0.59

Benign neoplasm: Rectum

566

1.62

4.56

1.5

1.3

0.37

0.42

g/l

0.68

389

Convergence insufficiency and excess

3.89

4.56

1.2

1.4

0.30

g/l

—

Acute gastritis

193

2.09

4.55

1.5

1.4

0.37

0.39

g/l

0.19

134

Congenital malformations of the urinary system

200

2.07

4.55

1.2

1.3

0.42

0.38

g/l

0.30

144

Arterial embolism and thrombosis

116

2.43

4.54

1.3

1.2

0.33

0.45

g/l

1.52

Osteomyelitis

167

2.17

4.53

1.6

1.2

0.42

g/l

0.01

119

Maternal care for other conditions predominantly related to pregnancy

137

922

1.47

4.52

1.2

1.4

0.38

g/l

0.04

663

Injuries to the neck

137

935

1.47

4.51

1.4

1.3

0.35

0.40

g/l

1.53

104

638

Pure hyperglyceridaemia

3.19

4.50

1.5

0.43

0.34

g/l

—

Hyperfunction of pituitary gland

161

2.19

4.50

1.3

0.38

0.42

g/l

0.23

108

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

214

1225

1.37

4.50

1.4

0.43

g/l

0.02

139

862

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

105

678

1.56

4.50

1.4

0.40

0.39

g/l

0.10

466

Recurrent dislocation of patella

161

2.19

4.50

1.1

1.4

0.35

0.38

g/l

0.29

106

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.4

0.35

0.42

g/l

0.53

Bell's palsy

401

1.73

4.48

1.4

1.3

0.33

0.41

g/l

2.08

280

Other disorders of gingiva or/and edentulous alveolar ridge

142

2.27

4.48

1.2

1.4

0.48

0.41

g/l

0.29

100

Benign neoplasm: Rectum, anus and anal canal

101

647

1.57

4.48

1.5

1.3

0.39

0.42

g/l

0.48

452

Endometriosis ASRM stages 1,2

116

767

1.52

4.47

1.4

0.46

0.37

g/l

0.66

535

Other and unspecified epidermal thickening

2.80

4.47

1.4

1.3

0.30

0.41

g/l

0.88

Myocardial infarction, without ST-elevation

173

1137

1.41

4.46

1.3

1.4

0.46

0.44

g/l

0.23

132

780

2.97

4.46

1.2

1.3

0.25

0.33

g/l

0.91

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

4.08

4.46

2.1

1.2

0.27

0.32

g/l

—

Other specified/unspecified dorsopathies

2.79

4.46

1.6

1.7

0.35

0.38

g/l

0.24

Malignant neoplasm of breast, HER2-negative

152

1586

0.70

4.45

1.2

1.4

0.42

0.40

g/l

0.16

1135

Female infertility, cervigal, vaginal, other or unspecified origin

166

780

1.43

4.44

1.4

0.38

0.39

g/l

0.07

123

539

Autoimmune hyperthyroidism

162

2.18

4.43

1.3

1.4

0.31

0.41

g/l

1.50

117

Acute appendicitis

424

3232

1.24

4.42

1.4

0.41

0.40

g/l

0.09

282

2265

Trigger finger

463

1.67

4.42

1.3

0.38

0.42

g/l

0.54

317

Presbycusis

270

1.89

4.41

1.5

1.2

0.31

0.52

g/l

3.74

191

Follicular lymphoma

112

2.44

4.40

1.7

1.4

0.25

0.37

g/l

1.52

Schizophrenia

681

0.48

4.40

1.1

1.4

0.41

0.40

g/l

0.07

461

Oral leukoplakia and related diseases, including avohilmo

265

1.90

4.40

1.3

1.4

0.48

0.38

g/l

0.77

183

Right bundle-branch block

2.84

4.40

1.1

1.2

0.47

0.39

g/l

0.40

Benign neoplasm: Pituitary gland, craniopharyngeal duct

163

2.17

4.38

1.4

0.34

0.38

g/l

0.20

114

Tubulo-interstitial nephritis, not specified as acute or chronic

163

2.16

4.37

1.2

1.3

0.50

0.38

g/l

0.77

112

Cholesteatoma of middle ear

131

2.31

4.36

1.9

1.3

0.31

0.42

g/l

1.29

Urethritis and urethral syndrome

3.24

4.35

1.4

1.3

0.38

0.39

g/l

—

Psychotic depression

170

2.13

4.34

1.2

1.5

0.41

0.42

g/l

0.02

113

Dermatitis due to ingested food

151

2.19

4.34

1.3

1.5

0.30

0.37

g/l

1.20

124

Scar conditions and fibrosis of skin

119

2.38

4.33

1.2

1.4

0.30

0.39

g/l

1.22

Ptosis of eyelid

295

1.84

4.33

1.8

1.4

0.29

0.43

g/l

2.77

207

Other disorders of the musculoskeletal system and connective tissue

505

1.63

4.31

1.5

1.4

0.38

0.40

g/l

0.19

357

Contusion of toe(s) without damage to nail

2.82

4.30

1.1

1.2

0.42

0.34

g/l

0.49

Intracranial injury

323

2455

1.27

4.28

1.6

1.4

0.38

0.41

g/l

0.87

228

1695

Fracture at wrist and hand level

202

1490

1.36

4.27

1.3

1.4

0.38

0.40

g/l

0.41

136

1015

Amenorrhoea

268

1.88

4.26

1.8

1.4

0.33

0.39

g/l

0.87

182

Follicular lymphoma, hilmo

114

2.39

4.24

1.7

1.4

0.25

0.38

g/l

1.59

Primary open-angle glaucoma, strict

113

750

1.51

4.24

1.3

1.4

0.34

0.44

g/l

2.97

523

Acute posthaemorrhagic anaemia

2.86

4.23

1.3

1.2

0.36

0.42

g/l

—

Gluteal tendinitis

2.58

4.23

1.4

1.7

0.33

0.38

g/l

0.35

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

276

1863

1.30

4.22

1.5

1.4

0.43

0.39

g/l

0.42

203

1333

Bruxism

2.79

4.21

1.3

1.4

0.44

0.34

g/l

0.23

Primary open-angle glaucoma

137

924

1.45

4.20

1.3

1.4

0.34

0.45

g/l

4.04

640

Other disorders of nervous system

186

2.06

4.20

1.4

1.5

0.42

0.37

g/l

0.36

132

Other specified disorders of muscle

2.93

4.18

1.6

1.2

0.38

0.33

g/l

0.24

Left ventricular outflow tract obstruction (LVOTO), broad definition

395

1.71

4.17

1.6

1.3

0.37

0.39

g/l

0.29

278

Benign neoplasm of other and unspecified endocrine glands

448

1.66

4.17

1.4

0.32

0.40

g/l

1.46

314

Endometriosis of rectovaginal septum and vagina

256

1.89

4.16

1.5

1.4

0.34

0.40

g/l

0.52

173

Other erythematous conditions

2.50

4.14

1.3

1.4

0.29

0.37

g/l

0.60

Viral hepatitis, IBD co-morbidity

109

2.40

4.14

1.0

1.2

0.49

0.42

g/l

0.35

Persistent mood disorders

111

740

1.51

4.14

1.3

0.35

0.41

g/l

1.55

500

Propionic acid derivatives

170

605

1.42

4.13

1.3

0.35

0.43

g/l

2.52

123

418

Thyrotoxicosis

137

953

1.44

4.12

1.5

1.4

0.35

0.40

g/l

1.00

651

DVT of lower extremities

613

1.56

4.12

1.4

1.3

0.39

0.41

g/l

0.19

427

Other and unspecified aplastic anaemias

3.84

4.11

1.4

1.3

0.34

0.30

g/l

—

Other local infections of skin and subcutaneous tissue

315

1.79

4.10

1.4

1.3

0.44

0.39

g/l

0.19

221

Other symptoms and signs involving general sensations and perceptions

2.58

4.06

1.2

1.3

0.44

0.43

g/l

0.05

Benign neoplasm: Sigmoid colon

568

1.57

4.05

1.4

0.41

0.42

g/l

0.15

405

Injuries to the hip and thigh

228

1579

1.32

4.05

1.3

1.4

0.43

g/l

0.01

173

1084

Testicular dysfunction

123

2.30

4.05

1.4

1.2

0.37

0.39

g/l

0.06

Angina pectoris

295

1552

1.29

4.05

1.5

1.4

0.44

0.41

g/l

0.43

198

1045

Other (not insulin) diabetes medications

567

2854

1.20

4.05

1.3

1.4

0.42

0.40

g/l

0.30

395

1999

Flat foot [pes planus] (acquired)

266

1.85

4.03

1.3

1.4

0.30

0.43

g/l

2.72

184

Alcohol abuse, main dg, excluding more controls

522

1.60

4.03

1.3

0.41

0.40

g/l

0.05

348

Scoliosis

259

1.86

4.02

1.3

1.4

0.39

0.43

g/l

0.42

180

Open wound of ankle and foot

347

1.74

4.01

1.3

0.38

g/l

0.03

239

Spontaneous rupture of synovium and tendon

217

1.95

4.01

1.9

1.3

0.40

0.42

g/l

0.11

149

Other acquired deformities of musculoskeletal system and connective tissue

143

2.19

4.00

2.0

1.3

0.46

0.39

g/l

0.35

Mixed and other personality disorders

318

1.77

3.99

1.5

1.4

0.27

0.37

g/l

2.73

226

Other and unspecified local infections of skin and subcutaneous tissue

296

1.80

3.99

1.4

1.3

0.44

0.39

g/l

0.21

207

Radial styloid tenosynovitis [de Quervain]

163

2.10

3.98

1.7

1.3

0.47

0.36

g/l

0.93

112

Vitamin B12 deficiency anaemia

260

1.85

3.97

1.1

1.4

0.44

0.42

g/l

0.20

181

Alcoholic liver disease

290

1.80

3.94

1.2

1.3

0.41

0.37

g/l

0.33

201

Mixed conductive and sensorineural hearing loss

349

1.73

3.93

1.3

0.41

g/l

0.04

244

Melanocytic naevi

163

1180

1.39

3.93

1.4

0.42

0.40

g/l

0.13

132

841

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

139

1281

0.71

3.93

1.1

1.4

0.43

0.39

g/l

0.38

921

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

139

1281

0.71

3.93

1.1

1.4

0.43

0.39

g/l

0.38

921

Alzheimer disease, including avohilmo

607

0.56

3.92

1.2

1.3

0.45

0.47

g/l

0.16

430

Sequelae of injuries, of poisoning and of other consequences of external causes

137

963

1.43

3.92

1.4

1.3

0.36

0.40

g/l

0.59

664

Benign neoplasm of other and unspecified endocrine glands

456

1.63

3.92

1.4

1.3

0.32

0.39

g/l

1.14

323

Hypertrophic cardiomyopathy

106

2.38

3.91

1.4

1.3

0.36

0.40

g/l

0.26

Herpesviral keratitis and keratoconjunctivitis

106

2.38

3.91

1.6

1.3

0.43

0.38

g/l

0.23

Occupational exposure to risk-factors

2.53

3.89

1.7

1.3

0.57

0.39

g/l

0.82

Respiratory tuberculosis, not confirmed

2.58

3.89

2.3

1.3

0.49

0.44

g/l

0.23

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

488

1.61

3.88

1.4

0.39

0.41

g/l

0.22

344

Hydronephrosis

306

1.77

3.88

1.5

1.4

0.47

0.40

g/l

0.34

219

Type 1 diabetes, wide definition, subgroup 1

121

832

1.46

3.87

1.4

1.3

0.36

0.39

g/l

0.29

612

Other/unspecified enthesopathies of lower limb, excluding foot

213

1.94

3.86

1.2

1.5

0.46

0.41

g/l

0.31

151

Hemiplegia

132

2.21

3.86

1.3

0.34

0.40

g/l

0.54

Poisoning by medicine

133

933

1.43

3.86

1.2

1.4

0.37

0.39

g/l

0.32

635

Other diseases of spinal cord

2.70

3.83

1.3

0.30

0.36

g/l

0.44

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

101

2.40

3.82

2.1

1.3

0.35

0.38

g/l

0.22

Lichen planus, including avohilmo

657

1.51

3.81

1.7

1.4

0.36

0.40

g/l

0.86

447

Chronic periodontitis, complicated

309

1.76

3.77

1.4

0.48

0.39

g/l

0.40

216

Speech therapy

144

1030

1.40

3.75

1.5

1.3

0.41

g/l

0.03

134

705

Dental caries 2 and operation codes

474

3129

1.21

3.75

1.4

1.3

0.41

0.40

g/l

0.42

362

2175

Campylobacter enteritis

2.67

3.74

1.3

1.4

0.39

0.33

g/l

0.37

Ventral hernia

122

848

1.44

3.73

1.4

1.3

0.40

0.41

g/l

0.12

589

Problems related to lifestyle

355

1.70

3.72

1.3

0.39

g/l

0.03

239

Other problems related to primary support group, including family circumstances

504

1.58

3.71

1.4

0.36

0.38

g/l

0.12

364

Poisoning by drugs, medicaments and biological substances

146

1049

1.40

3.71

1.3

1.4

0.37

0.40

g/l

0.39

103

726

Myocardial infarction, strict

222

1233

1.32

3.71

1.3

1.4

0.45

0.41

g/l

0.49

161

820

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

179

1330

1.35

3.70

1.2

1.4

0.34

0.39

g/l

1.53

122

930

D07AA Corticosteroids, weak (group I)

654

1.50

3.67

1.4

0.34

0.39

g/l

1.26

472

Hyperaldosteronism

2.72

3.67

1.4

1.2

0.40

0.42

g/l

0.08

174

1211

1.35

3.66

1.5

1.4

0.40

0.45

g/l

1.05

125

827

Hidradenitis suppurativa

129

2.19

3.65

1.3

0.42

0.36

g/l

0.51

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.44

3.64

1.5

1.2

0.55

0.44

g/l

0.37

Visual field defects

232

1.86

3.64

1.5

1.3

0.36

0.42

g/l

0.61

162

Impotence

149

2.10

3.63

1.4

1.3

0.35

0.43

g/l

1.16

Disorders of tooth development and eruption

192

1.94

3.60

1.3

0.38

0.35

g/l

0.14

143

Chromosomal abnormalities, not elsewhere classified

104

2.34

3.60

1.4

1.3

0.49

0.34

g/l

0.87

Abnormalities of gait and mobility

329

1.71

3.58

1.4

1.3

0.39

0.42

g/l

0.23

238

Thyrotoxicosis, other and/or unspecified

107

732

1.47

3.57

1.4

0.35

0.40

g/l

1.10

507

Other condition

523

1.56

3.56

1.8

1.3

0.35

0.39

g/l

0.70

361

Benign neoplasm: Sigmoid colon

587

1.52

3.55

1.4

1.3

0.41

g/l

0.02

412

Tinnitus

123

865

1.43

3.55

1.4

1.3

0.36

0.41

g/l

1.12

597

Artificial joint re-operation

164

2.03

3.55

1.3

1.5

0.43

g/l

0.03

117

KRA_PSY_EATING, excluding more controls

277

1.77

3.54

1.2

1.3

0.31

0.40

g/l

1.81

187

Epilepsy

159

1165

1.36

3.54

1.3

1.4

0.39

0.41

g/l

0.27

120

827

Skin changes due to chronic exposure to nonionizing radiation

159

1104

1.37

3.54

1.5

1.3

0.41

0.46

g/l

0.99

112

751

435

1.59

3.54

1.3

0.43

0.48

g/l

0.32

317

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

105

2.31

3.53

2.1

1.2

0.35

g/l

0.05

Actinic keratosis

153

1060

1.37

3.53

1.5

1.3

0.40

0.45

g/l

0.84

109

717

Deep endometriosis

346

1.69

3.52

1.5

1.4

0.35

0.38

g/l

0.24

242

Other specified and unspecified personality disorders

346

1.69

3.52

1.3

1.4

0.33

0.38

g/l

0.80

239

Cysts of oral region, not elsewhere classified

118

2.22

3.51

1.8

1.4

0.33

0.39

g/l

0.61

Nonischemic cardiomyopathy

158

2.04

3.51

1.3

0.58

0.39

g/l

1.50

112

Spirochaetal infections, other/unspecified

257

1.80

3.50

1.2

1.4

0.31

0.39

g/l

1.78

174

Leisure time condition

671

1.48

3.48

1.5

1.3

0.41

g/l

0.04

474

Other disorders of glucose regulation and pancreatic internal secretion

265

1.78

3.47

1.7

1.3

0.40

0.39

g/l

0.10

181

Ankylosing spondylitis, strict definition

159

2.03

3.46

1.2

1.3

0.44

0.35

g/l

0.69

112

Malignant neoplasm of breast, HER-positive

1357

0.68

3.44

1.2

1.4

0.41

0.39

g/l

0.23

958

Statin medication

453

2112

1.20

3.42

1.4

0.40

g/l

0.04

323

1436

Benign neoplasm of eye and adnexa

296

1.73

3.42

1.7

1.4

0.31

0.40

g/l

1.05

207

Tuberculosis of other organs, strict

3.01

3.42

2.1

1.3

0.57

0.46

g/l

—

Strabismus

157

1157

1.36

3.41

1.7

1.3

0.40

0.39

g/l

0.15

108

810

Other peripheral vertigo

274

1.76

3.41

1.5

1.4

0.38

0.39

g/l

0.11

194

Superficial injury of ankle and foot

466

1.57

3.39

1.5

1.3

0.40

0.37

g/l

0.18

320

Early lumbar disc prolapse, operated

365

1.65

3.39

1.3

0.37

g/l

0.06

239

Delirium, not induced by alcohol and other psychoactive substances

245

1.80

3.38

1.2

1.3

0.52

0.45

g/l

0.40

172

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

554

1.52

3.38

1.3

1.4

0.43

g/l

0.00

392

Left hemicolectomy

2.86

3.37

1.3

1.2

0.45

0.41

g/l

—

Thyroiditis, unspecified

3.29

3.36

1.7

1.2

0.30

0.33

g/l

0.19

Benign lipomatous neoplasm of other sites/unspecified

246

1.80

3.35

1.2

1.4

0.40

0.38

g/l

0.10

173

Other and unspecified injuries of lower leg

254

1.78

3.33

1.5

1.3

0.35

0.37

g/l

0.15

170

Myopia

508

1.54

3.33

1.3

1.4

0.34

0.38

g/l

0.73

346

Benign neoplasm of middle ear and respiratory system

225

1.83

3.32

1.8

1.3

0.37

0.41

g/l

0.35

153

Event of undetermined intent

218

1.85

3.32

1.2

1.3

0.41

0.39

g/l

0.12

151

Benign lipomatous neoplasm of other sites/unspecified

247

1.79

3.31

1.2

1.4

0.40

g/l

0.03

173

Muscle strain

2.56

3.30

1.2

0.32

0.37

g/l

—

Disorders of psychological development

456

1.55

3.29

1.3

1.4

0.37

g/l

0.02

322

Other and unspecified disorders of skin and subcutaneous tissue

176

1.94

3.29

1.5

1.4

0.29

0.40

g/l

2.09

123

Chondrocostal junction syndrome [Tietze]

2.31

3.27

1.5

1.3

0.30

0.37

g/l

0.53

Other dialysis

2.36

3.26

1.3

0.44

0.39

g/l

0.32

Bacterial, viral and other infectious agents

331

1.67

3.26

1.3

0.36

0.37

g/l

0.16

226

Dental caries 2

477

3162

1.19

3.25

1.4

1.3

0.41

0.40

g/l

0.37

366

2198

Benign neoplasm: Rectosigmoid junction

2.35

3.25

1.2

1.3

0.35

0.41

g/l

0.36

Other shoulder lesions

301

1.70

3.24

1.4

1.3

0.35

0.40

g/l

0.43

207

Sequelae of injuries of neck and trunk

2.41

3.24

1.6

1.3

0.28

0.37

g/l

0.68

Suppurative otitis media, unspecified

2.69

3.23

1.8

1.4

0.46

0.37

g/l

0.24

Chondropathies

625

1.48

3.23

1.5

1.4

0.33

0.40

g/l

1.77

426

Cardiac arrest

116

2.09

3.22

1.1

1.3

0.37

0.41

g/l

0.25

Degenerative diseases of the nervous system

633

0.61

3.21

1.2

1.3

0.45

0.46

g/l

0.07

450

Benign neoplasm of eye and adnexa

302

1.70

3.21

1.7

1.4

0.31

0.39

g/l

0.84

217

Hypertrophy of breast in women and men

115

816

1.41

3.20

1.4

1.3

0.35

0.38

g/l

0.77

567

Melanocytic naevi

163

1224

1.34

3.20

1.4

1.3

0.42

0.40

g/l

0.13

132

851

Oligomenorrhoea

110

2.20

3.19

1.6

1.4

0.27

0.38

g/l

1.69

Monoamine oxidase A inhibitors

411

1.59

3.17

1.2

1.3

0.44

0.42

g/l

0.11

280

Alzheimer disease

508

0.56

3.17

1.2

1.3

0.48

g/l

0.01

361

Unspecified privation

349

1.64

3.17

1.7

1.3

0.32

0.40

g/l

1.46

243

Other degenerative diseases of the nervous system

119

641

1.41

3.16

1.4

1.3

0.36

0.43

g/l

1.36

438

Pilonidal cyst

334

1.66

3.16

1.4

1.3

0.46

0.36

g/l

1.26

224

Amiodarone users

266

1.74

3.15

1.2

1.3

0.44

0.42

g/l

0.12

188

Embedded teeth, including avohilmo

342

1.65

3.14

1.4

0.42

0.37

g/l

0.50

233

Aortic valve malfunction, age under 60 years

350

1.64

3.14

1.6

1.3

0.39

0.38

g/l

0.10

244

Golimumab

111

2.18

3.14

1.0

1.3

0.36

g/l

0.01

Persons encountering health services in circumstances related to reproduction

366

2047

1.21

3.13

1.3

1.4

0.35

0.39

g/l

1.55

255

1428

Respiratory conditions due to other external agents

3.11

3.10

1.5

1.2

0.42

0.40

g/l

—

Fracture of foot, except ankle

137

1008

1.36

3.09

1.4

1.3

0.37

0.40

g/l

0.54

105

683

Social phobias

298

1.69

3.08

1.6

1.3

0.33

0.40

g/l

1.11

200

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

283

1.71

3.08

1.7

1.4

0.33

0.39

g/l

0.50

197

Major coronary heart disease event

352

1933

1.22

3.08

1.4

0.44

0.42

g/l

0.49

260

1309

Gonarthrosis, primary, with knee surgery

267

1749

1.25

3.08

1.4

0.43

0.42

g/l

0.13

188

1215

Calculus of kidney and ureter

148

1103

1.35

3.07

1.4

1.3

0.37

0.44

g/l

1.58

102

767

Other disorders of binocular movement

2.53

3.05

1.5

1.3

0.32

0.36

g/l

0.26

Pain associated with micturition

376

1.60

3.05

1.3

0.58

0.42

g/l

0.28

263

Abscess of anal and rectal regions

284

1.70

3.05

1.3

0.36

0.39

g/l

0.34

190

Oesophageal obstruction

2.52

3.05

1.2

0.78

0.40

g/l

0.58

Use of antiglaucoma preparations and miotics

167

1.93

3.04

1.4

1.3

0.33

0.45

g/l

1.28

118

Deficiency of other B group vitamins

2.92

3.03

1.2

1.3

0.52

0.33

g/l

—

Routine general health check-up of defined subpopulation

2.92

3.03

1.2

1.4

0.36

0.38

g/l

0.09

Injuries to unspecified part of trunk, limb or body region

315

1.66

3.02

1.6

1.4

0.36

0.41

g/l

0.59

219

Artificial opening status

147

1.99

3.00

1.4

0.34

0.44

g/l

0.85

108

Benign neoplasm of middle ear and respiratory system

233

1.77

3.00

1.8

1.4

0.37

0.39

g/l

0.15

169

Other menopausal disorders

152

650

1.35

3.00

1.7

1.4

0.39

0.38

g/l

0.05

106

445

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

2.49

2.97

1.1

1.2

0.39

0.37

g/l

—

Malignant neoplasm

531

2696

1.17

2.96

1.3

1.4

0.40

g/l

0.07

352

1908

Other benign neoplasms of skin

179

1352

1.30

2.96

1.7

1.4

0.38

0.41

g/l

0.58

127

943

Tooth eruption problems

598

1.46

2.96

1.4

0.39

0.38

g/l

0.08

428

Gestational [pregnancy-induced] hypertension

150

1125

1.33

2.96

1.6

1.4

0.47

0.38

g/l

0.43

108

795

Other female pelvic inflammatory diseases

621

1.46

2.95

1.2

1.4

0.37

0.40

g/l

0.32

428

Seborrhoeic dermatitis

302

1.66

2.95

1.4

1.3

0.47

0.43

g/l

0.28

223

Contusion of other and unspecified parts of foot

162

1.93

2.95

1.2

1.3

0.35

0.37

g/l

0.10

107

Use of anticholinesterases

634

0.61

2.94

1.2

1.3

0.45

0.47

g/l

0.12

446

N06DA Anticholinesterases

634

0.61

2.94

1.2

1.3

0.45

0.47

g/l

0.12

446

2.34

2.92

1.8

1.3

0.42

0.33

g/l

0.79

Ingrowing nail

177

1.88

2.91

1.2

1.3

0.44

0.38

g/l

0.35

125

Dislocation, sprain and strain of joints and ligaments at neck level

615

1.45

2.90

1.5

1.4

0.34

0.38

g/l

0.71

409

Melanocytic naevi, other sites/unspecified

258

1.72

2.90

1.7

1.4

0.30

0.37

g/l

0.82

185

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

101

691

1.42

2.90

1.3

1.4

0.38

0.39

g/l

0.17

502

Medicines for HER+ breast cancer

105

1419

0.72

2.90

1.2

1.4

0.40

0.39

g/l

0.12

1001

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

251

1.72

2.88

1.7

1.4

0.33

0.39

g/l

0.57

173

Melanocytic naevi, other sites/unspecified

259

1.71

2.87

1.7

1.4

0.30

0.38

g/l

1.07

178

Urolithiasis

155

1177

1.32

2.86

1.4

1.3

0.37

0.44

g/l

1.59

104

820

Degeneration of macula and posterior pole

195

1256

1.28

2.84

1.4

0.38

0.45

g/l

1.33

134

874

Other specified/unspecified hearing loss

215

1.78

2.84

1.6

1.3

0.41

0.43

g/l

0.16

152

Other facial nerve disorders

2.36

2.83

1.5

1.3

0.30

0.36

g/l

—

Chalazion

392

1.56

2.82

1.7

1.4

0.36

0.41

g/l

0.53

272

Speech and linguistic disorders

361

1.58

2.81

1.4

1.3

0.38

0.36

g/l

0.22

265

Other appendicitis

299

1.65

2.80

1.2

1.4

0.33

0.38

g/l

0.72

203

Use of donepezil

384

0.47

2.80

1.2

0.50

0.48

g/l

0.05

276

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

217

1724

1.26

2.79

1.4

1.3

0.42

0.39

g/l

0.18

168

1187

Disorders of breast

269

2030

1.23

2.79

1.5

1.4

0.37

0.40

g/l

0.67

197

1433

Major coronary heart disease event excluding revascularizations

312

1773

1.22

2.78

1.3

1.4

0.45

0.42

g/l

0.50

225

1192

Salpingitis and oophoritis

102

729

1.40

2.78

1.4

0.32

0.39

g/l

1.98

505

Crossbite

277

1.65

2.78

1.2

1.4

0.46

0.36

g/l

1.14

213

Benign neoplasm: Skin, unspecified

117

2.07

2.78

1.2

1.4

0.33

0.37

g/l

0.18

Dissociative [conversion] disorders

124

2.03

2.76

1.2

1.3

0.29

0.40

g/l

1.49

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

217

1.76

2.76

1.8

1.4

0.35

0.39

g/l

0.22

146

Other and unspecified trigeminal disorders

2.90

2.76

1.2

1.5

0.30

0.28

g/l

—

L01XX Other antineoplastic agents

124

2.03

2.76

1.2

1.4

0.39

0.41

g/l

0.08

Dislocation, sprain and strain of joints and ligaments of head

145

1.95

2.75

1.5

1.3

0.42

0.40

g/l

0.07

100

L02BG Aromatase inhibitors

1126

0.69

2.74

1.2

1.4

0.43

0.39

g/l

0.37

789

Other predominantly sexually transmitted diseases, not elsewhere classified

106

765

1.39

2.74

1.2

1.4

0.35

0.38

g/l

0.48

526

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

252

1.69

2.72

1.3

0.35

g/l

0.03

192

Cerebrovascular diseases

370

2225

1.19

2.72

1.3

1.4

0.45

0.41

g/l

0.44

276

1513

Biomechanical lesions, not elsewhere classified

125

2.01

2.71

1.2

1.4

0.38

g/l

0.01

Other disorders of bone density and structure

2.52

2.71

1.3

0.42

0.33

g/l

—

Oral leukoplakia and related diseases

146

1.93

2.70

1.4

0.43

0.40

g/l

0.20

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

0.75

0.42

g/l

—

Sub-endpoint used in defining T1D endpoints

160

1211

1.30

2.69

1.5

1.3

0.39

0.40

g/l

0.08

113

849

Other chondrocalcinosis

3.81

2.69

2.0

1.2

0.33

0.38

g/l

—

Speech disturbances, not elsewhere classified

219

1.74

2.68

1.3

1.4

0.37

0.42

g/l

0.33

149

Obsessive-compulsive disorder

212

1.75

2.67

1.4

1.3

0.34

0.38

g/l

0.53

142

Benign neoplasm: Skin, unspecified

119

2.03

2.67

1.2

1.4

0.33

g/l

0.03

Kyphosis

3.17

2.66

1.2

1.3

0.42

0.51

g/l

—

Benign neoplasm: Rectosigmoid junction

2.14

2.65

1.2

1.4

0.35

0.37

g/l

0.13

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.23

2.64

1.2

1.3

0.35

0.34

g/l

0.04

IgA nephropathy (IgA glomerulonephritis)

2.41

2.64

1.4

0.56

0.39

g/l

—

Idiopathic urticaria

2.49

2.63

1.3

0.35

g/l

0.03

Malignant neoplasm of endocrine gland

228

1.72

2.63

1.8

1.5

0.33

0.39

g/l

0.56

161

Dronedarone medication

2.48

2.62

1.3

1.1

0.27

0.38

g/l

—

Retinal vascular occlusion

289

1.63

2.62

1.2

1.3

0.37

0.44

g/l

1.00

205

Tobacco use

162

1.87

2.62

1.4

1.3

0.40

g/l

0.03

109

Hyperprolactinaemia

113

2.05

2.62

1.3

1.2

0.31

0.36

g/l

0.47

Suicide or other Intentional self-harm

140

1063

1.32

2.62

1.3

1.4

0.35

0.40

g/l

0.95

736

Diseases of male genital organs

299

1242

1.22

2.62

1.3

1.4

0.38

0.41

g/l

0.72

204

840

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

0.43

0.38

g/l

0.30

101

Coxarthrosis, primary

274

1954

1.22

2.60

1.3

1.4

0.46

0.42

g/l

0.79

219

1345

Urethral stricture

127

1.98

2.60

1.2

0.45

0.42

g/l

0.13

Dysplasia of cervi uteri

127

733

1.34

2.59

1.3

1.4

0.39

g/l

0.10

509

Type 1 diabetes, wide definition

127

952

1.34

2.58

1.4

1.3

0.37

0.39

g/l

0.20

676

Other specified disorders of kidney and ureter

2.20

2.58

1.5

1.3

0.37

0.42

g/l

0.25

Other puerperal infections

314

1.60

2.58

1.4

0.30

0.38

g/l

1.76

219

Congenital malformations of ovaries, fallopian tubes and broad ligaments

207

1.75

2.58

1.2

1.4

0.37

0.39

g/l

0.14

145

Malignant neoplasm of thyroid gland

207

1.75

2.58

1.8

1.5

0.33

0.38

g/l

0.44

149

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1056

0.72

2.57

1.2

1.4

0.41

0.40

g/l

0.13

757

Other secondary gonarthrosis

142

1.91

2.56

1.2

1.5

0.30

0.38

g/l

0.72

Impacted teeth

109

744

1.37

2.55

1.3

0.41

0.38

g/l

0.30

516

Benign neoplasm: Skin of eyelid, including canthus

483

1.48

2.55

1.7

1.4

0.37

0.39

g/l

0.21

344

Embedded and impacted teeth

157

1031

1.30

2.55

1.4

1.3

0.42

0.37

g/l

1.18

122

711

Mental and behavioural disorders due to alcohol

270

2165

1.22

2.54

1.2

1.4

0.42

0.41

g/l

0.27

174

1475

Achilles tendinitis

323

1.59

2.54

1.8

1.3

0.36

0.43

g/l

1.23

228

Acute nephritic syndrome

2.63

2.54

1.2

0.32

0.41

g/l

—

Other/unspecified disorders of vestibular function

101

2.10

2.53

1.1

1.5

0.29

0.42

g/l

1.49

Benign neoplasm of meninges

300

1.61

2.53

1.6

1.4

0.34

0.42

g/l

1.02

210

Use of other anti-dementia drugs

459

0.57

2.52

1.1

1.3

0.38

0.49

g/l

0.93

325

Use of memantine

459

0.57

2.52

1.1

1.3

0.38

0.49

g/l

0.93

325

Open wound of wrist and hand

242

1955

1.23

2.52

1.3

1.4

0.40

0.41

g/l

0.07

178

1334

Disturbances of smell and taste

108

2.05

2.52

1.3

1.6

0.34

0.35

g/l

0.03

Follicular cysts of skin and subcutaneous tissue

701

1.39

2.52

1.4

1.3

0.34

0.41

g/l

1.41

489

Sequelae of other external causes

150

1.88

2.52

1.6

1.3

0.42

0.37

g/l

0.41

104

Pustular psoriasis

143

1.90

2.51

1.2

1.5

0.43

0.34

g/l

0.65

Other congenital malformations of skin

136

1.93

2.51

1.3

0.45

0.39

g/l

0.36

100

Benign neoplasm: Skin of trunk

122

1.98

2.51

2.2

1.3

0.37

0.38

g/l

0.06

Cystic kidney disease

2.12

2.49

1.3

0.49

0.41

g/l

0.37

Family history of other conditions

2.86

2.49

1.1

1.4

0.46

0.41

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

317

1.58

2.49

1.4

1.3

0.39

0.41

g/l

0.21

221

Pregnancy hypertension

237

1740

1.23

2.49

1.5

1.4

0.44

0.38

g/l

0.42

173

1246

Papillary adenocarcinoma of thyroid gland

158

1.85

2.48

2.0

1.5

0.34

g/l

0.01

112

Retinal vascular disorders

294

1.60

2.47

1.2

1.3

0.37

0.44

g/l

0.96

208

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

123

1.97

2.46

1.3

0.33

0.38

g/l

0.55

Secondary polycythaemia

2.48

2.46

1.4

0.37

0.34

g/l

—

Benign neoplasm of bone and articular cartilage

295

1.60

2.44

2.1

1.4

0.29

0.37

g/l

1.65

210

Hypoglycaemia, other or unspecified

203

1.73

2.44

1.9

1.3

0.33

0.39

g/l

0.78

137

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

159

1242

1.28

2.44

1.2

1.3

0.39

g/l

0.00

117

858

Hallux rigidus

407

1.50

2.42

1.3

1.5

0.40

0.43

g/l

0.28

283

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

604

1.38

2.42

1.2

1.4

0.48

0.43

g/l

0.45

426

Status epilepticus

2.18

2.41

1.3

0.35

0.42

g/l

0.49

Contraceptive management

255

1472

1.22

2.41

1.3

1.4

0.38

0.39

g/l

0.21

181

1030

Other symptoms and signs involving the urinary system

304

1.59

2.41

1.5

1.3

0.34

0.41

g/l

1.00

209

Certain conditions originating in the perinatal period

346

1.52

2.41

1.3

0.38

0.36

g/l

0.23

256

Discitis, unspecified

2.78

2.38

1.5

1.3

0.60

0.46

g/l

—

Benign neoplasm: Choroid

153

1.84

2.38

1.2

1.5

0.32

0.40

g/l

0.78

106

Hypertrophic scar

175

1.78

2.38

1.4

1.3

0.32

0.39

g/l

0.56

123

Personal history of other diseases and conditions

464

1.47

2.38

1.5

1.4

0.33

0.39

g/l

0.71

345

Other disorders of veins

198

1593

1.24

2.36

1.3

1.4

0.34

0.41

g/l

2.19

132

1121

Inflammatory disease of uterus

575

1.41

2.36

1.4

1.3

0.34

0.39

g/l

0.73

396

Foreign body in respiratory tract

161

1.81

2.35

1.5

1.4

0.55

0.38

g/l

0.88

114

Unspecified event, undetermined intent

2.28

2.35

1.5

1.3

0.35

0.36

g/l

—

102

665

1.36

2.35

1.2

1.4

0.41

0.47

g/l

0.54

470

Other disorders starting during childhood or adolescence

242

1.65

2.34

1.3

1.4

0.36

g/l

0.00

184

Other and unspecified mood [affective] disorders

244

1.65

2.34

1.2

1.4

0.31

0.38

g/l

0.85

163

Astigmatism

229

1.67

2.32

1.2

1.3

0.42

0.37

g/l

0.42

163

Benign neoplasm of meninges

307

1.57

2.32

1.6

1.4

0.34

0.37

g/l

0.37

215

Contact with other hot fluids

2.06

2.32

1.5

1.2

0.37

0.39

g/l

0.08

Autism spe, excluding more controls

2.33

2.32

1.3

1.4

0.24

0.34

g/l

—

Other otitis externa (chronic)

199

1.72

2.32

1.2

1.4

0.36

0.38

g/l

0.11

143

Benign neoplasm: Cerebral meninges

268

1.61

2.32

1.7

1.4

0.35

0.38

g/l

0.39

187

Malignant neoplasm of eye, brain and central nervous system

112

1.98

2.31

1.6

1.2

0.33

0.40

g/l

0.35

Use of glatiramer acetate

2.40

2.30

1.4

0.36

0.32

g/l

—

Glaucoma-related operations

119

1.94

2.30

1.5

1.4

0.32

0.44

g/l

1.19

Emotionally unstable personality disorder

511

1.43

2.30

1.3

1.4

0.40

0.38

g/l

0.22

349

Thyrotoxicosis with diffuse goitre

511

1.43

2.30

1.5

1.3

0.31

0.40

g/l

2.83

357

Benign neoplasm: Choroid

155

1.82

2.30

1.2

1.5

0.32

0.38

g/l

0.62

110

Superficial injury of forearm

356

1.52

2.29

1.4

1.3

0.37

0.38

g/l

0.11

242

Exposure to other and unspecified inanimate mechanical forces

246

1.64

2.28

1.4

1.3

0.39

0.38

g/l

0.07

176

Acidosis

2.58

2.28

1.2

1.3

0.34

0.44

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

148

1.83

2.27

1.5

1.3

0.52

0.44

g/l

0.35

107

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

231

1.65

2.26

1.4

1.3

0.37

g/l

0.01

160

Pustulosis palmaris et plantaris

127

1.90

2.26

1.1

1.5

0.40

0.36

g/l

0.25

Malignant neoplasm of oesophagus

0.00

2.25

0.0

1.3

—

0.41

—

Transport accidents

258

1901

1.20

2.25

1.5

1.3

0.37

0.41

g/l

1.09

180

1327

Viral haemorrhagic fevers, not elsewhere classified/unspecified

247

1.63

2.24

1.4

1.3

0.37

0.40

g/l

0.18

167

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

126

968

1.31

2.23

1.2

1.4

0.39

0.40

g/l

0.18

658

Mental and behavioural disorders due to sedatives or hypnotics

240

1.63

2.22

1.3

1.4

0.37

0.38

g/l

0.05

170

malignant neoplasm of male genital organs

107

902

0.75

2.22

1.3

1.4

0.46

g/l

0.06

629

Dementia

853

0.74

2.22

1.2

1.4

0.44

g/l

0.03

590

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

735

1.35

2.22

1.3

1.4

0.33

0.39

g/l

0.78

496

Benign neoplasm: Skin of trunk

128

1.89

2.22

2.2

1.3

0.37

0.36

g/l

0.02

Hypertrophy of breast

727

1.35

2.21

1.4

1.3

0.35

0.38

g/l

0.42

505

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

2.05

2.21

1.4

0.52

0.42

g/l

0.41

Background retinopathy and retinal vascular changes

2.52

2.19

1.3

1.4

0.42

0.36

g/l

—

Palmar fascial fibromatosis [Dupuytren]

425

1.46

2.19

1.4

1.2

0.55

0.47

g/l

0.29

289

Diabetic retinopathy, excluding more controls

129

555

1.31

2.19

1.5

1.4

0.45

0.39

g/l

0.57

359

Psoriasis (vulgaris), strict definition

2.14

2.19

1.1

1.3

0.40

0.36

g/l

0.29

Benign neoplasm of bone and articular cartilage

304

1.55

2.19

2.1

1.4

0.29

0.37

g/l

1.42

211

Dementia, including avohilmo

101

929

0.75

2.19

1.2

1.4

0.45

0.44

g/l

0.12

638

Major anomalies of jaw size

2.04

2.17

1.4

1.3

0.38

0.35

g/l

0.15

Prolonged pregnancy

626

0.65

2.16

1.2

1.4

0.38

0.35

g/l

0.23

447

Benign neoplasm: Long bones of lower limb

101

2.00

2.16

1.9

1.3

0.25

0.31

g/l

—

Presence of other devices

661

1.36

2.16

1.3

0.38

0.45

g/l

1.24

483

Alzheimer’s disease, wide definition

410

0.59

2.15

1.1

1.3

0.52

0.49

g/l

0.17

294

Benign neoplasm: Cerebral meninges

274

1.58

2.14

1.7

1.4

0.35

0.40

g/l

0.54

194

Congenital malformations of eye, ear, face and neck

251

1.60

2.12

1.3

0.42

0.39

g/l

0.21

174

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

0.34

0.31

g/l

—

Somnolence, stupor and coma

109

1.94

2.10

1.3

1.4

0.43

0.41

g/l

0.04

Dental caries 2, only avohilmo

454

3131

1.14

2.10

1.4

0.40

g/l

0.16

347

2180

Injury of muscle and tendon at shoulder and upper arm level

169

1358

1.25

2.10

1.4

0.43

0.42

g/l

0.17

117

933

Female genital prolapse

153

695

1.27

2.10

1.5

1.4

0.38

g/l

0.01

109

475

Emotional disorders and disorders of social functioning with onset specific to childhood

195

1.68

2.09

1.4

0.32

0.36

g/l

0.60

144

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

316

2196

1.18

2.09

1.4

0.38

0.40

g/l

0.48

214

1574

Dental pulpitis 3

427

1.39

2.08

1.2

1.3

0.35

0.38

g/l

0.37

307

Superficial injury of head

110

838

1.32

2.08

1.6

1.3

0.35

0.40

g/l

1.04

575

Mental and behavioural disorders due to opioids

131

1.85

2.08

1.4

1.3

0.48

0.33

g/l

1.07

Other benign neoplasms of connective and other soft tissue

332

1.51

2.08

1.5

1.4

0.35

0.39

g/l

0.40

232

Bicipital tendinitis

124

1.87

2.07

1.3

0.39

0.37

g/l

0.11

Medical abortion

362

1689

1.17

2.05

1.3

1.4

0.41

0.38

g/l

0.74

251

1203

Arterial embolism and thrombosis of lower extremity artery

2.19

2.04

1.1

1.2

0.37

0.45

g/l

—

UC patients in KELA-register (code 208), prior to 1994

132

1.83

2.04

1.6

1.3

0.27

0.36

g/l

0.86

Alzheimer’s disease, wide definition, excluding more controls

269

0.55

2.04

1.1

1.5

0.56

0.43

g/l

0.62

173

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.04

1.5

1.3

0.29

0.36

g/l

1.23

111

Left bundle-branch block

154

1.76

2.04

1.4

1.3

0.39

0.40

g/l

0.07

105

Congenital malformations of genital organs

422

1.44

2.02

1.2

1.4

0.36

0.38

g/l

0.26

311

Benign neoplasm: Skin of eyelid, including canthus

508

1.40

2.02

1.7

1.4

0.37

0.40

g/l

0.40

351

Degenerative macular diseases

294

1.54

2.02

1.4

1.3

0.37

0.43

g/l

0.72

203

Alcohol abuse, main dg

610

1.37

2.02

1.3

0.41

0.39

g/l

0.22

409

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

0.37

g/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

107

817

1.31

2.01

1.8

1.4

0.32

0.40

g/l

2.14

560

Congenital malformations of the circulatory system

599

1.36

2.01

1.6

1.4

0.37

0.39

g/l

0.24

436

Varicella [chickenpox]

185

1.69

2.01

1.2

1.3

0.26

0.38

g/l

1.36

128

Exposure to other and unspecified animate mechanical forces

2.02

2.01

1.2

1.3

0.38

0.37

g/l

0.04

Sixth [abducent] nerve palsy

2.02

2.01

1.6

1.3

0.30

0.41

g/l

1.03

Benign neoplasm: Long bones of lower limb

104

1.94

2.01

1.9

1.3

0.25

0.32

g/l

—

Unspecified urinary incontinence

247

1.59

2.01

1.4

0.35

0.42

g/l

0.54

171

Molar incisor enamel hypoplasia

152

1.76

2.00

1.4

1.3

0.41

0.35

g/l

0.29

129

Coronary angioplasty

155

949

1.26

2.00

1.3

1.4

0.41

0.43

g/l

0.26

122

640

Any dementia

709

0.72

2.00

1.2

1.4

0.45

0.46

g/l

0.07

503

Primary gonarthrosis, bilateral

232

1693

1.20

1.99

1.3

1.4

0.43

0.42

g/l

0.14

175

1182

Blepharochalasis

123

959

1.29

1.98

1.5

1.4

0.40

0.43

g/l

0.26

663

Fall on same level involving ice and snow

297

2537

1.17

1.97

1.6

1.4

0.40

g/l

0.11

209

1769

Other benign neoplasms of connective and other soft tissue

337

1.49

1.96

1.5

1.4

0.35

0.38

g/l

0.29

241

Complications of other internal prosthetic devices, implants and grafts

2.04

1.96

1.1

1.2

0.36

0.41

g/l

0.36

Meralgia paraesthetica

1.99

1.95

1.2

1.4

0.35

0.37

g/l

0.09

Lesion of sciatic nerve

1.99

1.95

1.3

0.46

0.40

g/l

0.33

Allergic contact dermatitis due to drugs in contact with skin

2.21

1.95

1.3

0.40

0.35

g/l

—

Other noninflammatory disorders of vagina

249

1.57

1.95

1.3

0.36

0.40

g/l

0.24

169

Glucosamine medication

224

1488

1.20

1.95

1.3

1.4

0.42

0.43

g/l

0.06

152

1044

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

0.36

0.31

g/l

—

Laparoscopic right hemicolectomy

127

1.82

1.94

1.1

1.4

0.53

0.44

g/l

0.26

Malignant neoplasm of small intestine

2.47

1.93

1.1

1.2

0.36

0.45

g/l

—

Corns and callosities

195

1.65

1.93

1.2

1.4

0.48

0.40

g/l

0.62

139

Parkinson's disease

398

0.58

1.92

1.3

0.37

0.44

g/l

0.54

274

Hypermetropia

266

1.55

1.92

1.5

1.4

0.42

0.36

g/l

0.43

192

Other benign neoplasms of skin

179

1465

1.22

1.91

1.7

1.3

0.38

0.42

g/l

0.67

127

1012

Postmenopausal bleeding

129

553

1.28

1.91

1.3

1.4

0.36

0.39

g/l

0.46

377

Residual foreign body in soft tissue

150

1.74

1.91

1.4

1.3

0.28

0.38

g/l

1.18

Injury of unspecified body region

227

1.59

1.90

1.6

1.3

0.35

0.40

g/l

0.50

158

Other disorders of cornea

283

1.53

1.89

1.1

1.4

0.35

0.38

g/l

0.22

201

Lesion of femoral nerve

3.24

1.89

1.1

1.4

0.46

0.28

g/l

—

Fracture of femur

641

1.33

1.89

1.3

0.49

0.43

g/l

0.62

454

False labour

181

927

1.23

1.89

1.3

1.4

0.37

0.36

g/l

0.26

125

667

Presbyopia

228

1.59

1.87

1.4

0.38

0.34

g/l

0.22

156

Myeloproliferative diseases

228

1.59

1.87

1.1

1.4

0.39

0.42

g/l

0.12

158

Coxarthrosis, primary, with hip surgery

199

1563

1.21

1.87

1.3

1.4

0.48

0.43

g/l

0.77

159

1064

Endometriosis of ovary

643

1.34

1.86

1.3

1.4

0.41

0.39

g/l

0.11

444

Malignant neoplasm of prostate

106

865

0.77

1.86

1.3

1.4

0.47

0.46

g/l

0.12

602

Essential (haemorrhagic) thrombocythaemia

1.95

1.85

1.1

1.4

0.34

0.36

g/l

—

Other conjunctival vascular disorders and cysts

2.22

1.85

1.7

1.3

0.38

0.40

g/l

—

Other strabismus

123

967

1.27

1.84

1.6

1.3

0.42

0.38

g/l

0.55

675

Peripheral artery operations in Hilmo

301

1.50

1.84

1.3

0.57

0.43

g/l

1.09

209

Implicit parasitic Sepsis

4.26

1.83

1.6

1.2

0.34

0.28

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.14

1.82

1.5

1.3

0.37

0.38

g/l

—

Infective bursitis

2.14

1.82

1.3

1.4

0.22

0.39

g/l

—

Varicose veins

309

2010

1.16

1.82

1.5

1.4

0.38

0.42

g/l

0.93

208

1424

Benign lipomatous neoplasm

137

1096

1.25

1.82

1.2

1.4

0.42

g/l

0.04

769

Cerebral aneurysm, nonruptured

286

1.51

1.82

1.4

0.41

0.39

g/l

0.12

194

Familial hypercholesterolemia, with ischemic heart disease

222

1.58

1.81

1.3

0.35

0.44

g/l

1.26

155

Alzheimer disease, excluding more controls

304

0.61

1.80

1.3

1.4

0.46

0.42

g/l

0.20

198

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

263

1.53

1.78

1.3

1.4

0.42

0.37

g/l

0.43

182

Parkinson's disease, strict definition

351

0.57

1.78

1.4

1.3

0.37

0.45

g/l

0.47

244

Stroke, excluding SAH

271

1719

1.17

1.78

1.3

1.4

0.49

0.43

g/l

0.54

200

1172

Other noninflammatory disorders of uterus, except cervix

104

547

1.30

1.77

1.5

1.4

0.47

0.39

g/l

0.90

372

Endometriosis ASRM stages 3,4

120

949

1.27

1.77

1.3

1.4

0.38

0.37

g/l

0.10

656

Unstable angina pectoris

155

1043

1.23

1.77

1.3

1.4

0.45

0.44

g/l

0.15

121

701

Other and unspecified injuries of ankle and foot

124

1.78

1.76

1.9

1.2

0.43

0.38

g/l

0.30

Disorder of external ear, unspecified

1.99

1.75

1.6

1.3

0.49

0.33

g/l

—

Dementia in Alzheimer disease

288

0.56

1.74

1.1

1.3

0.51

0.50

g/l

0.04

212

Outcome of delivery

494

0.71

1.74

1.2

1.4

0.36

0.34

g/l

0.38

354

Effects of foreign body entering through natural orifice

127

1014

1.26

1.73

1.3

1.4

0.38

0.40

g/l

0.19

694

Diabetic nephropathy, excluding more controls

407

1.38

1.73

1.4

1.5

0.44

0.39

g/l

0.49

260

Haemangioma and lymphangioma, any site

306

1.48

1.72

1.6

1.4

0.37

0.39

g/l

0.26

213

Brain meningioma, excluding all cancers (controls excluding all cancers)

140

1.72

1.5

0.29

0.36

g/l

0.76

Other vitreous opacities

103

1.86

1.72

1.4

1.3

0.39

0.37

g/l

0.09

Behavioural disorders, excluding more controls

2.14

1.71

1.3

1.4

0.38

0.35

g/l

—

Additional codes for the location of defect, injury or illness

163

1.66

1.71

1.2

1.3

0.34

0.38

g/l

0.27

111

Melanoma in situ

1.89

1.71

1.6

1.4

0.37

0.39

g/l

—

Amputation

226

1.55

1.70

1.3

1.2

0.58

0.44

g/l

0.98

159

Other eating disorders

187

1.61

1.69

1.2

1.4

0.33

0.37

g/l

0.30

123

Lichen sclerosus et atrophicus

308

1.47

1.68

1.6

1.4

0.37

0.40

g/l

0.27

217

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

149

1.69

1.67

1.6

1.3

0.35

0.34

g/l

0.15

112

Eating disorders

425

1.39

1.66

1.2

1.4

0.46

0.40

g/l

0.22

292

Maltreatment syndromes

188

1.60

1.66

1.2

1.3

0.42

0.34

g/l

0.63

134

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

268

1.50

1.66

1.3

1.4

0.42

0.37

g/l

0.49

191

Myeloproliferative diseases (CML excluded)

196

1.59

1.65

1.1

1.4

0.41

0.42

g/l

0.04

134

Single spontaneous delivery

153

995

0.82

1.65

1.4

0.35

0.38

g/l

0.70

735

Oral lichen ruber planus wide, hypothyreosis or thyroxin

150

1.68

1.63

2.4

1.5

0.34

0.40

g/l

0.53

107

Haemangioma and lymphangioma, any site

310

1.46

1.63

1.6

1.3

0.37

0.39

g/l

0.21

222

Conductive hearing loss, unspecified

261

1.50

1.63

1.3

0.41

g/l

0.04

187

Fracture of neck

135

1.71

1.62

1.0

1.3

0.26

0.39

g/l

1.66

Melanoma in situ

1.85

1.62

1.6

1.3

0.37

0.42

g/l

—

Myocardial infarction, with ST-elevation

496

1.35

1.61

1.2

1.4

0.40

0.46

g/l

1.02

347

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

219

1271

1.18

1.61

1.6

1.4

0.39

0.43

g/l

0.78

155

893

Alcohol use disorder, ICD-based

209

1770

1.18

1.61

1.2

1.4

0.41

g/l

0.02

134

1220

Preterm labour and delivery

138

1124

1.23

1.60

1.4

0.45

0.37

g/l

0.74

801

Biguanides

524

2902

1.11

1.59

1.4

0.42

0.41

g/l

0.33

368

2020

Diffuse brain injury

1.96

1.59

1.1

1.4

0.35

0.39

g/l

—

Cyst of kidney

175

1.61

1.57

1.6

1.4

0.36

0.42

g/l

0.64

120

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

129

1.71

1.57

1.2

1.4

0.44

0.36

g/l

0.35

!Aliquae complicationes praecoces traumatis

114

1.76

1.56

1.3

0.36

0.39

g/l

0.18

Early complications of trauma

114

1.76

1.56

1.3

0.36

0.39

g/l

0.18

Alzheimer’s disease (Late onset), excluding more controls

234

0.60

1.55

1.1

1.4

0.58

0.44

g/l

0.67

153

Hereditary corneal dystrophies

1.94

1.54

1.1

1.3

0.19

0.40

g/l

—

Adenomyosis (Endometriosis of uterus)

466

1.36

1.54

1.2

1.5

0.40

0.39

g/l

0.12

320

Female infertility, associated with anovulation

314

1.44

1.54

1.6

1.5

0.33

0.38

g/l

0.88

218

Haemangioma, any site

281

1.46

1.54

1.6

1.3

0.37

0.40

g/l

0.22

193

Carcinoma in situ of skin of other and unspecified parts of face

145

1.66

1.54

1.1

1.3

0.50

0.43

g/l

0.19

107

Stroke, including SAH

289

1860

1.15

1.54

1.3

1.4

0.47

0.42

g/l

0.48

215

1269

Glaucoma, exfoliation

208

1.54

1.53

1.3

0.35

0.46

g/l

1.14

152

Alzheimer’s disease (Late onset)

361

0.64

1.52

1.1

1.3

0.53

0.50

g/l

0.14

265

Malignant neoplasm of digestive organs

150

1220

1.21

1.52

1.3

1.4

0.45

0.44

g/l

0.06

842

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.62

1.52

1.0

1.2

0.48

0.44

g/l

—

Hydatidiform mole

0.00

1.52

0.0

1.5

—

0.35

—

Carcinoma in situ of skin of other and unspecified parts of face

146

1.65

1.50

1.1

1.3

0.50

0.45

g/l

0.15

108

Any dementia, excluding more controls

648

0.76

1.50

1.3

1.4

0.45

0.46

g/l

0.02

446

Other disorders of breast

486

1.34

1.50

1.4

1.3

0.39

g/l

0.02

331

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

615

0.77

1.49

1.3

1.4

0.49

0.45

g/l

0.38

428

Other lesions of median nerve

2.08

1.49

1.1

1.3

0.26

0.43

g/l

—

Other congenital malformations of circulatory system

1.96

1.49

2.9

1.3

0.44

0.32

g/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

2.01

1.49

1.2

1.3

0.51

0.33

g/l

0.92

Transient ischemic attack

228

1621

1.17

1.49

1.4

0.41

0.42

g/l

0.15

160

1113

Primary coxarthrosis, bilateral

116

937

1.24

1.48

1.4

0.47

0.43

g/l

0.32

642

Insulin, fast-acting (human)

548

1.32

1.47

1.3

0.37

0.38

g/l

0.07

372

Acute alcohol intoxication, ICD10

777

1.26

1.47

1.3

1.4

0.44

0.39

g/l

0.57

534

Complications predominantly related to the puerperium

142

1173

1.21

1.46

1.5

1.4

0.34

0.39

g/l

1.18

106

829

Ménière disease

301

1.43

1.46

1.5

1.4

0.39

0.40

g/l

0.10

209

Ischaemic Stroke, excluding all haemorrhages

247

1613

1.16

1.46

1.3

1.4

0.50

0.43

g/l

0.56

179

1099

Benign neoplasm of ovary

619

1.30

1.46

1.2

1.4

0.33

0.39

g/l

1.34

427

Inflammatory diseases of prostate (prostatitis)

411

1.37

1.46

1.2

1.3

0.32

0.46

g/l

4.57

276

Infectious mononucleosis

335

1.41

1.45

2.1

1.4

0.38

g/l

0.02

227

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

664

0.78

1.45

1.3

1.4

0.50

0.45

g/l

0.51

459

Atlantoaxial subluxation

3.17

1.44

1.0

1.6

0.33

0.29

g/l

—

Parkinson's disease, including avohilmo

414

0.65

1.44

1.3

0.45

g/l

0.00

287

Specific development disorders of speech and language

235

1.48

1.44

1.4

1.3

0.43

0.36

g/l

0.56

181

Dementia in other diseases classified elsewhere

1.80

1.43

1.2

0.38

0.44

g/l

—

Mental disorders, not otherwise specified

311

1.42

1.43

1.3

1.4

0.31

0.36

g/l

1.03

218

Contact with heat and hot substances

180

1.56

1.43

1.4

1.3

0.39

g/l

0.04

124

Impacted cerumen

270

1.45

1.41

1.2

1.3

0.40

0.43

g/l

0.15

192

Benign neoplasm of urinary organs

118

1.70

1.41

1.2

1.3

0.33

0.37

g/l

0.23

Postmenopausal atrophic vaginitis

118

574

1.24

1.41

1.4

1.3

0.42

0.38

g/l

0.30

393

Carcinoma in situ of breast, intraductal

289

0.59

1.41

1.2

1.4

0.60

0.37

g/l

—

203

Benign neoplasm: Kidney

1.86

1.40

1.3

0.26

0.40

g/l

—

Coronary revascularization (ANGIO or CABG)

192

1138

1.18

1.40

1.4

0.44

0.42

g/l

0.24

147

759

Specific development disorders of scholastic skills

195

1.53

1.39

1.4

1.3

0.29

0.38

g/l

1.42

141

Sequelae of injuries of upper limb

355

1.38

1.39

1.2

1.4

0.35

0.37

g/l

0.19

250

Recurrent dislocation and subluxation of joint

247

1.46

1.37

1.3

1.4

0.35

0.39

g/l

0.31

163

Benign neoplasm of ovary

625

1.28

1.37

1.2

1.5

0.33

0.41

g/l

1.89

438

Postprocedural musculoskeletal disorders, not elsewhere classified

190

1.53

1.37

1.3

1.5

0.31

0.39

g/l

0.74

131

Carcinoma in situ of skin

182

1.54

1.37

1.4

0.51

0.40

g/l

0.54

129

Other spirochaetal diseases

123

1010

1.22

1.37

1.3

1.4

0.35

0.41

g/l

1.55

699

Haemangioma, any site

289

1.42

1.36

1.6

1.3

0.37

0.39

g/l

0.12

207

Nontoxic multinodular goitre

661

1.27

1.36

1.5

1.4

0.40

0.43

g/l

0.34

455

Macular pucker

408

1.35

1.36

1.7

1.4

0.42

0.45

g/l

0.12

294

Anomalies of dental arch relationship, including avohilmo

109

794

1.24

1.35

1.3

1.4

0.39

0.38

g/l

0.23

557

Carcinoma in situ of skin

183

1.54

1.34

1.4

1.3

0.51

0.43

g/l

0.31

132

Amputation of toe

167

1.56

1.34

1.2

0.57

0.43

g/l

0.71

113

Granulomatous disorders of skin and subcutaneous tissue

1.92

1.33

1.6

1.2

0.41

g/l

—

Use of interferon beta-1a

1.79

1.33

1.4

0.34

0.33

g/l

—

Sequelae of infectious and parasitic diseases

249

1.45

1.33

1.4

0.36

0.39

g/l

0.19

171

Wet age-related macular degeneration

360

1.37

1.32

1.2

1.3

0.46

0.48

g/l

0.05

266

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

208

1.50

1.32

1.4

0.36

0.39

g/l

0.21

150

Delivery

159

997

0.84

1.31

1.4

0.36

0.38

g/l

0.32

737

Mental and behavioural disorders due to alcohol, excluding acute intoxication

221

1917

1.15

1.30

1.2

1.4

0.41

g/l

0.03

141

1319

Carcinoma in situ of breast, intraductal

282

0.60

1.30

1.2

1.5

0.60

0.37

g/l

—

201

Anorexia (incl.atypical)

209

1.49

1.30

1.1

1.4

0.57

0.38

g/l

0.44

140

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

137

1.61

1.29

1.2

1.4

0.44

0.35

g/l

0.41

Congenital lens malformations

2.83

1.29

1.2

1.4

0.25

0.31

g/l

—

Wide developmental disorders, excluding more controls

105

1.71

1.29

1.3

1.4

0.26

0.37

g/l

1.87

Vitreous haemorrhage

276

1.42

1.28

1.5

1.4

0.34

0.40

g/l

0.69

196

Pregnancy with abortive outcome

365

1705

1.12

1.28

1.3

1.4

0.42

0.38

g/l

0.89

253

1214

Dental pulpitis 3, only avohilmo

395

1.30

1.27

1.2

1.3

0.33

0.38

g/l

0.98

282

Benign lipomatous neoplasm

137

1148

1.20

1.26

1.2

1.4

0.42

0.40

g/l

0.22

802

Calcific tendinitis of shoulder

178

1.52

1.26

1.1

1.4

0.37

g/l

0.01

118

Endometriosis diagnosis and infertility diagnosis occurring together

466

1.31

1.26

1.4

0.44

0.38

g/l

0.25

320

Motorcycle rider injured in other and unspecified transport accidents

211

1.48

1.25

1.5

1.2

0.42

0.37

g/l

0.60

143

Fracture of shoulder and upper arm

163

1387

1.18

1.25

1.5

1.3

0.41

g/l

0.06

120

958

Open wound of forearm

295

1.39

1.24

1.2

1.3

0.57

0.40

g/l

1.01

206

Eating disorder

363

1.35

1.23

1.2

1.4

0.31

0.40

g/l

1.76

254

Scabies

155

1.56

1.23

1.8

1.3

0.46

0.36

g/l

0.80

106

Other renal tubulo-interstitial diseases

1.92

1.23

1.1

1.3

0.39

0.33

g/l

—

Retinoschisis and retinal cysts

1.98

1.22

2.8

1.3

0.35

0.37

g/l

—

Bursitis of shoulder

1.98

1.22

1.5

0.48

0.34

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

0.29

0.37

g/l

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

529

1.26

1.22

1.2

1.4

0.53

0.44

g/l

0.84

377

Delivery, wide proxy

125

799

0.83

1.22

1.4

0.35

0.37

g/l

0.36

576

Malignant neoplasm of respiratory system and intrathoracic organs

536

1.27

1.21

1.2

1.3

0.47

0.45

g/l

0.15

384

Other disorders of the genitourinary system

408

1.33

1.21

1.4

0.44

0.39

g/l

0.21

280

Malignant neoplasm of breast, HER-negative

752

0.77

1.21

1.2

1.4

0.42

0.41

g/l

0.09

534

Retinal detachments and breaks

147

1246

1.18

1.20

1.7

1.4

0.35

0.43

g/l

2.22

106

865

Female infertility, tubal origin

189

1.49

1.19

1.1

1.5

0.39

0.37

g/l

0.07

138

Polyp of the female genital tract

154

759

1.18

1.3

1.4

0.34

0.39

g/l

0.75

113

522

Vestibular neuronitis

281

1.39

1.18

1.3

1.4

0.44

0.42

g/l

0.08

202

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

117

1.63

1.18

1.2

0.39

0.36

g/l

0.14

Parkinson's disease, excluding more controls

338

0.66

1.18

1.3

1.4

0.37

0.46

g/l

0.70

224

LSIL lesion of the cervix uteri, vagina or vulva

613

1.26

1.18

1.3

1.4

0.38

0.37

g/l

0.11

419

Congenital musculoskeletal deformities of head, face, spine and chest

2.02

1.17

1.6

1.3

0.30

0.34

g/l

—

In situ neoplasms

153

1245

1.17

1.16

1.4

0.47

0.41

g/l

0.69

874

Benign neoplasm: Adrenal gland

215

1.45

1.16

1.2

1.5

0.27

0.38

g/l

1.50

150

Thyrotoxicosis with toxic single thyroid nodule

2.52

1.15

1.8

1.4

0.44

0.27

g/l

—

Colitis due to radiation

2.52

1.15

1.4

0.18

0.39

g/l

—

Fracture of lower leg, including ankle

275

2437

1.12

1.15

1.5

1.4

0.41

g/l

0.06

203

1679

Conduct disorder

1.82

1.15

1.3

0.38

0.34

g/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

274

1.39

1.15

1.0

1.4

0.35

0.42

g/l

0.58

198

Schizophrenia or delusion

120

1429

0.84

1.15

1.2

1.3

0.40

0.39

g/l

0.11

965

Benign neoplasm of urinary organs

126

1.59

1.14

1.2

1.4

0.33

0.39

g/l

0.37

Erectile dysfunction

224

1.43

1.14

1.5

1.2

0.50

0.43

g/l

0.30

157

Parkinson's disease, strict definition, excluding more controls

302

0.65

1.14

1.4

0.37

0.46

g/l

0.58

199

Any event in cancer register

530

2886

1.09

1.13

1.3

1.4

0.42

0.40

g/l

0.54

356

2047

Sequelae of injuries of lower limb

344

1.34

1.12

1.6

1.4

0.40

0.37

g/l

0.25

239

Melanocytic naevi of trunk

423

1.30

1.11

1.2

1.4

0.34

0.39

g/l

0.57

300

Early lumbar disc prolapse operation

476

1.29

1.11

1.2

1.3

0.38

0.37

g/l

0.15

314

Schizophrenia, schizotypal and delusional disorders

121

1434

0.84

1.11

1.2

1.3

0.40

0.39

g/l

0.06

971

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

345

1.34

1.11

1.1

1.4

0.41

0.38

g/l

0.27

235

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

285

1.37

1.10

1.3

1.4

0.37

0.40

g/l

0.26

185

Diabetic nephropathy

532

1.26

1.09

1.4

1.5

0.44

g/l

0.03

350

Superficial injury of thorax

513

1.27

1.08

1.5

1.4

0.42

0.40

g/l

0.20

361

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

203

1225

1.14

1.08

1.7

1.4

0.37

0.43

g/l

1.20

145

861

Benign neoplasm: Kidney

1.69

1.08

1.3

1.5

0.26

0.34

g/l

—

Basal cell carcinoma

223

1568

1.13

1.06

1.6

1.4

0.37

0.44

g/l

2.00

163

1072

Infections of genitourinary tract in pregnancy

365

1.32

1.06

1.3

1.5

0.37

0.38

g/l

0.07

254

Lyme disease

118

995

1.19

1.06

1.3

1.4

0.35

0.41

g/l

1.53

690

Impacted maxillary molar

186

1.46

1.06

1.4

0.38

0.37

g/l

0.09

121

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

814

0.80

1.05

1.2

1.4

0.43

0.40

g/l

0.15

577

Gilbert syndrome

2.30

1.04

2.2

1.3

0.39

0.29

g/l

—

Other congenital malformations of heart

2.09

1.03

1.4

1.2

0.31

0.41

g/l

—

Injury of muscle and tendon at hip and thigh level

341

1.32

1.03

1.1

1.4

0.40

0.36

g/l

0.29

234

Obstructed labour due to maternal pelvic abnormality

625

1.23

1.03

1.3

1.4

0.63

0.35

g/l

0.98

439

Benign neoplasm: Adrenal gland

221

1.41

1.02

1.2

1.4

0.27

0.39

g/l

1.78

159

Peripheral arterial reconstruction

420

1.29

1.02

1.2

1.3

0.47

g/l

0.02

306

Chronic periodontitis, including avohilmo

476

3242

1.09

1.02

1.4

0.42

0.40

g/l

0.54

340

2239

Acute alcohol intoxication

116

981

1.18

1.02

1.3

1.4

0.44

0.41

g/l

0.36

675

Malignant neoplasm of brain

1.69

1.01

1.4

1.3

0.29

0.40

g/l

—

In situ neoplasms

153

1324

1.16

1.01

1.4

1.3

0.47

0.42

g/l

0.59

924

Melanocytic naevi of trunk

430

1.28

1.01

1.2

1.4

0.34

0.39

g/l

0.56

308

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

0.27

0.30

g/l

—

Sequelae of injuries of head

172

1.46

1.00

1.4

0.38

0.37

g/l

0.02

115

Bitten or struck by other mammals

422

1.28

0.99

1.4

0.42

0.38

g/l

0.50

290

Other disorders of pigmentation

115

1.57

0.99

1.4

1.3

0.46

0.40

g/l

0.29

Behavioural disorders

1.72

0.99

1.3

1.2

0.38

0.35

g/l

—

Complications of the puerperium, not elsewhere classified

156

1.48

0.98

1.3

1.4

0.28

0.38

g/l

1.44

110

LSIL lesion of the cervix uteri

476

1.26

0.98

1.3

1.4

0.40

0.37

g/l

0.23

331

Other malignant neoplasms of skin (=non-melanoma skin cancer)

218

1526

1.13

0.98

1.5

1.4

0.39

0.44

g/l

0.82

152

1046

Other and unspecified vascular occlusions

206

1.41

0.98

1.2

1.3

0.34

0.44

g/l

1.36

149

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.98

0.0

1.3

—

0.31

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.2

—

0.39

—

Impacted maxillary canine

1.96

0.97

1.3

0.54

0.39

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.5

0.51

0.34

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.3

0.51

0.33

g/l

—

Right hemicolectomy

132

1.52

0.97

1.3

0.79

0.41

g/l

1.26

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

0.25

0.37

g/l

—

Maternal care for other known or suspected fetal problems

134

737

1.17

0.96

1.3

1.4

0.39

0.36

g/l

0.58

537

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

182

1.43

0.96

1.6

1.4

0.52

0.38

g/l

0.64

130

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

245

1496

1.12

0.96

1.6

1.4

0.44

0.42

g/l

0.10

171

1059

Benign mammary dysplasia

505

1.25

0.95

1.5

1.4

0.42

0.40

g/l

0.12

344

Other and unspecified mononeuropathies, also in other diseases

1.70

0.95

1.4

1.3

0.44

0.38

g/l

0.23

Primary ovarian failure

1.79

0.94

1.2

1.3

0.45

0.36

g/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

285

1.34

0.94

1.4

0.43

0.42

g/l

0.08

199

Vertical strabismus

101

1.59

0.93

1.4

1.3

0.57

0.39

g/l

0.80

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

205

1250

1.13

0.93

1.7

1.4

0.37

0.43

g/l

1.32

147

876

Long labour

976

0.84

0.93

1.3

1.4

0.38

0.35

g/l

0.56

701

Torticollis

1.74

0.92

1.1

1.3

0.43

0.33

g/l

—

Contact with machinery

374

1.29

0.92

1.2

1.3

0.41

0.39

g/l

0.09

262

Pediculosis, acariasis and other infestations

201

1.40

0.91

1.7

1.3

0.50

0.37

g/l

0.77

136

Mental and behavioural disorders due to cannabinoids

102

1.58

0.90

1.1

1.3

0.52

0.33

g/l

—

Other chromosome abnormalities, not elsewhere classified

2.11

0.90

1.5

1.3

0.49

0.40

g/l

—

L02BA Anti-estrogens

608

0.79

0.89

1.1

1.4

0.38

0.39

g/l

0.16

426

Malignant neoplasm of bronchus and lung

443

1.25

0.89

1.2

1.3

0.53

0.45

g/l

0.60

312

Perineal laceration during delivery

660

0.81

0.88

1.7

1.4

0.44

0.35

g/l

1.38

463

Leiomyoma of uterus

251

1272

1.11

0.88

1.4

0.39

0.38

g/l

0.07

168

933

Parodontitis

474

3242

1.08

0.87

1.4

0.42

0.40

g/l

0.54

341

2237

Varicose veins of other sites

203

1.38

0.87

1.2

1.3

0.52

0.38

g/l

0.69

139

Dental caries 1 and operation codes, only avohilmo

141

814

0.87

0.86

1.5

1.4

0.36

0.40

g/l

0.73

588

Pedestrian injured in transport accident

212

1.37

0.86

1.2

1.3

0.41

0.39

g/l

0.07

143

Premature rupture of membranes

728

0.84

0.86

1.3

1.4

0.40

0.36

g/l

0.66

523

Toxic effect of contact with venomous animals

128

1.49

0.86

1.2

1.3

0.27

0.38

g/l

1.94

Emotional disorders starting during childhood or adolescence

202

1.38

0.86

1.5

1.4

0.29

0.38

g/l

1.69

153

Non-small cell lung cancer

414

1.26

0.85

1.2

1.3

0.52

0.44

g/l

0.82

295

Parodontitis or operation codes

474

3243

1.08

0.85

1.4

0.42

0.40

g/l

0.54

341

2238

Fracture of skull and facial bones

833

1.18

0.85

1.4

1.3

0.39

0.40

g/l

0.15

566

Graves disease, strict definition

370

1.27

0.85

1.4

1.5

0.31

0.40

g/l

2.18

261

Injury of eye and orbit

559

1.22

0.84

1.2

1.3

0.39

0.40

g/l

0.06

376

Juvenile osteochondrosis

104

1.54

0.84

1.8

1.4

0.35

0.37

g/l

0.14

Other and unspecified injuries of abdomen, lower back and pelvis

1.95

0.84

1.0

1.1

0.43

0.30

g/l

—

Inguinal hernia

291

1786

1.10

0.84

1.3

1.4

0.45

0.40

g/l

1.18

204

1208

Assault

533

1.22

0.83

1.2

1.3

0.45

0.36

g/l

1.31

358

Male infertility

171

1.41

0.83

1.3

0.34

0.37

g/l

0.19

109

Parodontitis and operation codes

446

3219

1.08

0.83

1.4

0.42

0.40

g/l

0.28

319

2224

Hyperplasia of prostate

152

760

1.14

0.83

1.2

1.5

0.43

0.45

g/l

0.18

105

527

Injuries to the elbow and forearm

364

3033

1.09

0.82

1.4

0.42

0.40

g/l

0.32

260

2127

Basal cell carcinoma, including avohilmo

226

1604

1.11

0.81

1.6

1.4

0.37

0.44

g/l

2.21

165

1095

Traumatic subdural haemorrhage

288

1.30

0.81

1.6

1.4

0.55

0.44

g/l

0.76

200

L02BB Anti-androgens

201

0.65

0.81

2.2

1.2

0.51

0.48

g/l

—

141

Fall on and from stairs and steps

113

977

1.16

0.81

1.4

1.3

0.37

0.40

g/l

0.47

679

Diabetic retinopathy

150

833

1.14

0.80

1.5

1.4

0.43

0.42

g/l

0.10

564

Dipeptidyl peptidase 4 (DPP-4) inhibitors

356

1.27

0.79

1.3

1.4

0.43

0.40

g/l

0.23

250

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.6

—

0.31

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

0.32

—

All dysplastic lesions of the cervix uteri, vagina or vulva

145

1270

1.14

0.79

1.3

1.4

0.38

g/l

0.03

104

900

Intracerebral haemorrhage

294

1.29

0.79

1.2

1.3

0.43

0.42

g/l

0.09

207

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

0.35

—

Graves ophthalmopathy, strict

1.68

0.79

1.3

0.46

0.35

g/l

0.74

Autism

1.54

0.78

1.3

0.24

0.35

g/l

—

Oral leukoplakia, including avohilmo

1.63

0.78

1.4

1.3

0.47

0.39

g/l

—

Other and unspecified corneal deformities and disorders

1.56

0.78

1.2

1.4

0.43

0.38

g/l

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

0.32

—

Benign leiomyoma with endometriosis

538

1.21

0.77

1.2

1.5

0.39

0.41

g/l

0.12

374

Ovarian dysfunction

278

1.30

0.77

1.4

0.35

0.38

g/l

0.21

191

Parodontitis, under 40 years and operation codes

349

1.26

0.77

1.2

1.3

0.41

0.39

g/l

0.14

243

Parodontitis, operation under 40 years and operation codes

349

1.26

0.77

1.2

1.3

0.41

0.39

g/l

0.14

243

Other osteochondropathies

261

1.31

0.76

1.4

1.3

0.32

0.37

g/l

0.43

176

Autism spe

1.52

0.76

1.3

0.24

0.34

g/l

—

Parodontitis or/and operation codes

331

2134

0.92

0.76

1.3

1.4

0.41

0.38

g/l

0.70

240

1468

Nontoxic goitre/thyroid nodule

127

1115

1.14

0.75

1.9

1.4

0.37

0.40

g/l

0.69

777

Cicatricial alopecia [scarring hair loss]

2.10

0.75

1.6

1.4

0.37

0.28

g/l

—

Pre-eclampsia or poor fetal growth

156

1385

1.12

0.74

1.4

0.40

0.38

g/l

0.32

110

984

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

333

1.26

0.74

1.2

1.5

0.36

0.37

g/l

0.10

233

Nontoxic single thyroid nodule

227

1.32

0.74

2.1

1.3

0.31

0.42

g/l

1.28

159

Use of levodopa decarboxylase inhibitor

324

0.74

1.4

1.3

0.33

0.45

g/l

1.08

227

Pregnancy, childbirth and the puerperium

109

657

0.87

0.73

1.4

1.5

0.39

0.38

g/l

0.13

469

Overexertion and strenuous or repetitive movements

361

1.25

0.73

1.2

1.4

0.30

0.37

g/l

0.90

250

Sequelae of cerebrovascular disease

130

1005

1.14

0.73

1.3

1.4

0.44

0.43

g/l

0.11

103

683

Unspecified maternal hypertension

1.81

0.73

1.1

1.4

0.34

0.35

g/l

—

Fitting and adjustment of other devices

129

1057

1.14

0.72

1.4

0.34

0.43

g/l

3.76

108

726

Foreign body in alimentary tract

159

1.39

0.72

1.2

1.3

0.39

0.41

g/l

0.07

113

Injury of muscle and tendon at wrist and hand level

516

1.20

0.71

1.3

1.4

0.36

0.40

g/l

0.37

362

Emergency coronary revascularization (for ACS)

213

1387

1.10

0.71

1.4

0.44

g/l

0.09

165

937

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

378

0.77

0.71

1.3

1.4

0.33

0.43

g/l

0.93

271

Diabetic neuropathy

378

1.24

0.71

1.6

1.4

0.46

0.44

g/l

0.10

251

Pervasive developmental disorders excl. Autism + Asperger

1.58

0.71

1.0

1.2

0.24

0.41

g/l

—

Inflammatory disorders of breast

212

1.32

0.70

1.8

1.4

0.38

0.36

g/l

0.15

144

Supervision of normal pregnancy

622

0.86

0.70

1.1

1.4

0.32

0.37

g/l

0.97

448

Crushed, pushed or stepped on by crowd or human stampede

283

1.28

0.69

1.2

1.3

0.41

0.39

g/l

0.25

196

Sequelae of other and unspecified infectious and parasitic diseases

204

1.33

0.69

1.5

1.4

0.35

0.37

g/l

0.10

140

Other congenital malformations of the digestive system

177

1.35

0.68

1.5

1.3

0.46

0.37

g/l

0.68

136

Bipolar affective disorders

797

1.16

0.68

1.3

0.40

0.39

g/l

0.08

531

Other and unspecified nonorganic psychotic disorders

855

0.85

0.67

1.2

1.4

0.40

0.38

g/l

0.19

573

Hydrocele

356

1.24

0.67

1.4

0.43

0.46

g/l

0.21

251

Focal brain injury

153

1.37

0.67

1.7

1.3

0.51

0.42

g/l

0.26

106

Vascular dementia

123

1.42

0.67

1.3

1.2

0.34

0.52

g/l

1.33

Nonalcoholic steatohepatitis

1.80

0.66

1.8

1.4

0.54

0.37

g/l

—

Other degenerative diseases of the basal ganglia

1.79

0.66

1.0

1.3

0.32

0.47

g/l

—

Benign neoplasm: Skin of other and unspecified parts of face

312

1.25

0.66

1.5

1.4

0.45

0.40

g/l

0.24

222

Organic, including symptomatic, mental disorders

153

1229

0.90

0.65

1.2

1.4

0.42

0.43

g/l

0.07

110

838

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

406

1.21

0.64

1.2

1.4

0.52

0.44

g/l

0.82

292

Spontaneous abortion

238

1486

1.09

0.63

1.3

1.4

0.37

0.38

g/l

0.10

170

1067

Malignant neoplasm of bladder

146

1.37

0.63

1.5

1.1

0.34

0.45

g/l

0.55

109

Inguinal or femoral hernia, bilateral

323

1.24

0.63

1.2

1.3

0.58

0.43

g/l

0.55

228

Pregnancy examination and test

487

1.16

0.63

1.6

1.4

0.32

0.34

g/l

0.38

349

Calculus of lower urinary tract

121

1.41

0.62

1.7

1.3

0.40

0.43

g/l

—

Sexual dysfunction

1.64

0.62

1.5

1.3

0.40

0.35

g/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

333

1.23

0.62

1.0

1.4

0.36

0.43

g/l

0.63

237

Inguinal hernia, bilateral

315

1.24

0.62

1.2

1.3

0.58

0.43

g/l

0.52

221

Aneurysms, operations, SAH

553

1.18

0.62

1.4

0.45

0.39

g/l

0.45

380

1.67

0.61

1.8

1.1

0.24

0.42

g/l

—

Maternal care for known or suspected fetal abnormality and damage

639

0.85

0.61

1.4

0.35

0.36

g/l

0.21

455

Puerperal sepsis

498

1.19

0.61

1.7

1.4

0.38

0.40

g/l

0.18

345

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

199

0.70

0.61

1.3

1.5

0.48

0.37

g/l

—

136

Other fall from one level to another

105

927

1.13

0.61

1.3

0.38

0.40

g/l

0.34

650

HSIL lesion of the cervix uteri, vagina or vulva

888

0.87

0.60

1.4

0.38

g/l

0.02

629

Traction detachment of retina

0.00

0.59

0.0

1.2

—

0.33

—

Epidural haemorrhage

0.00

0.59

0.0

1.4

—

0.42

—

Foreign body entering into or through eye or natural orifice

290

1.24

0.59

1.3

0.38

0.39

g/l

0.11

206

Postpartum haemorrhage due to retained placenta

541

0.83

0.58

1.2

1.3

0.41

0.38

g/l

0.28

376

Femoral hernia

106

1.42

0.57

1.4

1.2

0.40

0.38

g/l

—

Mandibular retrognathia

264

1.25

0.57

1.4

0.36

0.38

g/l

0.17

185

HSIL lesion of the cervix uteri

818

0.87

0.56

1.4

0.41

0.37

g/l

0.30

577

Other and unspecified mental retardation

0.56

1.0

1.4

0.52

0.35

g/l

—

Congenital malformations of heart and great arteries

541

1.17

0.56

1.4

0.36

0.38

g/l

0.22

391

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.56

1.0

1.2

0.34

0.40

g/l

—

Unspecified abortion

194

1.29

0.56

1.5

1.4

0.32

g/l

0.00

135

Retinal breaks without detachment

550

1.17

0.55

1.8

1.3

0.33

0.40

g/l

0.90

384

Open wound of head

239

2182

1.08

0.55

1.5

1.3

0.38

0.41

g/l

0.93

156

1495

Intrahepatic Cholestasis of Pregnancy (ICP)

284

1.24

0.55

1.1

1.4

0.35

0.37

g/l

0.12

200

Car occupant injured in other and unspecified transport accidents

775

1.14

0.55

1.6

1.4

0.36

0.40

g/l

0.43

535

Foreign body on external eye

560

1.16

0.55

1.2

1.3

0.35

0.40

g/l

0.92

377

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

348

1.21

0.55

1.2

1.4

0.36

0.39

g/l

0.20

236

Abnormal findings in secretions and smears from cervix uteri vagina vulva

245

1786

1.08

0.54

1.4

0.37

0.40

g/l

0.56

175

1286

Xerosis cutis

1.59

0.54

1.3

1.2

0.31

0.40

g/l

—

Maternal care for known or suspected malpresentation of fetus

632

0.87

0.54

1.4

0.39

0.36

g/l

0.30

455

Other blood glucose lowering drugs, excl. Insulins

543

1.16

0.53

1.2

1.4

0.45

0.40

g/l

0.35

376

Superficial injury of shoulder and upper arm

386

1.19

0.53

1.7

1.3

0.49

0.39

g/l

1.15

270

Polyhydramnios

169

1.31

0.53

1.4

0.43

0.37

g/l

0.21

114

Benign neoplasm: Skin of other and unspecified parts of face

322

1.21

0.53

1.5

1.3

0.45

0.40

g/l

0.26

225

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

204

0.73

0.53

1.3

1.4

0.59

0.37

g/l

—

148

Medical treatment for female infertility

106

946

1.12

0.52

1.3

1.4

0.32

0.37

g/l

1.55

663

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.62

0.52

1.3

1.4

0.35

0.38

g/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.61

0.52

1.3

1.4

0.35

0.39

g/l

—

Other abnormal products of conception

170

1037

1.09

0.52

1.4

0.42

0.36

g/l

1.63

117

749

Scissor bite

134

0.67

0.52

1.1

1.5

0.30

0.37

g/l

—

108

Alcohol dependence

118

1065

1.11

0.51

1.2

1.4

0.38

0.41

g/l

0.64

742

Graves ophthalmopathy

1.47

0.51

1.3

1.4

0.46

0.34

g/l

0.91

Intermittent heterotropia

233

1.25

0.51

1.4

0.46

0.37

g/l

0.50

164

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

324

1.21

0.50

1.4

0.33

0.36

g/l

0.26

224

Other disorders of amniotic fluid and membranes

612

0.86

0.50

1.8

1.4

0.38

0.36

g/l

0.28

435

Benign leiomyoma with endometriosis

565

1.15

0.50

1.2

1.4

0.39

g/l

0.01

382

Coronary artery bypass grafting

601

1.13

0.50

1.5

1.4

0.46

0.44

g/l

0.14

406

Redundant prepuce, phimosis and paraphimosis

816

1.12

0.50

1.2

1.4

0.35

0.41

g/l

1.56

543

Foreign body or object entering through skin

216

1.25

0.49

1.4

1.3

0.41

0.35

g/l

0.33

151

Injury of muscle and tendon at lower leg level

557

1.15

0.49

2.0

1.3

0.40

0.41

g/l

0.18

381

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

0.48

0.40

g/l

—

Leiomyoma of uterus

316

1689

1.06

0.49

1.4

0.39

g/l

0.06

217

1215

Malignant neoplasm of head and neck

217

1.25

0.47

1.2

1.3

0.36

0.41

g/l

0.56

150

Postpartum care and examination

427

0.87

0.47

1.3

1.4

0.36

0.34

g/l

0.27

303

Postpartum haemorrhage due to anatomy

430

0.84

0.47

1.1

1.3

0.40

0.37

g/l

0.28

298

Generalized epilepsy

155

1.29

0.46

1.4

1.3

0.35

0.40

g/l

0.37

110

Complications following abortion and ectopic and molar pregnancy

111

1.36

0.46

1.1

1.6

0.37

g/l

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

299

1.20

0.46

1.5

1.4

0.37

0.46

g/l

0.84

219

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

291

1.21

0.46

1.1

1.4

0.35

0.37

g/l

0.15

201

Bulimia nervosa (incl. atypical)

120

1.34

0.46

1.3

1.4

0.29

0.37

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

683

1.13

0.46

1.3

1.4

0.40

g/l

0.01

487

Manic episode

1.43

0.45

1.4

1.3

0.23

0.34

g/l

—

Focal epilepsy

816

1.12

0.45

1.3

0.39

0.40

g/l

0.01

577

Malignant neoplasm of kidney, except renal pelvis

228

1.23

0.45

1.0

1.3

0.38

0.44

g/l

0.37

162

All dysplastic lesions of the cervix uteri

125

1139

1.10

0.45

1.3

1.4

0.39

0.37

g/l

0.22

814

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

293

1.20

0.43

1.2

1.3

0.37

0.40

g/l

0.39

205

Diabetic retinopathy, strict definition

586

1.13

0.43

1.4

0.43

0.42

g/l

0.07

392

Kela-code for severe mental illness

156

1684

0.93

0.42

1.2

1.4

0.41

0.39

g/l

0.21

106

1148

Parodontitis, under 40 years

378

1.17

0.42

1.2

1.4

0.41

0.38

g/l

0.15

263

Parodontitis, under 40 years, or operation codes

378

1.17

0.42

1.2

1.4

0.41

0.38

g/l

0.15

263

Malignant melanoma

453

1.15

0.41

1.3

0.74

0.41

g/l

0.51

316

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

0.77

0.41

1.3

1.5

0.59

0.36

g/l

—

132

Frostbite

1.52

0.41

1.4

0.34

0.31

g/l

—

Pedal cyclist injured in noncollision transport accidents

434

0.85

0.41

1.5

1.3

0.39

0.37

g/l

0.13

297

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.41

0.0

1.4

—

0.33

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

114

1.32

0.40

1.4

1.3

0.32

0.37

g/l

—

Antenatal screening

104

644

0.91

0.40

1.2

1.4

0.33

0.37

g/l

0.82

463

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.1

—

0.38

—

Pedal cyclist injured in transport accident

929

0.90

0.39

1.5

1.3

0.39

0.40

g/l

0.12

650

Pre-eclampsia

873

1.10

0.39

1.5

1.4

0.42

0.38

g/l

0.47

606

0.00

0.39

0.0

1.1

—

0.33

—

Noise effects on inner ear

124

1.29

0.38

1.2

1.3

0.35

0.41

g/l

0.37

Wide developmental disorders

142

1.27

0.38

1.3

0.26

0.37

g/l

2.09

105

Acute and transient psychotic disorders

484

0.87

0.38

1.1

1.4

0.34

0.39

g/l

0.85

333

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

261

1.19

0.38

1.1

1.5

0.52

0.38

g/l

0.47

182

Multiple gestation

392

1.15

0.37

1.4

1.3

0.40

0.34

g/l

0.70

272

Colorectal cancer, excluding all cancers (controls excluding all cancers)

834

0.90

0.37

1.2

1.4

0.44

0.42

g/l

0.13

578

Open bite

216

1.21

0.37

1.2

1.4

0.40

0.39

g/l

0.05

153

Dental caries 3 and operation codes, only avohilmo

181

971

0.94

0.36

1.4

0.35

0.41

g/l

1.56

120

704

Polycystic ovarian syndrome, broad definition

450

1.13

0.36

1.5

1.4

0.33

0.37

g/l

0.86

321

Follow-up examination after treatment for malignant neoplasms

217

1.20

0.35

1.2

1.3

0.35

0.43

g/l

0.53

127

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.40

0.35

1.0

1.4

0.23

0.32

g/l

—

Malignant neoplasm of urinary organs

245

1.19

0.35

1.0

1.3

0.41

0.44

g/l

0.18

177

Unspecified lump in breast

584

1.11

0.35

1.6

1.4

0.34

0.40

g/l

1.07

405

Type 1 diabetes, strict (exclude DM2)

460

1.13

0.34

1.2

1.4

0.42

0.37

g/l

0.45

332

Single delivery by forceps and vacuum extractor

459

0.90

0.34

1.2

1.4

0.40

0.34

g/l

0.88

347

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.34

0.34

1.2

1.3

0.48

0.31

g/l

—

Assault by bodily force

302

1.16

0.34

1.2

1.3

0.45

0.34

g/l

1.27

208

Focal epilepsy, strict definition

738

1.10

0.34

1.3

0.40

g/l

0.07

527

Colorectal adenocarcinoma

573

0.89

0.33

1.3

0.37

0.44

g/l

0.78

403

Maternal care related to the fetus and amniotic cavity and possible delivery problems

236

1317

1.06

0.33

1.4

0.37

0.39

g/l

0.40

175

951

Type 1 diabetes, definitions combined

462

1.12

0.32

1.2

1.3

0.42

0.37

g/l

0.45

335

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.28

0.32

1.0

1.3

0.23

0.36

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

426

1.13

0.32

1.3

0.34

0.37

g/l

0.19

301

Twin gestation

379

1.14

0.32

1.4

1.3

0.39

0.34

g/l

0.65

261

Pedestrian injured in collision with pedal cycle

1.33

0.32

1.2

1.3

0.34

0.36

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

980

0.92

0.32

1.3

1.4

0.45

0.35

g/l

2.07

704

Malignant melanoma, excluding all cancers (controls excluding all cancers)

550

1.11

0.32

1.3

1.4

0.68

0.41

g/l

0.47

387

Malignant neoplasm of skin

247

1769

1.05

0.31

1.5

1.4

0.45

0.43

g/l

0.11

173

1220

Deep bite

423

1.12

0.31

1.3

1.4

0.33

0.38

g/l

0.96

307

Labour and delivery complicated by fetal stress [distress]

123

764

1.07

0.31

1.2

1.4

0.40

0.34

g/l

1.47

549

Viral hepatitis

268

1.16

0.30

1.1

1.3

0.45

0.37

g/l

0.54

186

Carcinoma in situ of cervix uteri

346

0.87

0.29

1.5

1.4

0.42

0.38

g/l

0.16

236

Transient global amnesia

260

0.85

0.29

2.5

1.4

0.57

0.45

g/l

0.18

177

Non-small cell lung cancer, adenocarcinoma

140

1.22

0.27

1.1

1.2

0.46

0.41

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

140

1.22

0.27

1.1

1.2

0.46

0.41

g/l

—

Burn and corrosion of head and neck

1.23

0.27

1.3

0.46

0.37

g/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

113

1.24

0.26

1.0

1.3

0.44

0.41

g/l

—

Clear cell adenocarcinoma of kidney

113

1.24

0.26

1.0

1.3

0.44

0.42

g/l

—

Colorectal cancer

708

0.92

0.26

1.2

1.4

0.44

0.43

g/l

0.07

502

Nontraumatic intracranial haemmorrhage

596

1.09

0.26

1.3

1.4

0.46

0.42

g/l

0.30

414

Postpartum hemorraghe, all women as controls

109

1157

0.94

0.26

1.2

1.4

0.42

0.37

g/l

0.79

825

Otosclerosis

244

1.15

0.25

1.0

1.5

0.48

0.39

g/l

0.83

171

Macular hole

127

0.79

0.25

1.1

1.5

0.37

0.40

g/l

—

Benign neoplasm of other and unspecified female genital organs

123

1.22

0.25

1.5

1.7

0.28

0.35

g/l

—

Other disorders of penis

339

1.12

0.25

1.6

1.3

0.39

0.44

g/l

0.36

243

416

1.11

0.24

1.2

1.4

0.37

g/l

0.05

285

Sulfonylureas

110

934

0.94

0.24

1.1

1.4

0.41

0.43

g/l

0.25

637

Postpartum haemorrhage

109

1009

0.94

0.24

1.2

1.4

0.42

0.35

g/l

1.39

727

Other and unspecified injuries of head

170

1.18

0.24

1.3

0.33

0.42

g/l

0.97

115

Burn and corrosion of trunk

1.27

0.24

1.3

0.35

0.40

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

503

1.09

0.24

1.2

1.3

0.38

0.41

g/l

0.28

354

Benign neoplasm of breast

444

0.90

0.24

1.3

1.4

0.31

0.40

g/l

1.55

313

Diabetes mellitus in pregnancy

163

1005

1.05

0.24

1.2

1.4

0.35

0.37

g/l

0.63

117

728

Supervision of high-risk pregnancy

107

607

1.07

0.24

1.4

0.35

0.37

g/l

0.29

439

Pre-eclampsia or eclampsia

101

948

1.07

0.24

1.5

1.4

0.40

0.38

g/l

0.30

660

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

254

0.87

0.23

1.4

1.3

0.29

0.41

g/l

1.42

178

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

504

1.09

0.23

1.2

1.3

0.38

0.40

g/l

0.11

358

Abnormalities of forces of labour

464

0.90

0.23

1.3

1.4

0.32

0.34

g/l

0.22

327

Carcinoma in situ of cervix uteri

338

0.89

0.23

1.5

1.4

0.42

0.38

g/l

0.15

231

malignant neoplasm of female genital organs

474

0.91

0.23

1.2

1.5

0.54

0.38

g/l

0.74

320

Memory loss

237

1.14

0.23

1.2

1.4

0.57

0.43

g/l

0.28

163

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

264

0.87

0.23

1.3

1.4

0.29

0.42

g/l

1.76

188

Other specified disorders of external ear

1.24

0.23

1.8

1.3

0.31

0.45

g/l

—

Left ventricular outflow tract obstruction, narrow definition

181

1.16

0.22

1.5

1.3

0.29

0.39

g/l

0.98

127

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

556

0.92

0.22

1.3

1.4

0.37

0.44

g/l

0.81

391

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

462

0.91

0.22

1.4

0.71

0.41

g/l

0.40

328

Complications of labour and delivery

320

1726

1.03

0.22

1.3

1.4

0.42

0.37

g/l

1.39

221

1221

Other viral hepatitis

229

1.14

0.21

1.1

1.3

0.48

0.36

g/l

0.69

157

HSIL lesion of the vagina

1.19

0.21

1.4

0.65

0.29

g/l

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.21

0.0

1.1

—

0.51

—

Dental caries 2 and operation codes, only avohilmo

411

2480

1.03

0.21

1.4

0.41

0.38

g/l

0.92

315

1700

Type 1 diabetes, strict definition, subgroup 1

343

1.11

0.21

1.3

0.34

0.36

g/l

0.18

259

Convergent concomitant strabismus

239

1.13

0.21

1.5

1.4

0.43

0.37

g/l

0.33

169

Ectopic pregnancy

750

1.07

0.21

1.4

0.40

0.36

g/l

0.28

531

Poor fetal growth

566

1.08

0.20

1.2

1.4

0.39

0.35

g/l

0.51

400

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

145

1.17

0.20

1.1

1.4

0.46

0.40

g/l

—

102

Other and/or unspecified nontoxic goitre

261

0.88

0.20

3.3

1.3

0.31

0.41

g/l

1.26

179

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.18

0.19

1.2

1.3

0.31

0.38

g/l

—

Malignant neoplasm of ovary

122

0.82

0.19

1.4

1.6

0.41

0.37

g/l

—

Placenta praevia

184

1.14

0.19

1.3

1.4

0.37

0.35

g/l

0.12

125

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

725

0.94

0.18

1.2

1.4

0.45

0.42

g/l

0.22

513

Family history of malignant neoplasm

386

1.09

0.18

1.2

1.4

0.28

0.39

g/l

2.13

276

Alcohol withdrawal state with delirium

223

1.12

0.18

1.1

1.2

0.44

0.41

g/l

0.16

155

Renal cell carcinoma of kidney

0.72

0.17

1.0

1.2

0.42

0.44

g/l

—

Abnormal spermatozoa

359

1.09

0.16

1.2

1.3

0.42

0.45

g/l

0.14

255

Chronic viral hepatitis

194

0.88

0.16

1.1

1.3

0.54

0.37

g/l

0.74

133

Retinal detachment with retinal break

402

0.92

0.16

1.6

1.4

0.29

0.41

g/l

1.65

287

Myocardial infarction, unclassifiable

515

0.93

0.16

1.3

0.43

0.47

g/l

0.39

365

Malignant neoplasm of rectum

246

0.89

0.16

1.4

1.3

0.34

0.41

g/l

0.56

172

Struck by thrown, projected or falling objec

158

1.14

0.16

1.3

0.38

0.37

g/l

—

107

Other complications of labour and delivery, not elsewhere classified

470

1.07

0.14

1.1

1.4

0.45

0.35

g/l

1.46

336

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.83

0.14

1.4

1.3

0.25

0.37

g/l

—

Lesion of plantar nerve

189

1.11

0.13

2.2

1.4

0.43

0.39

g/l

0.25

133

Adenocarcinoma and papilloma adenocarcinoma of rectum

242

0.91

0.13

1.4

1.3

0.29

0.42

g/l

1.44

171

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

252

0.91

0.12

1.3

1.4

0.29

0.42

g/l

1.72

178

Single delivery by caesarean section

100

556

1.04

0.12

1.4

0.38

0.35

g/l

0.55

424

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

143

1.12

0.11

1.4

1.3

0.36

0.37

g/l

—

104

Pedal cyclist injured in collision with motor vehicle

1.16

0.11

2.0

1.3

0.33

0.38

g/l

—

Other obstructed labour

299

1.07

0.10

1.2

1.4

0.30

0.35

g/l

0.67

207

Malignant melanoma of skin

321

0.93

0.10

1.4

0.85

0.41

g/l

0.44

228

Acute appendicitis, with complications

759

0.96

0.10

1.4

1.3

0.57

0.41

g/l

0.38

535

HSIL lesion of the vulva

1.14

0.10

1.2

1.3

0.21

0.33

g/l

—

Abnormal findings on antenatal screening of mother

351

0.94

0.10

1.5

0.36

0.38

g/l

0.15

252

Dislocation, sprain and strain of joints and ligaments of elbow

232

1.08

0.09

2.0

1.4

0.46

0.37

g/l

0.59

166

Benign neoplasm of breast

422

0.95

0.09

1.3

1.5

0.31

0.40

g/l

1.48

297

Malignant neoplasm of corpus uteri

213

1.08

0.09

1.1

1.4

0.62

0.40

g/l

0.61

150

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

552

0.96

0.08

1.2

1.4

0.48

0.44

g/l

0.26

384

Congenital malformations of aortic and mitral valves

146

1.10

0.08

1.4

1.3

0.31

0.39

g/l

0.56

101

Spermatocele

224

1.07

0.08

1.5

1.3

0.43

0.49

g/l

0.36

152

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.77

0.08

1.0

1.2

0.42

0.39

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

156

1.09

0.08

1.1

1.3

0.42

0.37

g/l

0.25

110

Other disorders of prostate

1.05

0.08

1.6

1.2

0.38

0.50

g/l

—

Burns and corrosions of external body surface, specified by site

421

1.05

0.07

1.6

1.3

0.43

0.39

g/l

0.33

293

Use of disulfiram, acamprosate or naltrexone

343

1.05

0.07

1.4

1.3

0.32

0.36

g/l

0.79

231

Gestational diabetes (for exclusion)

176

1267

0.98

0.07

1.2

1.4

0.38

0.37

g/l

0.25

129

914

Failed induction of labour

216

1.07

0.06

1.3

1.4

0.32

0.36

g/l

0.35

149

Benign neoplasm of other and unspecified female genital organs

138

1.09

0.06

1.5

1.6

0.28

0.37

g/l

—

Antepartum haemorrhage, not elsewhere classified

386

0.96

0.06

1.3

0.36

0.34

g/l

0.17

273

Uterine polyps

335

0.95

0.06

1.4

0.29

0.38

g/l

1.05

236

Subarachnoid haemorrhage

294

0.95

0.06

1.4

0.50

0.38

g/l

0.42

207

Multiple delivery

365

1.04

0.06

1.4

1.3

0.39

0.35

g/l

0.50

279

Unspecified mental disorder

194

1914

1.01

0.05

1.2

1.4

0.38

0.39

g/l

0.14

136

1315

Crowding of teeth, including avohilmo

334

0.96

0.05

1.3

1.4

0.43

0.35

g/l

0.87

236

Fall on and from ladder

228

1.05

0.05

1.4

1.2

0.48

0.41

g/l

0.42

161

severe traumatic brain injury, does not include concussion

703

1.02

0.05

1.5

1.3

0.47

0.43

g/l

0.35

492

Fracture of forearm

249

2353

0.99

0.04

1.3

1.4

0.40

0.39

g/l

0.16

176

1629

Traumatic amputation of wrist and hand

119

0.92

0.04

1.5

1.3

0.20

0.45

g/l

—

Postpartum hemorraghe, parous women as controls

109

966

0.99

0.03

1.2

1.3

0.42

0.38

g/l

0.57

682

Colon adenocarcinoma

282

1.03

0.02

1.2

1.3

0.44

0.42

g/l

0.10

200

Contact with sharp glass

127

0.94

0.01

1.2

1.3

0.39

0.37

g/l

—

Maternal care for known or suspected abnormality of pelvic organs

116

794

1.01

0.01

1.3

1.4

0.37

g/l

0.04

573

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

297

0.98

0.01

1.2

1.4

0.44

0.43

g/l

0.04

211

Divergent concomitant strabismus

283

1.02

0.01

1.7

1.4

0.43

0.37

g/l

0.24

193

Orchitis and epididymitis

293

1.02

0.01

1.3

0.45

0.44

g/l

0.03

201

Pedal cyclist injured in other and unspecified transport accidents

403

1.02

0.01

1.3

0.37

0.39

g/l

0.10

278

Type1 diabetes, definitions combined, early onset

322

1.02

0.01

1.3

0.37

g/l

0.02

233

Type 1 diabetes, strict definition

393

1.02

0.00

1.3

0.36

0.37

g/l

0.05

287

Malignant neoplasm of colon

391

1.00

0.00

1.1

1.3

0.54

0.42

g/l

0.57

276

Combinations of oral blood glucose lowering drugs

103

1034

1.00

0.00

1.3

1.4

0.42

g/l

0.01

710

Thyrotoxicosis with toxic multinodular goitre

151

0.99

0.00

2.0

1.5

0.37

0.41

g/l

—

108

Schizophrenia or delusion, excluding more controls

120

1192

1.00

0.00

1.2

1.4

0.40

g/l

0.01

793

Other sexually transmitted chlamydial diseases

251

1.00

0.00

1.3

1.4

0.45

0.38

g/l

0.46

164

Retained placenta and membranes, without haemorrhage

495

1.01

0.00

1.3

1.4

0.33

0.35

g/l

0.25

341

Burns and corrosions

564

0.99

0.00

1.5

1.3

0.41

0.38

g/l

0.26

388

Maternal care for cervical incompetence

119

1.01

0.00

1.3

1.5

0.41

0.35

g/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

590

1.00

0.00

1.2

1.5

0.55

0.41

g/l

0.82

408

Rubella [German measles]

123

0.98

0.00

2.5

1.3

0.29

0.37

g/l

—

Liveborn infants according to place of birth

0.94

0.00

1.0

1.2

0.27

0.36

g/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

1.2

—

0.54

—

Hirsprung

0.00

0.0

1.0

—

0.48

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.0

1.0

—

0.43

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.97

0.00

1.2

0.20

0.39

g/l

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.3

—

0.42

—

Burns and corrosions of multiple and unspecified body regions

0.99

0.00

1.0

1.3

0.47

0.36

g/l

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.4

—

0.24

—

Exposure to other and unspecified man-made environmental factors

1.02

0.00

1.0

1.3

0.37

0.33

g/l

—

Malignant neoplasm of testis

1.02

0.00

1.2

1.4

0.34

0.41

g/l

—

Birth injury to skeleton

0.00

0.0

1.5

—

0.32

—

Acne varioliformis

0.00

0.0

1.0

—

0.49

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.2

—

0.30

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 3 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS